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ABSTRACT 
An investigation into the conformational stability of the small globular protein 
ubiquitin (Ub) is described. Solid phase peptide synthesis has been successfully 
applied to the construction of both mammalian ubiquitin, as well as to a ubiquitin 
analogue (Ubdes-Core) lacking the protein's pronounced hydrophobic core. In each 
case the synthetic protein was purified to homogeneity using a combination of gel 
filtration, dialysis and ion exchange chromatography. Synthetic ubiquitin was 
found to be fully active in a ubiquitin specific in vitro protein conjugation assay, 
whereas Ubdes-Core was found to be completely inactive. The structure of these 
two proteins has been studied in some detail. Synthetic ubiquitin possesses an 
identical crystal and NMR derived solution structure to its natural counterpart. 
Removal of the hydrophobic core from ubiquitin results in a substantial loss in 
conformational stability (3.7 kcal mol 1 ) and consequently Ubdes-Core is unable to 
adopt the ubiquitin native fold. This leads to the conclusion that hydrogen bonding 
contributions are not in themselves sufficient to stabilize the native conformation of 
ubiquitin. 
The preparation of a 128 residue precursor protein comprising ubiquitin fused to a 
C-terminal extension protein (CEP52) is presented along with the CEP52 fragment 
alone. The compounds were prepared by solid phase peptide synthesis and purified 
using a combination of gel filtration, ion exchange and HPLC. Two-dimensional 
NMR analysis of the UbCEP52 precursor revealed, significantly, that it possesses 
no well defined tertiary structure. However, the protein was found to be processed 
in vitro to mature ubiquitin and CEP52. A possible novel function of ubiquitin in 
unfolded C-terminally fused conjugates is suggested. 
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Chapter 1 - Introduction 
The study of biological systems at a molecular level enables us to appreciate the 
complex and fascinating mechanisms fundamental to life itself. Increasingly 
though, our ability to make sense out of what at times appears impossibly 
complicated and inaccessible, relies heavily upon the use of primary metabolite 
probes which help to resolve this complex area of study. 
In the last decade or so there have been substantial and indeed extremely innovative 
advances in the field of molecular biology. These have provided researchers with 
the tools to more efficiently study many aspects of the discipline. Recombinant 
DNA technology, probably the single most important development, is to a great 
extent responsible for the wealth of data and understanding which have been 
accumulated over this relatively brief period of time. However, this powerful 
technique does have its shortcomings. For example, by and large researchers are 
limited to using the 20 naturally ocurring amino acids, although it is now possible 
in certain cases to incorporate unnatural amino acids in moderate yields 1 . Naturally 
occurring amino acids bearing isotopic labels cannot be site mutated into proteins 
via recombinant technology, since there is no method of distinguishing the codon at 
the mutation site from the codons for other amino acids of that type in the protein. 
Recent advances in the field of solid phase peptide chemistry have made it possible 
to artificially synthesise small proteins. For example, HIV-1 protease ( 99 amino 
acids ) has been successfully constructed and subsequently crystallized, yielding 
considerable information on the mode of action of the enzyme 2  The range of 
unnatural and labelled amino acids that can be incorporated into proteins via 
chemical synthesis is limited only by our imaginations, although is sometimes 
hindered by the lack of availability of the required amino acid. Chemical synthesis 
can in addition afford precursor proteins which normally would be processed in 
vivo. Finally, it is possible to obtain relatively large amounts of synthetic proteins, 
which allows for detailed structural analysis. 
In our work we have chosen to study the small globular protein ubiquitin (Ub). 
This highly conserved polypeptide has a primary sequence of 76 amino acids and is 
thus of an ideal size for establishing methods of routine and efficient synthesis. The 
tertiary structure of this protein is well understood in both crystal 3  and solution 
inirouucuon 
phases 45,  therefore making it easier to authenticate the conformation of a 
synthetic ubiquitin with that of the natural material. Ubiquitin is a good model for 
the study of protein structure and folding, since its tertiary structure contains many 
of the secondary structural units commonly found within globular proteins, whilst 
being small enough to facilitate a comprehensive study of folding intermediates. 
Our aims were initially to synthesise ubiquitin in a biologically active form and 
thereafter to synthesise analogues of ubiquitin by the insertion of unnatural and 
specifically labelled amino acids which would allow investigation into the folding 
mechanism of the protein. 
Section 1.1 Ubiquitin Biology 
Ubiquitin is a highly conserved ( 76 amino acids, 8565 Da) protein found in all 
eukaryotes 6  both as the free protein and covalently attached to other proteins. It 
was first discovered in 1975 by Gideon Goldstein 7,  who isolated it as a protein 
capable of inducing -lymphocyte differentiation. 
The extraordinary conservation of ubiquitin throughout eukaryotes (see figure 1.1) 
points to a fundamental involvement in cellular functions and indeed since its 
discovery it has been associated with an astonishing array of biological processes, 
many of which will subsequently be discussed. 
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Figure 1.1 	Primary Sequence of Ubiquitin in Plant and Animal. 
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1.1.1 The Ubiquitin Gene 
There have been a number of ubiquitin encoding genes isolated from a variety of 
organisms. Analysis of these data reveals that ubiquitin genes can be divided into 
two discrete categories, namely those which encode polyubiquitin precursors and 
those which encode ubiquitin fused to C-terminal extension proteins ( CEPs  ) 
bearing no resemblance to ubiquitin. 
A series of genes has been identified in man 8,  chicken  9,  yeast  10,  xenopus 
laevis' 1 and plant cells 12,  all of which encode a sequential pattern of ubiquitin 
units connected in a head to tail manner with no internal spacer elements. In each 
case the C-terminus of the gene codes for a single extra amino acid followed by a 
stop codon. The number of ubiquitin repeats varies according to source as indeed 
does the type of amino acid at the C-terminal ( see figure 1.2). 
1 	76 	1 	76 	1 	76 
Met-Gly-(Met-Gly)- Met- G1y-X 
X = Val - human, n =9 or 3 
X=Asn - yeast, n=5 
X=Tyr - chicken, n=5 
Figure 1.2 Polyubiquitin Genes 
Proteolytic cleavage at the Gly-Met and Gly-X junctions would be required to 
liberate mature ubiquitin from the precursor. The ubiquitin carboxy-terminal 
amidases responsible for these hydrolyses have been isolated from bovine calf 
thymus 13,  but are yet to be fully characterized. Exactly how quickly after 
translation this processing occurs is as yet unknown, however the single amino acid 
extension presumably acts to prevent the precursor undergoing reactions at its C-
terminus ( part of mature ubiquitin's mode of action ). This would imply that the 
unprocessed material was relatively long lived. Polyubiquitin precursors may well 




The second category of ubiquitin gene which has been identified encodes for 
ubiquitin fused through the C-terminus to a highly basic extension protein ( so 
called CEPs ). These extension segments, isolated from human 14,15  dictyostelium 
16 and yeast 17  genomes, can be either 52 or 76-80 amino acids in length and 
indeed are highly conserved ( 80% ) between these organisms. Unlike the 
polyubiquitin case, the lifetime of these precursors is thought to be relatively short. 
In fact, it has been proposed that the processing may even occur co-
translationally 18. The biology of UbCEPs will be discussed in some detail in a later 
section. 
1.1.2 Ubiquitin and Chromatin Structure 
The earliest role of ubiquitin to be identified was an involvement in chromatin 
structure. Sequencing of the nuclear protein, A24, by Busch and Goldnopf had 
revealed the existence of a branched structure in which ubiquitin was a 
component 19. Subsequent work by Hunt and Dayhoff established that this 
branched structure involved the conjugation of the C-terminal glycine of ubiquitin 
to the c-amino group of lysine- 119 of histone-2A 20  It has since been shown that 
ubiquitin forms conjugates with histone-2B 21  (uH2B ) and with all subtypes of 
histone-2A 22,23  (uH2A , see figure 1.3). 
G76 
—L-P-K-I-T-E-S— 	 uH2A 
119 
? 76 
—A-V-T-K-Y-T-S— 	 uH2B 
120 
Figure 1.3 Branching Region in uH2A & uH2B 
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Histones are nuclear proteins which contain a large proportion of positively charged 
lysine and arginine residues, obviously allowing the protein to complex with the 
negatively charged phosphate backbone of DNA. The four types of histone 
involved in chromatin structure form an octamerous aggregation around which the 
DNA diploid is wound forming a negatively coiled superhelix. Up to 10% of 
histone-2A24 and 1.5% of histone-2B 21 can be ubiquitinated within the resulting 
nucleosome. 
Histories 2A and 2B have been shown to be polyubiquitinated (pu) in trout livers 25 , 
and the structure of puH2A has been studied in detail using residue specific 
proteolysis 26  Peptide mapping of the resulting digest points to individual 
ubiquitin molecules being joined to one another via isopeptide bonds between the 
C-terminal glycine of one ubiquitin and an F--amino lysine group of the next 
ubiquitin. Ultimately the polyubiquitin unit is again attached to the histone through 
lysine- 119. 
Ubiquitination of histories was initially thought to have a direct role on gene 
regulation. Early results indicated that actively transcribing avian erythrocytes had 
a much higher level of uH2A than the corresponding transcriptionally inactive 
chicken erythrocytes 27  Other studies have similarly suggested that ubiquitination 
of histones is in some way associated with increased transcription within the 
nucleus 28,29,30  However, it is significant that inhibition of transcription in HeLa 
cells is not accompanied by a short-term fall in u}{2A levels 31 It seems more 
likely that the ubiquitination of histones is implicated in overall chromatin 
structure, and that its apparent involvement in transcription is actually a 
consequence of the association of DNA binding proteins with the nucleosome, 
leading to a change in that structure. Levels of uH2A do not remain constant 
throughout the cell cycle. In fact, there are conspicuous fluctuations which tend to 
reinforce the proposed involvement in chromatin structure. Studies have shown 32 
that the amount of uH2A in the nucleus falls to a minimum just before metaphase, 
thereafter returning to normal levels by the GI stage in the cell cycle ( see figure 
1.4). These results imply a role in cell mitosis and indeed it has been suggested that 
















Figure 1.4 	Variation of uH2A levels during the Cell Cycle 
Recently it has been reported 33  that cyclin, a regulatory protein whose proteolysis 
precedes exit from cell mitosis, is ubiquitinated before being degraded via the 
ubiquitin degradation pathway (see section 1. 1.5 
). It may therefore be the case that 
ubiquitin is involved in both the entrance to and exit from cell mitosis. As yet it is 
unknown what, if any, conformational changes occur upon ubiquitination of a 
histone, and it is also unclear why some histones are polyubiquitinated and not 
others. However, it is clear that the involvement of ubiquitin in chromatin is an 
important variable in the cell cycle, and therefore of some significance. 
1.1.3 Ubiquitin and Cell Surface Structures 
The functions of ubiquitin are not restricted to the intracellular worlds of the 
cytoplasm and nucleus but are known to extend to various cell surface structures. 
The first identified example of such a system, the lymphocyte homing receptor, was 
found to be ubiquitinated by Weissman and co-workers 3435.  Lymphatic organs 
such as the thymus, lymph nodes and spleen are constantly fuelled with mature 
lymphocytes in a process known as homing. Entry of the correct type of 
lymphocyte into the organ, through blood vessels called high endothelial venules 
(HEV 's), is controlled by specific lymphocyte homing receptors. Weissman and 
co-workers used a monoclonal antibody ( Mel-14  ) in order to study the murine 
Inu-ouucuon 
receptor. This antibody, specific for peripheral lymph nodes, was used to locate the 
gene coding for the homing receptor on these organs. Cloning of this gene was 
followed by purification of the Mel-14 reactive antigen by immunoprecipitation. 
Analysis of this glycoprotein revealed the existence of two N-termini, one of which 
corresponded to that of ubiquitin. Subsequent analysis with monoclonal antibodies 
raised to ubiquitin, have confirmed that the 90 kDa cell surface protein is 
ubiquitinated. It is interesting that while Mel- 14 has its epitope in the C-terminal 
region of ubiquitin,- it appears not to recognize this protein when it is not 
conjugated to the rest of the receptor. This implies that ubiquitin undergoes a 
conformational change upon conjugation. Little is known about the number of 
ubiquitin molecules covalently attached to the receptor, however, ubiquitination is 
thought to occur fairly early on in the receptors biosynthesis 36,  and in a manner 
similar to that of histones. It seems equally unclear why these receptors are 
ubiquitinated, although it is possible that this has implications for the structure of 
the receptor. 
Two receptors involved in cell replication are believed to be ubiquitinated. 
Sequencing of the receptors specific for platelet-derived growth factor 37  and 
somatotropin 38  has, in each case, revealed the existence of two N-terminal 
sequences, one of which was identified as that of ubiquitin. It is not known whether 
ubiquitin is attached to the extracellular domain or the intracellular domain of these 
receptors. The role played by ubiquitin in these membrane bound proteins is 
equally unclear, however, two different functions have been proposed. Firstly, 
ubiquitination may be the signal for proteolysis of these relatively short-lived 
receptors ( see later for ubiquitin dependant proteolysis). Clearly the proliferation 
of these receptors would have to be carefully regulated in order to prevent 
malignant cellular growth. It has also been proposed that receptor 
ubiquitination/de-ubiquitination is involved in signal transduction in a manner 
analogous to that of kinase activity. 
A novel autocrine growth factor, involved in myeloma and lymphoid cell growth, 
may be a ubiquitin-protein conjugate 39.  Initial studies have shown that the N-
terminal sequence of leukemia derived growth factor corresponds to that of 
ubiquitin. Although virtually nothing is known about this growth factor, the 
possibility that its membrane bound receptor also has a ubiquitin component does 
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reinforce the suggestion that ubiquitin has a regulatory role within the autocrine 
system. 
1.1.4 Ubiquitin and Neural and Muscular Degeneration 
Alzheimer's disease, the principle cause of dementia in aged humans, is 
characterized by the progressive formation of cytoplasmic neurofibrillary tangles in 
brain tissue 40• 
A monoclonal antibody specific for paired helical filaments, the major constituent 
of these neuronal fibres, was found to recognize ubiquitin 41•  Subsequent studies 
involving proteolytic digestion followed by sequencing of the resulting peptides, 
confirmed that paired helical filaments were ubiquitinated. This initial observation 
was followed by the discovery that ubiquitin specific antibodies recognized the 
neuronal fibres in a variety of other neurodegenerative diseases such as Down's 
syndrome and Creutzfeldt-Jakob disease 42• 
The insolubility of neuronal fibres has resulted in their pathology being poorly 
understood and consequently one can only speculate as to why they are 
ubiquitinated. Ubiquitin, however, is not evenly distributed throughout a neuronal 
fibre, instead being localised within subpopulations. This suggests it is, by in large, 
not involved in the formation of the inclusion body. Instead, it has been proposed 
that it is involved in the cellular proteolytic response to the formation of these 
cytoplasmic tangles 41 
The involvement of ubiquitin in muscular degeneration is far better understood. 
Deterioration of muscle tissue, frequently a non-pathological process, can in some 
cases be accompanied by an increase in polyubiquitin gene translation 43.  This is 
thought to be because degeneration associated proteolysis occurs via the ubiquitin 
pathway. 
1.1.5 Ubiquitin and ATP-Dependant Proteolysis 
The ATP-dependant proteolytic system is easily the most vibrant and indeed best 
understood area of ubiquitin research. There has been quite a wealth of publications 




Turnover of cytoplasmic proteins is extremely important to the continuing vitality 
of a cell, and it is in this area that ubiquitin appears to perform its most 
fundamental role. Early investigations found that ion exchange chromatography 
could resolve murine reticulocyte lysates into two fractions ( I & H ) and that 
separation of these resulted in the loss of the normal proteolytic activity associated 
with the unresolved lysate 46  Ubiquitin was subsequently shown to be the active 
component in fraction 147  and analysis of fraction II has revealed the existence of 
a multi-enzymic conjugation system which mediates the attachment of ubiquitin to 
proteins destined for degradation by protease 48•  As with the nuclear protein uH2A, 
the C-terminal of ubiquitin forms an isopeptide link with the e - group of a lysine 
residue and ultimately a target protein may be multi-ubiquitinated 49. 
1.1.5(1) Mechanism of Ubiquitin Conjugation 
The covalent attachment of ubiquitin to a substrate protein utilises a specific ligase 
system of three distinct enzymes, which together activate the C-terminus of 
ubiquitin in a four step process (see figure 1.5). 
In the first step, the C-terminus of ubiquitin is adenylated 50•  Furthermore, 
studies involving radiolabelled pyrophosphate, released during the reaction, 
indicate this process occurs in the presence of the so called ubiquitin activating 
enzyme ( El). 
The ubiquitin C-terminal adenylate then reacts with a cysteine thiol group on the 
El enzyme, resulting in the formation of a thioester 51 
A transthiolation step involving a second enzyme, ubiquitin carrier protein (E2), 
gives rise to a new thioester linkage capable, in some cases, of transporting 
ubiquitin to a substrate protein 52• 
Actual conjugation of ubiquitin to a protein destined for degradation usually 
requires the presence of a third class of enzyme. Ubiquitin-protein ligase (E3 ) is 





El-SH.Ub-AMP + PP  
El-SH.Ub-AMP 
	
El -S-Ub + AMP 
El-S-Ub + E2-SH 
E3 
A 	 I I I. 
	Protein • 	_ + r- LeIn -,J'-- 
E2-S-Ub + El-SH 
E2-SH + Ub-Protein 
Figure 1.5 Chain of Events in Ubiquitin Protein Conjugation 
1.1.5(u) Enzymology of the Ligase System 
Several forms of El, E2 and E3 have been isolated from a variety of organisms, 
and this has led, along with analysis of the corresponding gene sequences, to 
information being obtained on their structures. 
A ubiquitin affinity column was used to isolate El from murine reticulocyte 
fraction 11 53.  This enzyme, a homodimer with a subunit of 110 kDa, appears to be 
the only form of El in murine reticulocytes. Two apparently different forms of El 
have been been identified in humans 54,55,  however, both are thought to act as 
homoclimers. The inability of many mammalian cells to tolerate specific mutations 
in El suggests the existence of only one form of the enzyme in these 
organisms54'56. A similar argument undeniably points to there being a single El 
gene in yeast 57.  Multiple forms of El have been isolated from wheat germ 58, 
again using a ubiquitin affinity column. Analysis of this heterogeneous mixture of 
El enzymes by SDS and Native-PAGE, indicates they exist as monomers, all 
having a molecular weight of around 120 kDa. 
The isolation of several E2-encoding genes from yeast may help to explain the 
extraordinary selectivity of the ubiquitin-dependant proteolytic system 59.  These 
E2 enzymes differ in their molecular weight and perhaps significantly in their 
requirement for the E3 enzyme in transferring ubiquitin to a substrate protein 60• 
Examination of their gene sequences reveals the existence of a conserved core 
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region of about 150 amino acids (containing the active cysteine ) around which 
there may or may not be a C-terminal extension sequence 59. Three of these genes, 
designated UBC4, UBC5 and UBC7, encode E2 enzymes which require an E3 
enzyme to effect final ubiquitin-protein conjugation. Interestingly, these three 
enzymes consist only of the central conserved region. However, the UBC1, UBC2 ( 
RAD6 ) and UBC6 genes, all of which have various C-terminal extensions, encode 
E2s able to operate independently of the E3 enzyme 59. In these cases, it is not 
unreasonable to suggest that the extensions play a "E3-like" role in recognizing a 
substrate protein, indeed this proposal is supported by the fact that E2s having 
highly acidic C-terminal extensions can readily conjugate ubiquitin to extremely 
basic histones 61 
The UBC2 (RAD6 ) enzyme appears to have a DNA repair function, this is most 
probably connected with its ability to conjugate ubiquitin to histories 61 
Ubiquitination of a histone complexed to damaged DNA may well mark the site for 
binding of repair enzymes or, alternatively, lead to exposure of the damaged DNA 
by targeting the histone for degradation 62  Genetically removing the C-terminal 
tail from RAD6 does not appear to completely eliminate this DNA repair 
function63, perhaps suggesting there are substrate recognition features within the 
remaining core region of the enzyme. 
Two E3 enzymes have, to date, been isolated from rabbit reticulocytes 64,65 and a 
yeast gene (UBR1 ) has recently been identified and cloned 66•  The two murine 
E3s, known as E3a and E3, have different binding affinities towards substrate 
proteins ( see N-end rule 1.1.5(v)). Proteins with bulky hydrophobic or basic 
residues at their N-termini are recognized by Ma, whereas E33 appears to 
recognize small uncharged amino acids 67  At the present time it is not known 
whether a class of E3 enzymes recognizing internal sequences exist. 
The possibility of proteins being incorrectly or unnecessarily ubiquitinated leads to 
a requirement for de-ubiquitination enzymes which would play a role in 
maintaining the integrity of the proteolytic system. However, such a requirement 
will not always be due to errors in the conjugation process; we have already seen 
that the liberation of mature ubiquitin from polyubiquitin and UbCEP precursors is 
carried Out by specifically tailored hydrolases 13,18  Clearly there would also be a 
demand for enzymes with the ability to regenerate ubiquitin from conjugates 
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arising from the reaction of El-Ub or E2-Ub with any one of the numerous cellular 
nucleophiles such as glutathione. De-ubiquitination of isopeptide linked ubiquitin-
protein conjugates is carried out by a third class of enzyme, of which five have 
have been identified 13,68  These isopeptidases, all from mammalian cells, appear 
to have different specificities relating to the particular cell type to which they 
belong. 
1.1.5(iii) ATP-Dependant Protease of the Ubiquitin System 
While a great deal is known about how ubiquitin becomes attached to a substrate 
protein, relatively little information is available on the subsequent mode of 
degradation of that protein. 
Initial observations noted that the digestion required both ATP and Mg 2 ions 69• 
Subsequent use of ubiquitin-lysozyme conjugates as substrates, enabled Rechsteiner 
and co-workers to identify the protease that degrades proteins conjugated to 
ubiquitin in a ATP dependant manner 70•  This protease, isolated from rabbit 
reticulocytes, was found to have an extremely high molecular weight (26S, 1500 
kDa ) and indeed other protease of comparable size have since been detected in 
other organisms 71  Ganoth and co-workers found that reticulocyte cells starved of 
ATP contained three different factors, all of which were required for degradation of 
proteins tagged with ubiquitin 72•  These three components (each of 250-650 kDa) 
apparently assemble to form the 26S protease in the presence of ATP and Mg2+ 72 • 
One of these has been identified as the 20S proteasome 73,  a multi-catalytic 
cylindrical protease complex which was previously thought to be distinct from the 
26S protease. Immunoprecipitation of the proteasome with specific antibodies was 
found to inhibit the 26S protease, implying the proteasome is the catalytic centre of 
the complex 74. The second, 250 kDa, factor of 26S is thought to inhibit some of 
the catalytic functions of the proteasome, thereby modifying its activity to suit the 
ubiquitin dependant system 75. As yet, the role played by the third, 600 kDa, 
component of 26S is unknown, although there has been speculation about a 
possible proof-reading function. Alternatively, it could act as a structural template, 




In a recent paper, Hershko and co-workers reported the isolation of a 100 kDa 
monomeric ubiquitin binding protein abundant in erythrocytes and reticulocytes 76• 
This enzyme was purified from fraction H by a combination of ubiquitin-affinity 
chromatography and subsequent gel filtration chromatography. The enzyme 
apparently converts high molecular weight polyubiquitin-protein conjugates into 
lower mass forms with the liberation of mature ubiquitin, but importantly not of 
free protein substrate. Surprisingly, this isopeptidase appears to actually stimulate 
the degradation of substrate proteins by the 26S protease complex 76•  This implies 
that some polyubiquitin-protein conjugates are simply too large for the 26S 
protease to deal with and that this isopeptidase effectively tailors them into a 
convenient size. Furthermore, addition of the isopeptidase to an in vitro system in 
which polyubiquitin-protein conjugates had been pre-incubated with the 26S 
complex, resulted in high levels of free ubiquitin being formed. Therefore, the 
isopeptidase appears to regenerate the ubiquitin from the polyubiquitin remains of 
the degradation process. Figure 1.6 illustrates a possible order of events in the 
degradation process. 
U b-Proteins 




26S Protease 	Isopeptidase 
Ub+ 	 Ub 
polyUb 
Peptides 
L = Large polyUb, S = Small polyUb 
Figure 1.6 Proposed Degradation Pathway 
1.1.5(iv) Turnover of Proteins via the Ubiquitin Pathway 
Attempting to organize cellular proteins into groups according to their half-lives is 
a somewhat capricious affair, however, most proteins fall into one of the following 
three general classes. 
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Short Lived Proteins. These are endogenous proteins with a high turnover rate. 
Long Lived Proteins. The vast majority of cytoplasmic and nuclear proteins have 
a relatively slow rate of turnover. 
Abnormal Proteins. This class of proteins would include exogenous proteins, as 
well as damaged or mutated endogenous proteins. Turnover of these would 
necessarily be the highest of all. 
Proteolysis of short lived intracellular proteins appears to principally occur via the 
ubiquitin pathway, whereas, long lived proteins are thought to undergo lysosomal 
degradation 77.  Radiolabelling studies have shown that many abnormal exogenous 
proteins also undergo degradation via the ubiquitin pathway 78•  Autoradiography 
of reticulocyte cell contents clearly shows that these proteins are both mono- and 
multi-ubiquitinated. 
Whilst the ubiquitin pathway is usually associated with cytosolic protein 
degradation, there is some controversy over whether it also operates within 
lysosomes. Docherty and co-workers found ubiquitin-protein conjugate levels to be 
greatly enhanced within lysosomes relative to cytosolic levels, clearly suggesting a 
lysosome-ubiquitin affiliation 79.  However, other studies indicate that ubiquitin-
protein uptake is non-selective and that their accumulation is a result of lysosomes 
not possessing the required 26S protease to degrade them 80  In a further study, 
Gropper and co-workers have shown that an El enzyme is required for stress-
induced lysosomal degradation of long lived proteins 81•  This group ultimately 
propose that ubiquitin activation is somehow required for the formation of 
autophagic vacuoles, the vessels through which proteins enter lysosomes. 
1.15(v) Importance of the N-terminus of Substrate Proteins 
It is estimated that around 80% of cellular proteins are N-terminally acetylated 82 
Of the remaining 20%, the nature of the free N"-amino residue is crucially 
important in determining these proteins rate of turnover via the ubiquitin pathway 
(see N-end rule ). Clearly though, most proteins must have a signal downstream of 
their blocked N-termini which controls how quickly they are tagged with ubiquitin 
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for degradation. As already mentioned, this "internal signal" may be recognized by 
an as yet unknown class of E3 enzyme. 
Naacetylated proteins are not degraded in reticulocyte lysate fraction II 
supplemented with ubiquitin, however, these proteins are degraded in whole lysates 
in a ubiquitin dependant manner 83  Ciechanover and co-workers have recently 
isolated a protein from reticulocyte fraction I which appears to be the active 
component required for the ubiquitin-dependant degradation of Naacetylated 
proteins 84  This enzyme, designated Factor H, is a homodimer of subunit size 46 
kDa, and was shown to be required for the degradation of ubiquitinated histone-2A, 
an Naacetylated protein. Interestingly, this group were unable to form ubiquitin 
conjugates to other Naacetylated proteins, including actin and ct-crystallin, this 
was thought to be because the in vitro conjugation system contained only E3a and 
E313, thereby implying a third form of E3 is generally required for this type of 
conjugation. While little is known about the mode of action of Factor H, it 
presumably must in some way interact with conjugates before proteolysis can 
occur. 
1.1.5(vi) The N-End Rule 
A remarkably straightforward rule governing the susceptibility of free Naamino 
proteins to degradation has been discovered by researchers performing experiments 
utilising site directed mutagenesis 85 All twenty amino acids have been 
systematically site mutated at the N-terminal of the long lived bacterial protein, 13-
galactosidase, and the turnover of the resulting twenty variants investigated in both 
yeast 85  and more recently reticulocytes 86•  As with most proteins the first amino 
acid in wild-type -galactosidase is methionine, whose codon (AUG) also happens 
to be the start codon for gene transcription. Mutation of N-terminal methionine can 
therefore lead to certain problems. However, Varashavsky overcame these by 
constructing a plasmid encoding ubiquitin fused to the N-terminus of 13-
galactosidase, which results in the 19 mutations being located at the junction 85• 
Following expression, the fusion protein is rapidly de-ubiquitinated, thereby 
exposing mature 13-galactosidase bearing the required N-terminal mutation. 
Studies revealed that certain amino acids are destabilizing when located at the N- 
terminal of the protein, whereas others apparently have the opposite effect. The 
turnover rate of the former class of proteins is markedly higher than the later ( see 
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table 1.1 ). This seemingly simple relationship between the cellular lifetime of a 
protein and the identity of its N-terminal residue is known as the N-end rule. 
Indeed, the order of susceptibility is similar in both reticulocytes and yeast, with the 
differences being ascribed to the presence of E33 in the former but not the later. 
N-TERMINAL AMINO ACID 






Primary Destabilizing Residues Yeast Reticuloctyes 
Arginine 2 minutes 1 hour 
Type I Lysine 3 minutes 1.3 hours 
Histidine 10 minutes 3.5 hours 
Phenylalanine 3 minutes 1.1 minutes 
Leucine 3 minutes 5.5 hours 
Type II Tryptophan 3 minutes 2.8 hours 
Tyrosine 10 minutes 2.8 hours 
• 	Isoleucine 30 minutes 20 hours 
- 	Alanine >20 hours 4.4 hours 
Type III Senne >20 hours 1.9 hours 
- 	Threonine >20 hours 7.2 hours 
Secondary Destabilizing Residues  
Aspartic acid 3 minutes 1.1 hours 
Glutamic acid 30 minutes 1 hour 
Cysteine 1 	>20 hours 1.2 hours 
Tertiary Destabilizing Residues  
Asparagine 3 minutes 1.4 hours 
Glutamine 10 minutes 1 	0.8 hours 
Table 1.1 	Comparison of Destabilizing Residues in Yeast and 
Reticulocytes 
The destabilizing effect of certain N-terminal amino acids can be neatly explained 
by the affinity E3 enzymes have towards them. Yeast and reticulocytes both contain 
E3cx, an enzyme which apparently recognizes basic type I residues, as well as bulky 
hydrophobic type II amino acids. Evidence for E3a having two separate binding 
sites comes from the observation that dipeptides with type I or H residues at their 
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N-termini are full antagonists of the enzyme 87. Reticulocytes, which also contain 
E3, have a third class of destabilizing amino acid. These small uncharged residues 
are, however, not destabilizing in yeast, implying that type III residues bind to E30. 
The above explanation cannot directly account for the destabilizing effects of Asp, 
Glu, Asn and Gln residues, none of which are recognized by E3ct or E30. However, 
studies have shown that proteins with acidic amino acids at their N-termini can be 
post-translationally modified, resulting in an arginine residue being added onto 
their N-termini 89,  Such arginylation, resulting in recognition by Ma, is thought to 
be catalysed by a multi-enzymic system comprising of arginyl-tRNA-protein 
transferase and arginyl-tRNA synthetase 89. Aspartic acid and glutamic acid are 
therefore known as secondary destabilizing residues, whereas, asparagine and 
glutamine, which initially have to hydrolysed to the corresponding acids, are 
referred to as tertiary destabilizing residues. 
1.1.5(vii) Multi-Ubiquitination of Protein Substrates 
Clearly not all ubiquitinated proteins are targeted for proteolysis, for example, 
nuclear histone proteins are for the most part relatively stable when ubiquitinated. 
The possibility that multi-ubiquitination of a protein can somehow convey the 
necessary information for or against degradation, has a certain elegant attraction. 
Addition of exogenous lysozyme to reticulocytes results in ubiquitin-lysozyme 
conjugates in excess of a 100 kDa being formed 69,90,91.  Lysozyme, with seven 
free amino groups, would be expected to have a maximum weight of 74 kDa if 
mono-ubiquitination were to occur at every site. The extra weight can be accounted 
for by the formation of multi-ubiquitin chains similar to those found in histone-
2A25 . Chemical analysis of these conjugates subsequently confirmed this, as well 
as suggesting adjacent ubiquitin molecules in the chain are linked through 
isopeptide bonds 91,69 
A similar situation is found in 3-galactosithse and, furthermore, peptide mapping of 
this ubiquitin-protein conjugate indicated that the afore mentioned isopeptide bonds 
occur between the C-terminal of one molecule and the c-amino group of Lys-48 in 
the next 91  A mutant ubiquitin in which Lys-48 had been changed to an arginine 
residue ( unable to form isopeptide bonds ) was found to yield only mono-
ubiquitinated 3-galactosidase in vitro 91 . In addition, this ubiquitin mutant could 
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not sustain the in vitro proteolysis of 3-galactosidase by the 26S protease complex, 
thus, implying multi-ubiquitination is necessary for protein degradation. 
It seems likely that multi-ubiquitination is, in most cases, a requirement for 
substrate degradation, however, exactly why this is so is still under dispute. One 
can envisage a whole range of branched multi-ubiquitin "flags", each one signaling 
a specific turnover rate for the conjugated protein. Alternatively, multi-
ubiquitination may simply be a way of amplifying a considerably weaker mono-
ubiquitin signal. 
ATP 	AMP +PP1 
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Figure 1.7 The Ubiquitin Pathway 
1.1.5(viii) Overall Picture 
In summary, we have seen how ubiquitin becomes attached to a substrate protein 








The existence of a group of proof-reading enzymes which prevent needless and 
erroneous ubiquitination has also been described. A protein's rate of turnover, by 
the 26S protease specific for the ubiquitin pathway, is dependant upon the number 
of ubiquitin molecules conjugated to it, which in turn may be dependant upon 
specific variables in the protein's primary structure. These include the N-terminal 
amino acid or, in the case of N-terminally acetylated proteins, possible internal 
signal sequences. Figure 1.7 attempts to illustrate the events in the ubiquitin 
pathway. 
1.1.6 Ubiquitin and The Heat Shock Response 
Exposure of cells to temperatures above the physiological norm, results in the 
synthesis of a specific set of proteins. These heat shock proteins, the cells response 
to environmental stress, are also induced by exposure to toxic chemicals, starvation 
and various other metabolic challenges. In whatever way it manifests itself, cellular 
stress would be expected to bring about the build up of damaged or denatured 
proteins. 
Early evidence for the involvement of ubiquitin in the heat shock response came 
from work carried out on the mouse carcinoma cell-line, ts85 92,93  These mutant 
cells contain a thermolabile ubiquitin activating enzyme (El) which is inactivated 
at 39.5 °C, the non-permissive temperature. This observation implied that at the 
elevated temperature, ubiquitination of proteins is repressed and that this in some 
way triggers the synthesis of heat shock proteins. However, this interpretation is 
undermined by a later study in which 1251-ubiquitin was shown, using 
autoradiography, to conjugate very small amounts of substrate proteins at the 
elevated temperature 94.  Nevertheless, degradation of long lived cellular proteins, 
which normally increases under heat shock 95,  is greatly obstructed in ts85 cells, 
suggesting that proteolysis of denatured proteins is ubiquitin dependant. That heat 
shock induces ubiquitin synthesis in ts85 cells 92,93  and in chicken embryo 
fibroblasts 96,  surely affirms the above hypothesis that degradation of the abnormal 
proteins produced during heat shock goes via the ubiquitin pathway. 
It has been estimated that the increased rate of protein ubiquitination, which occurs 
during heat shock, results in the cellular ubiquitin concentration dropping to around 
25% of the normal level 97.  Activation of ubiquitin genes is required to prevent 
cells becoming starved of the protein during times of stress. Finlay and co-workers 
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found that in yeast, the ubiquitin UBI4 gene becomes activated during heat 
shock98. This polyubiquitin gene is virtually dormant during normal physiological 
conditions throughout which yeast cells rely on three other ubiquitin genes (UBI1-
3 ) to maintain regular pools. Two ubiquitin conjugating enzymes (E2s, UBC4 and 
UBC5 ) also appear to be induced by heat shock 99. 
Although other heat shock proteins have been identified, ubiquitin is the only one 
known to be involved in cytoplasmic protein degradation. Three other heat shock 
proteins, of subunit sizes 89 kDa, 20 kDa and 24 kDa, have been isolated from 
chicken fibroblasts. Moreover, proteins of similar size and bearing high levels of 
homology have been found induced in heat shocked drosophila 100•  Since none of 
these has any known connection with cellular proteolysis, one can easily speculate 
on the possible interactions they may have with misfolded proteins, resulting in 
their renaturation and hence rescue from the imminent destruction afforded by the 
ubiquitin system. 
1.1.7 Ubiquitin and Ribosome Biogenesis 
A family of genes encoding ubiquitin fused to a carboxy-terminal extension 
sequence has been identified in the human 14,15  dictyostelium  16  and yeast 17 
genomes ( see figure 1.8). 
These highly basic carboxyl extension proteins ( CEPs ) are either 52 or 76-80 
amino acids long and are always synthesised in the accompaniment of ubiquitin. 
Moreover, both classes of CEP undergo rapid de-ubiquitination either during or 
very soon after translation 18,101  Within each class there is a high degree of 
homology between organisms, and furthermore, every CEP contains a putative 
"zinc finger" DNA binding motif of the (Cys) 4 variety ( see ref 102 for a review 
zinc fingers). 
Speculation over the cellular fate of CEPs was resolved when Redman and 
Rechsteiner found that the 80 amino acid extension protein ( CEP80) is ultimately 
located within a ribosomal subunit 103  Antibodies specific for CEP80 reacted with 
the previously characterized ribosomal protein, S27a, which is a component of the 
small 40S ribosomal subunit. Further evidence for CEP80 being S27a came from 
amino acid composition and two-dimensional electrophoresis. The smaller CEP52 
subclass has since been identified as a component of the larger 60S ribosomal 
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subunit 104,105  Finley and co-workers have generated yeast mutants bearing 
deletions of the UbCEP encoding genes, UBI 1-3 104  This group found that those 
mutants lacking UbCEP52 ( ubi1E and ubi2it ) were deficient in the ribosomal 60S 
subunit, whereas the UbCEP80 deletion mutant ( ubi3.) had lower than normal 
40S subunits. In the same study, it was found that the removal of the ubiquitin 
encoding element from the UBI3 gene, leaving only the CEP80 component, 
resulted in lower levels of the 40S ribosomal subunit being produced. 
10 	 20 
Ubiquitin - I-I-E-P-S-L-R-Q-L-A-Q-K-Y-N-C-D-K-M-I-C-R-K-C-Y-A-R-L-H-P-
Ubiquitin -A-L-L-R-L-L-L-S-Y-T-T-P-K-K-N-K-H-K-R-K-K-V-K-L-A-V-L-K-Y- 
30 	 40 	 50 
- R-A-V-N-C-R-K-K-K-C-G-H-T-N-N-L-R-P-K-K-K-V-K-0O2H 
- Y-K-V-D-E-N-G-K-I-S-R-L-R-R-E-C-P-S-D-E-C-G-A-G-V-F-M-A- 
60 	 70 
-S-H-F-D-R-H-Y-C-G-K-C-C-L-T-Y-C-F-N-K-P-E-D-K-0O2H 
Figure 1.8 Primary Sequence of Human UbCEP52 & UbCEP80 
Interestingly, the yeast genes, UBI1-3, all of which encode UbCEPs, are most 
active during times of cell growth. This is obviously a time when protein synthesis, 
and hence ribosome biogenesis, is at a maximum level. However, the remaining 
ubiquitin encoding yeast gene, pUBI4, is not at all active during normal cell 
growth, instead being maximally expressed in times of cellular stress. This increase 
in polyubiquitin precursor synthesis is accompanied by the shut-down of UbCEP 
production, presumably because during cellular stress ribosomal protein synthesis is 
naturally at a minimum and protein degradation is a higher priority. 
Exactly why CEPs are synthesised N-terminally fused to ubiquitin is a question 
which, as yet, has not been answered unequivocally. It has been suggested that 
ubiquitin increases the incorporation of CEPs into ribosomes in a way similar to a 
molecular chaperon type protein 104  In this model ubiquitin would not only aid 
the actual biogenesis step, but would also act as a guardian against degradation 
right from the moment the CEP is translated. The fusion of ubiquitin to the N- 
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terminal of the CEP may block any N-end rule degradation signal it might have and 
hence protect it from ubiquitin mediated proteolysis. Recent evidence, however, 
suggests that de-ubiquitination of UbCEPs occurs almost co-translationally, thus 
making the alleged chaperon function of ubiquitin very difficult to justify 18. 
Given that deletion of the ubiquitin encoding element from the yeast UBI3 gene 
results in lower levels of the remaining CEP component reaching its final ribosomal 
destination 104,  it has been proposed that ubiquitin is required for enhanced 
translation of the extension protein 18.  This theory is given some credibility in the 
light of the observation that N-terminally fused ubiquitin substantially increases the 
expression of heterologous gene products in E. coli and yeast 106408  For 
example, the expression in E. coli of a plasmid encoding ubiquitin N-terminally 
fused to human poly(ADP-ribose) polymerase results in this protein being 
synthesised at levels 10 times higher then for the mature enzyme alone 108•  It 
seems likely that ubiquitin does have a translatory activating function within 
UbCEPs, however, the question of whether it also acts as a molecular chaperon 
thereafter is yet to be resolved. 
Section 1.2 Ubiquitin Structure 
The primary structure of ubiquitin is uniquely conserved across eukaryotes; its 
sequence is identical among animals, and differs from this in only a few sites in 
yeast 10  and plants 12  Ubiquitin contains one histidline and one tyrosine, but no 
tryptophan or cysteine residues, hence there are no structure stabilizing disulphide 
bridges. However, the observation that human and yeast ubiquitin's are 
indistinguishable in their ability to sustain ubiquitin dependant protein degradation 
in mammalian reticulocytes 109  strongly suggests the same well defined tertiary 
structure is common to both. 
1.2.1 The Secondary and Tertiary Structure 
In an early investigation, Lenkinski and co-workers noted that the 1D NMR 
spectrum of ubiquitin changed very little over the temperature range 23 - 80 °C and 
the pH range 1 - 8 110•  Although carried out on a relatively, at least by today's 
standards, insensitive 270 MHz spectrometer, these results suggest ubiquitin 
possesses a very stable tertiary structure, a conclusion supported by its resistance to 
digestion by many enzymes 111 
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General information on the secondary structure of ubiquitin was obtained by 
Goldstein and co-workers, who performed a series of physico-chemical 
experiments on the protein 112.  Their interpretation of the far ultra-violet circular 
dichroism (CD) spectrum of ubiquitin, suggested the protein contained little 
organized secondary structure. This conclusion was based on similarities between a 
theoretical spectrum (calculated for 6% a-helix, 10% 13-sheet and 84% random 
coil ) with that of ubiquitin. However, agreement between theoretical and 
experimental curves rapidly breaks down below 210 nm, raising doubts about the 
validity of such a direct comparison. No significant changes in the CD spectra were 
observed between pH 3 and 12, which in keeping with the previously described 
NMR study implies ubiquitin has a stable conformation. 
In the same study, both ultra-violet absorption spectroscopy and fluorescence 
spectroscopy were used to probe the environment of the single tyrosine residue in 
ubiquitin ( consequently, it is far easier to interpret fluorescence data from proteins 
containing single fluorophores than for those with multiple fluorophores 113 
Spectrophotometric titration of the tyrosine revealed it has a pKa of 11. 1, a high 
value usually indicating the phenolic group of tyrosine is involved in hydrogen 
bonding. Furthermore, the fluorescence of the tyrosine is greatly quenched relative 
to a free tyrosine amino acid standard. This type of quenching is commonly caused 
by other amino acids in the protein being in the immediate vicinity of the 
fluorophore 113 . Both solvent perturbation absorption and iodide quenching of the 
fluorescence indicated that the tyrosine is partially buried within the ubiquitin 
structure. Finally, other fluorescence studies suggested that the protein is fully 
denatured in 7M guanidine. 
The crystallization and preliminary X-ray investigation of bovine ubiquitin was 
first reported by Cook and co-workers in 1979 114. The same group later published 
the full crystal structure of human erythocytic ubiquitin at 2.8 Ang. resolution 3, 
and ultimately refined this to 1.8 Ang. resolution 115.  These X-ray studies have 
revealed ubiquitin to be an extremely compact globular protein, in which around 
87% of the peptide backbone is involved in hydrogen bonded secondary structure. 
Oat and yeast ubiquitin sequences have also been crystallized, and analysis of these 
reveals they have similar tertiary structures to that of the animal form 116. A 
ribbon representation of the tertiary structure of ubiquitin is shown in figure 1.9. 
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Examination of its crystal structure reveals ubiquitin contains all the secondary 
structure units commonly found within proteins, the small size of ubiquitin results 
in these being tightly packed together forming a very compact tertiary structure. 
The most salient of these are 3.5 turns of cc-helix involving residues 23 - 34, a short 
length of 310 helix incorporating amino acids 56 - 59 and a five stranded mixed 13-
sheet. In addition, there are seven reverse turns (types I-Ill) linking the various 
helices and components of the sheet together. The left handed twist of the f3-sheet 
forms a cavity into which fits the a-helix, thus forming the basis of the pronounced 
hydrophobic core exhibited by the protein. It is a combination of this hydrophobic 
core and hydrogen bonding between helices and turns, that is thought to account for 
the remarkable stability of the molecule to ranges of temperature and pH 110 
One of the most prominent features of the tertiary structure is the C-terminal 
region. Amino acids 73-76 clearly protrude from the core of the molecule, indeed, 
the C-terminus is often referred to as the "stinger" in ubiquitin's tail. The absence of 
any surrounding structure would suggest the C-terminal region has considerable 
freedom of movement, this may have some significance given that much of the 
protein's biological function involves this region. 
One curious feature in the structure is the unusual hydrogen bond which occurs 
between the sulphur atom of Met-i and the peptide NH group of Lys-63. This 
effectively buries the amino terminus, thus rendering it inaccessible, a property 
which may explain the protein's apparent immunity from degradation via its own 
pathway. Moreover, given that ubiquitin can be synthesised as a polymeric 
precursor in which individual units are linked in a head to tail manner 8-12,  the N-
terminal region must undergo considerable conformational changes after cleavage 
of the precursor into mature ubiquitin molecules. 
Another significant hydrogen bond occurs between the phenolic group of Tyr-59 
and the backbone nitrogen atom of Glu-51. This interaction, which explains the 
tyrosine's atypical physico-chemical properties 112,  helps to stabilize the loop 
occurring between a reverse turn (residues 51-54) and the 310 - helix (residues 56-
59). The tyrosine appears to reside at a "hinge-like" position in the protein, that is 
to say, the loop in which it is located practically ensures that the final component of 
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the 13-sheet (residues 64-72 ) is oriented in the correct way. Destabilization of this 
loop, essentially loss of the Tyr-59 - Glu-5 1 hydrogen bond, may result in the final 
strand of the 13-sheet not being formed, indeed, one might speculate that another 
conformation would ultimately be adopted by the protein ( see section 1.2.2). 
Figure 1.9 Ribbon Structure of Ubiquitin 
One final piece of information that can be abstracted from the crystal structure, is 
the availability of lysine residues for isopeptide bond formation. Multi-
ubiquitination of substrate molecules involves the formation of an isopeptide bond 
between the E-amino group of lysine in one ubiquitin and the C-terminal of the next 
one in the chain. Of the seven lysines in ubiquitin, two (Lys- l 1 & Lys-27) are 
completely inaccessible. Three of the remaining five (Lys-6, Lys-33 & Lys-63) are 
fully exposed on the surface of the protein and form no intra-molecular contacts. 
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Lysine 29 and lysine 48 are both on the surface of the protein, but do have 
hydrogen bonds between their c-amino groups and peptide carbonyl groups. 
Therefore, it appears that lysines 6, 33 & 63 should be predisposed to isopeptide 
bond formation with residues 29 & 48 also being candidates, but to a lesser extent. 
Until recently, X-ray crystallography offered the only approach to tertiary structure 
elucidation of small proteins, however rapid advances in both methodology and 
spectrometer technology, have resulted in nuclear magnetic resonance spectroscopy 
becoming a fully complementary technique. The principle advantage NMR has 
over X-ray crystallography is that it provides the conformation of the protein in 
solution, its natural environment, and this allows more dynamic investigations to be 
carried out, ie protein folding. 
In the past the sheer complexity of a protein's 1D NMR spectrum made 
comprehensive proton resonance assignment impossible. The advent of powerful 
spectrometer magnets, along with the two-dimensional NMR experiment ( 2D 
NMR ), has not only made complete proton assignment a reality, but has also 
allowed secondary and tertiary structures to be determined. Since its conception in 
the early seventies by Jeener and Ernst 117,  2D NMR has progressed with 
phenomenal speed, indeed today there exist a number of such experiments, each 
delivering different, yet complimentary, information on the connectivities of 
individual proton resonances. Application of these techniques to the sequential 
assignment of proton resonances in small proteins, was introduced and developed 
by Wiithrich and co-workers 118-120.  A comprehensive treatment of 2D NMR 
studies on biomolecules, which is outside the scope of this text, is given in 
Wüthrich's seminal book on the subject 121• 
Two papers, both describing the complete 1 H NMR assignment and subsequent 
secondary structure analysis of ubiquitin, were published simultaneously in 1987 
4,5. In each case, a combination of Double Quantum Filter Correlated 
SpectroscopY ( DQF-COSY 122 , Double Quantum Filter Relayed Spectroscopy 
(DQF-RELAY 123 ), Total COrrelated SpectroscopY (TOCSY 124)  and Nuclear 
Overhauser and Exchange SpectroscopY (NOESY 125 ) were used to assign the 
observable proton resonances. Secondary structure was identified using 
characteristic through space interactions observable in the NOESY spectrum. For 
example, in helices there are typically strong crosspeaks between adjacent amide 
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protons ( denoted dNN ), also because of the helical shape, medium range 
interactions (eg, dc4[11 +3] ) would be expected 121 . The secondary structure of 
ubiquitin in solution (derived from all of these sequential, medium and long range 
NOESY crosspeaks ) is in remarkable agreement with its crystalline counterpart. In 
their assignment, Di Stefano and Wand identified the long a-helix and short 310 - 
helix, the five stranded mixed 3-sheet and five of the seven 3-tums 5. Similarly, 
Weber and co-workers' 4  secondary structure assignment was completely consistent 
with the crystal structure 115  Although no attempts were made to elucidate the 
tertiary structure, clearly both these studies strongly point to ubiquitin having an 
identical overall conformation in solution and crystal phases. 
The tertiary structure of a protein in solution can also be derived from 2D NMR 
data 121  Distance-Geometry (DG) constraints, extracted from the appropriate 2D 
NMR experiment, are used to optimize the structure by way of molecular 
mechanics or dynamics calculations. Distance constraints ( by constraints, 
approximate values are meant) can be obtained from NOESY crosspeak intensities, 
whereas geometrical information ( ie torsion angles ) can be acquired from J-
coupling values between nuclei by way of the Karplus relationship 126  Weber and 
co-workers used 700 constraints to generate a distance-geometry derived tertiary 
structure for ubiquitin 127  Two different DG programs were used, AMBER 128 
and DSPACE 129,  both of which gave essentially the same result; ubiquitin has an 
energy minimized solution conformation very close to its X-ray structure ( there are 
minor changes in side-chain positions ). It is noteworthy that neither of these DG 
programs use the X-ray structure as a starting point for minimisation. 
1.2.2 Structure Function Studies on Ubiquitin 
To date, only a few studies have addressed the question of structure-function 
correlations in ubiquitin. The first, and by far the most comprehensive of these, was 
published in 1987 by Ecker and co-workers 130•  In this study, the ubiquitin 
conformation was conveniently divided into three general categories. 
The hydrophobic core. 
The protein surface. 
3. The C-terminal region. 
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Examination of the ubiquitin tertiary structure using molecular graphics, allowed 
important interactions to be identified within each category, and from these 
appropriate mutations were conceived ( see table 1.2). 
PROTEIN STRUCTURE LOCATION OF 
CHANGE 




Animal ubiguitin  100%  
Pro 19 . Ser, A1a28 -uSer, 
G1u24_,Asp  
Surface 100% Minimal 
ProI9-u.Ser Surface 100% Minimal 
Leu674 Asn, Leu69 -Asn Core 0% Severe 
G1y76 -.Ala Tail 0-10% Minimal 
Leu73-*deleted Tail 0% Minimal 
Leu 73-.deleted, Arg72-.Ser Tail 0% Minimal 
Tyr59..Phe Surface 70-100% Slight 
His68..Lys Surface 30% Slight 
Tyr59.Phe, Hi s68-.Lys Surface 30% Slight 
Table 1.2 	Ubiquitin Mutants and their Biological Activities 
These mutants, some containing multiple changes, were then synthesised by 
construction of a plasmid encoding a synthetic ubiquitin gene into which eight 
restriction enzyme sites had been engineered, thereby facilitating the range of 
mutations required. After site directed mutagenesis had been performed, the 
plasmid was expressed in E. coli and the resulting mutant ubiquitin purified by ion 
exchange chromatography. 
The effect these mutations had on the protein's structure, was determined by NMR 
spectroscopy. In addition, each mutant ubiquitin was assayed for its ability to be 
recognized and activated by a ubiquitin activating enzyme (El), as well as its 




Two ubiquitin mutants with conservative surface substitutions, that is to say the 
triple mutant Pro 19 - Ser, Ala28 - Ser & G1u24 - Asp and the single site mutant 
Pro19 - Ser, had both El recognition and protein conjugation activities identical to 
the wild type protein. Furthermore, other than at the point of mutation, no changes 
were observed in the 1D NMR or in the DQF-COSY 2D NMR in either of these 
mutants relative to wild type ubiquitin. This indicates that these mutations have 
very little effect on the protein's overall structure. Therefore, it seems ubiquitin is 
quite tolerant to these rather guarded mutations on its surface. 
Two surface mutations with some damaging effect upon both El recognition and in 
vitro protein conjugation activity, were the Tyr59 - Phe and the His68 - Lys 
substitutions. In the light of this, it is somewhat surprising that neither of these 
mutants had any significant changes in their 2D NMR spectra, again suggesting 
very little structural reorganization had occurred relative to the native form. One 
apparently contradictory observation was that the Tyr59 to Phe mutant was 
extremely insoluble. This is often associated with exposure of hydrophobic 
residues, which in this case could be caused by disruption of the tyrosine containing 
loop. 
The importance the hydrophobic core has upon the ubiquitin structure, was 
investigated using the double mutant Leu67 - Asn, Leu69 - Asn. These two leucine 
residues, both components of the hydrophobic core, can be mutated to asparagine 
without creating any steric problems. Of course, such mutations would lead to the 
core being considerably less hydrophobic. In fact, this double mutant had 
absolutely no El recognition activity or protein conjugation activity, and perhaps 
not surprisingly, the NMR data indicated the native structure of ubiquitin had been 
devastated by these two changes. The introduction of two weakly hydrophilic side-
chains into the, hydrophobic core, would create energetically unfavourable 
interactions which may well be enough to prevent the protein from folding. Clearly 
the hydrophobic core of ubiquitin is very important to its structure and, 
consequently, the protein is very intolerant to drastic changes in this region. 
The final aspect of the ubiquitin structure to be investigated was the C-terminal 
region. Three "tail mutants" were constructed (G1y76 -Ala, Leu73 - A & Leu73 - 
, Arg72 - Ser) all of which were completely inactive in both the El recognition 
assay and the protein conjugation assay. As one would expect, NIMR indicated that 
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mutations in the tail had no effect on the bulk structure of protein. The first step in 
the ubiquitin pathway is activation of the C-terminus by the El enzyme. Mutations 
in the tail lead to loss of activity, implying the El enzyme recognizes specific 
features within this region, as well as the protein conformation as a whole. 
Although ubiquitin alone is regarded as an extremely stable protein, over the years 
there has been some speculation over whether it undergoes conformational changes 
upon conjugation to other proteins. Wilkinson and Mayer found that lowering the 
dielectric constant of a ubiquitin solution, by addition of various alcohols, was 
accompanied by a dramatic increase in the helical content of the protein 131•  For 
example, lowering the dielectric constant from 80 to 45, resulted in ubiquitin 
having a circular dichroism spectrum consistent with 50% helical structure. Indeed, 
it. is commonly accepted that addition of alcohols can increase the helical content of 
peptides and proteins 132,133  In a related study, Williams and co-workers claim 
that at low pH, addition of methanol to a ubiquitin solution brings about a stable, 
partially structured form of the protein 134  Ubiquitin is completely transformed 
into this form in 60% methanol! 40% water at pH 2.0, and detailed characterization 
of this structure was carried out by 2D NMR. The a-helix and first two strands of 
the 13-sheet remain remain intact in this novel form, however, the turn rich area of 
the protein, which includes the 13-turn - 3m-helix loop, appears to be destroyed. 
Unlike the preceding CD study, this NMR analysis suggests the helical content 
actually decreases in the more hydrophobic environment, an unexpected 
observation which has yet to be resolved. Clearly though, exposure to a more 
hydrophobic environment does induce changes in the ubiquitin structure. In vivo, 
ubiquitin could encounter a localised hydrophobic environment in the vicinity of a 
cellular membrane, this might be enough to trigger the above conformational 
change. Also, conjugation to particularly hydrophobic proteins might induce a 
switch to this other form. 
In an attempt to elucidate the importance of conformational mobility in ubiquitin 
mediated proteolysis Ecker and co-workers constructed, expressed in E. coli and 
purified a number of cysteine containing mutants of ubiquitin 135  (see table 1.3). 
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MUTANT STRUCTURE No of Cys Activity 
Bovine Ubiguitin 0 100% 
Phe4-Cys 1 90% 
Thr14-Cys 1 68% 
Thr66-Cys 1 110% 
Phe4 - Cys, Thrl4 - Cys 2 100% 
Phe4 - Cys, Thr66 - Cys 2 30% 
Phe4 - Cys, Thr14 - Cys, Thr66 - 
Cys  
3 20% 
Table 1.3 	Cysteine Containing Mutants of Ubiquitin 
In vitro Protein Conjugation Activities are shown relative 
to Bovine Ub 
Three of these mutants contained single X-Cys substitutions, while the remainder 
contained two or more mutations, the latter facilitating disulphide bridge formation. 
All six mutants were recognized and hence activated by the El enzyme, however, 
there were striking differences in their in vitro protein conjugation activities. The 
three mutants containing single cysteine residues, as well as the mutant containing a 
disulphide linking the first two strands of the p-sheet (Phe4 - Cys, Thr14 - Cys), 
were found to be as active as wild type ubiquitin in the conjugation assay. On the 
other hand, the two mutants containing the very constricting disulphide linking the 
amino and carboxyl termini (Phe4 - Cys, Thr66 - Cys and Phe4 - Cys, Thr14 -Cys 
& Thr66 - Cys) were only 20 -30 % as active as wild type ubiquitin. 
The tertiary structure of the 4/66 disulphide was determined using 2D NMR 
followed by distance-geometry calculations (AMBER & DSPACE). In solution, 
the 4/66 mutant was found to have a left-handed disulphide geometry, but more 
importantly the overall conformation of the molecule was more or less identical to 
wild type ubiquitin. Together these results suggest that initial activation of ubiquitin 
by El does not involve any conformational change ( all the mutants were 
activated), however, full protein conjugation activity requires a certain amount of 
conformational mobility. If ubiquitin is conform ationally constrained, as in the 4/66 
disulphide, then protein conjugation and hence degradation decreases perhaps 
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because ubiquitin can no longer achieve a conformation that is active in signaling 
proteolysis. 
The importance of the unusual hydrogen bond between the sulphur atom in 
methionine and the peptide NH of Lys-63, has been investigated by Breslow and 
co-workers 136  Chemical oxidation of Met-1 to the sulphoxide or to the suiphone, 
was found to destabilize the ubiquitin structure resulting in the protein becoming 
more susceptible to conformational change when, for example, the di-electric 
constant of the solvent is lowered. Interestingly, oxidation of the sulphur in 
methionine results in ubiquitin being slightly more active in protein degradation. 
This reinforces the contention that ubiquitin requires a certain amount of 
conformational freedom to fulfil this function. Cyanogen bromide cleavage of the 
final methionine affords a truncated ubiquitin species which completely unfolds 
below pH 4.0, it is also much less active in its protein degradation function. The 
authors suggest that the oxidised Met species may still have a hydrogen bond 
(although weaker) between the suphoxide or sulphone oxygen atom and NH of 
Lys-63. No such hydrogen bond can form in the des-Met species and consequently 
removal of the methionine is a far more damaging modification. 
1.2.3 The Ubiquitin Folding Pathway 
There are two fundamental questions that can be asked about the tertiary structure 
of a protein: 
Why did it adopt this particular conformation in the first place? 
Given that a particular fold is somehow inherent in a protein's sequence, just 
what is the mechanism involved in going from the unfolded post-ribosomal state to 
this final conformation, if indeed this is a 2-stage process? 
1.2.3(1) Protein Structure in General 
In addressing the first question surely what we have to ask is, what factor or factors 
stabilize a given tertiary structure over every other? The identity of these factors 
has never really been in dispute, it has long been agreed that the two principle 
forces governing protein stability are the hydrophobic effect and hydrogen bonding. 
A protein's native conformation should be that which contains the greatest possible 
stabilizing contributions from these two elements. However, destabilizing 
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contributions from the loss of internal rotations and the increase in torsional strain 
associated with folding, result in the overall net stability being rather small 
(typically 5 - 20 kcal mol). 
Over the years there has been some controversy over which of these two stabilizing 
determinants has the major input. As long ago as 1936, Pauling and Mirsky 
contended that hydrogen bonding was the more significant of the two 137•  This 
contention remained more or less unchallenged until the 1960's, when the work of 
Kauzmann 138,  and later Tanford 139,  suggested that in model compounds at least, 
the hydrophobic effect was the most important in determining the three 
dimensional structure of a protein. 
In recent years, site directed mutagenesis has provided researchers with the 
experimental means to investigate the relative importance of the hydrophobic effect 
vs. hydrogen bonding in protein tertiary structure. While opinion is undeniably split 
over their relative contributions, the majority of researchers believe the 
hydrophobic effect to be the dominant, and have accordingly designed their 
experiments to show this. These experiments generally involve the mutation of 
hydrophobic residues within a protein's core to smaller hydrophobic residues such 
as alanine. The stability of the resulting mutants are then measured relative to the 
wild type protein. Unfortunately, such experiments have not afforded any unifying 
data, for example Matthews and co-workers have found that Leu to Ala mutations 
in the core of lysozyme can lower the free energy of stabilization ( zGo) by 
between 2.0 and 8.0 kcal mold, depending upon the position of the substitution 
140 Fersht and co-workers 141,142  have similarly found that the effect a mutation 
has on the stability of a protein, in this case barnase, is very much dependant upon 
its position within the core (their results suggest a loss in iGH20 of between 1.0 
and 1.6 kcal mol' per methylene group removed from the core). 
One of the leading exponents of the hydrogen bonding school of thought, is 
Williams. Based upon his work on small molecules he suggests that hydrogen 
bonding may well make a much underestimated contribution to protein stability 
143, 144 Model systems have revealed that a single hydrogen bond can provide a 
free energy of stabilization of between 3 and 5 kcal mo1, most of which comes 
from an entropic factor associated with the release of bound water molecules. In a 
recent paper, Pace and co-workers have used site directed mutagensis to probe the 
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importance hydrogen bonding has to the conformational stability of ribonuclease 
Ti 145•  Deletion of a series of intra-molecular hydrogen bonds, by construction of 
the necessary mutants, was found to destabilize the overall structure by on average 
1.3 kcal mo!-1 per bond deleted. Given the number of such bonds within the 
protein, this group conclude that hydrogen bonding makes a comparable 
contribution to the hydrophobic effect in stabilizing its structure. 
The apparent discordance of opinion and results within this whole area makes it 
difficult to abstract any unifying principles. This lack of consistency is 
understandable since every protein has its own unique contributions from both 
hydrogen bonding and the hydrophobic effect and, therefore, any attempt to 
construct a detailed set of general rules will be extremely difficult. 
1.23(u) Protein Folding in Genera! 
It has long been accepted that there are just too many conformations of an unfolded 
protein for its native conformation to be adopted by random processes, statistically 
such a mechanism would require a ridiculously long timescale. If we, therefore, 
rule out random processes, this leads us to conclude that protein folding is an 
inevitable consequence of the primary sequence, and that all the necessary 
information required for this phenomenon is somehow contained therein. 
The work of Lim and Sauer on the 2L receptor protein has led them to conclude that 
the particular connectivities between hydrophilic and hydrophobic residues in the 
sequence, limits the number of ways the protein can arrange itself so as to position 
the majority of the hydrophobic residues on the inside and hydrophilic residues on 
the outside 146  In evolutionary terms, it has been suggested that all present day 
protein structures descend from a finite number of simple degenerate patterns 
which nature long ago discovered were sufficient to give a basic globular protein 
scaffold 147 
It is now generally accepted that there exist protein folding pathways with well 
defined intermediates, so called molten globular states 148  while precise structural 
analysis of these intermediates would undoubtedly represent the first step to 
understanding protein folding, it is only relatively recently that techniques to do so 
have become available. These novel NMR techniques all rely on the fact that amide 
protons involved in hydrogen bonded secondary or tertiary structure, exchange at a 
34 
Introduction 
slower rate than those not involved in such bonding. If a protein is unfolded in a 
D20 denaturant solution, then all backbone amide protons will be replaced by 
deuterons. Rapid dilution of the protein solution in D 20 allows folding to proceed. 
However, if after certain times intervals the refolding protein is briefly exposed to 
H20 at basic pH, then only those deuterons not involved in hydrogen bonding will 
exchange with protons. Consequently, only those protons not involved in hydrogen 
bonding in the intermediate will be observed in the 1 H NMR spectrum of the 
refolded protein. 
This type of stop-flow NMR experiment was first applied to bovine pancreatic 
trypsin inhibitor ( BPTI ), a relatively small 6 kDa protein, although only a 1D 
NMR analysis was carried out 149  More recent folding studies, all involving 
powerful 2D NMR approaches, have been carried out on cytochrome C 150, 
barnase 151,  lysozyme  152  and ribonuclease A 153•  These studies have all shown 
that secondary structures, such as helices, are formed very early in the folding 
pathway and that the generation of tertiary structure hydrogen bonds occurs at a 
later stage. This is broadly in keeping with the kinetic circular dichroism results of 
Kuwajima, which also indicate secondary structure is formed very early in the 
folding pathways of several proteins 154• 
Clearly this H-D exchange technique does have its limitations, for example, it is 
completely insensitive to hydrophobic interactions and can only be applied to 
proteins small enough to have fully assigned 'H NMR spectra. These limitations 
aside, the technique has furnished us with the only tangible evidence for the 
existence of folding intermediates and its continued application to other proteins is 
currently the only way of assessing the generality of such molten globule states. 
1.2.3(iii) Stability of the Ubiquitin Structure 
Ubiquitin, as we have seen, has a very condensed conformation containing a high 
degree of hydrogen bonded secondary structure and a pronounced hydrophobic 
core. In asking which of these two elements contributes most to the stability of the 
ubiquitin structure, it is necessary to examine the effects specific mutations make 
on this conformation. Although not ideal for this purpose, the work of Ecker and 
co-workers (discussed in section 1.2.2) can certainly give us an insight into the 
relative importance of these two fundamental components in stabilizing the 
ubiquitin structure 130•  Very briefly, this group found the ubiquitin conformation 
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to be more tolerant to mutations disrupting hydrogen bonding than to mutations 
disturbing the hydrophobic core of the protein, perhaps implying the latter conveys 
the major stabilizing contribution. Neither this nor any other group has tried to 
quantify the contribution made by the hydrophobic effect to the overall free energy 
of stabilization of ubiquitin. 
1.23(iv) The Ubiquitin Folding Pathway 
The folding pathway of ubiquitin has recently been investigated using the pulse-
labelling 2D NMR approach described in section 1.2.3(u). In this study, Briggs and 
Roder found that amide protons in the cc-helix and 3-sheet, as well as those 
involved in hydrogen bonds between these two regions of secondary structure, 
become protected from H-D exchange very quickly ( 8 ms ) after refolding is 
allowed to begin 155•  This indicates that these two elements of secondary structure 
rapidly form and associate with each other during folding, in fact the authors 
suggest that the formation and association of the a-helix and the 3-sheet is a co-
operative folding event. A much later folding event in the pathway seems to be the 
formation of the surface loop containing the 310-helix and the reverse turn 
incorporating residues 59,61 &69. These residues have much slower rates of 
protection from H-D exchange, indicating their loop stabilizing hydrogen bonds are 
correspondingly as slow in forming. 
Interestingly, this folding intermediate appears to remarkably similar to the alcohol 
induced partially structured state of ubiquitin described by Williams and co-
workers 134  The similarities are quite remarkable, both contain the a-helix and - 
sheet and both apparently lack the afore mentioned surface loop. Perhaps the most 
intriguing aspect of the partially structured state proposed by Williams is that it is 
effectively produced going in the opposite direction ( folded to unfolded ) to the 
refolding experiment of Briggs and Roder, implying the same intermediate is 
associated with both the denaturing and renaturing of ubiquitin 155 
wo 
Introduction 
1.3 Peptide Synthesis 
1.3.1 General 
The term "peptide" is derived from the greek word "pepsis" which means digestion 
(of proteins). Consequently, peptides are typically low molecular weight 
compounds, albeit low refers to their weight relative to proteins. At exactly what 
size a peptide ceases to be a peptide and becomes a protein is really a matter of 
taste, but 100 amino acids is generally recognized as being the cut-off point. The 
relationship between peptides and proteins goes far beyond this simple arithmetic 
connection, in that the majority of peptides actually originate from proteins which 
have been processed by specific enzymes. As with their protein counterparts, 
peptides are employed by nature to execute all manner of biological functions. 
Cellular assembly of peptides and proteins involves two distinct steps. DNA, the 
genetic blueprint for all peptides and proteins, is initially transcribed into mRNA 
which then acts as the template for their subsequent ribosome-mediated 
construction. Within the cell these processes are performed with great speed and 
fidelity, thus, accounting for the proliferation of cellular proteins. The peptide 
chemist, attempting to artificially carry out something that nature performs with 
almost unerring efficiency, is confronted by a whole host of problems that make 
chemical synthesis very laborious in comparison. Given the apparent difficulties of 
peptide synthesis, it is perhaps surprising to learn that Emil Fisher reported the 
synthesis of the dipeptide, glycylglycine, as long ago as 1901 156  The following 
sixty years saw a gradual understanding of the fundamental requirements and 
problems specific to peptide construction, and an appreciation of these allowed 
Merrifield to conceive solid phase peptide synthesis (SPPS) in 1963 157 
The field of peptide chemistry is now such a large one that it would be impossible 
to cover every facet of the subject within the limited space available, several 
reviews and books cover the subject thoroughly ( for example refs. 158, 159 ). 
However, there are selected crucial topics which should be discussed. 
1.3.2 Peptide Synthesis - A Chemical Challenge 
The majority of the chemical obstacles confronting the chemist can be adequately 
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Figure 1.10 A Dipeptide Illustrating the Trans-Peptide Bond 
As they stand, the two amino acids will simply not react with one another to form a 
peptide bond. This lack of nucleophilicity and electrophilicity can be attributed to 
the zwitterion nature of amino acids. To overcome this hurdle, a dehydrating agent, 
the so called "coupling agent" must be added to the mixture, this allows formation 
of the peptide bond to take place. If the two amino acids are different in any way, 
then clearly more than one product will be obtained ( see figure 1.11). 
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Figure 1.11 Ambiguity of a Simple Coupling Reaction 
Moreover, this problem is compounded by the observation that many of the side-
chains of amino acids contain functional groups (eg 4 & 5 figure 1.12 ) that can 
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Aspartic Acid (4) 	 Lysine (5) 
Figure 1.12 Reactive Side-Chains of Two Amino Acids 
The codon-anticodon system used by nature prevents such random processes from 
occurring, however, the chemist has to protect certain parts of the molecule from 
reaction in order to achieve complete specificity. Figure 1.13 illustrates a suitable 
protection strategy for the reaction of (4) with (5). 
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Figure 1.13 Unambiguous Condensation of Aspartic Acid and Lysine 
Until now only the construction of a dipeptide has been considered. If, however, we 
wish to extend the peptide any further, whilst retaining absolute specificity in each 
coupling step, then a level of orthogonality must be incorporated into the protection 
strategy. Clearly, either the N-terminal or the C-terminal protecting group will have 
to be removed, whilst leaving the remainder unaffected. 
1.3.3 Activation and Coupling Methods 
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Activation of the a-amino group can be brought about by, for example, conversion 
to the hydrazide 160•  This then facilitates the coupling to the carboxylic acid group 
of the next amino acid, as shown in figure 1.14. 
R 
I- - - -. - 	
AcyI—NHNH2 	+ 	HP 	CO2 





AcyI — NH—CH——NHNH2 (12) 
Figure 1.14 Hydrazide Activation in Peptide Synthesis 
Although this procedure involves some rather elegant chemistry, it does require 
somewhat elaborate side-chain protection, and for this reason is not commonly 
used. 
A far more convenient approach is to activate the carboxyl group to nucleophilic 
attack. Replacement of its hydroxyl function with any electron withdrawing group 
(X), will substantially increase the electrophilicity of the carboxyl group. 
Generation of the acid chloride is an obvious route to carboxyl activation and 
indeed this method was used in Fisher's early attempts at peptide synthesis 161 
Acid chlorides, though powerful acylating agents, do have one serious limitation. 
Under the reaction conditions, the commonly used urethane Na  protecting group 
becomes involved in a process which gives rise to N-carboxyanhydrides (14), these 
highly reactive amino acid derivatives are generally unsuitable for peptide synthesis 












Figure 1.15 Conversion of a Protected Amino Acid Chloride into an 
N-Carboxyanhydride 
The use of acid azides (15) in carboxyl activation also dates back to the turn of the 
century 162  While this mode of activation, pioneered by Curtius, is generally of 
greater practical importance than the acid chloride approach, it is limited by the 
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Figure 1.16 The Acid Azide Method 
Given that amines are readily acetylated using acetic anhydride, it is perhaps 
surprising that amino acid anhydrides were not used as coupling reagents from the 
outset. Several mixed anhydrides have enjoyed various levels of success as 
activating agents (reviewed in ref. 159). All of these can be conveniently prepared 
by treatment of the protected amino acid with condensing agents such as 
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diisopropyl- 163  or dicyclohexylcarbodiimides 164,  usually referred to as DIC and 
DCC respectively. By far the most widely used of these are the isobutylcarbonic 
acid mixed anhydrides (19). These have the advantage of producing easily removed 
carbon dioxide and isobutanol as by-products of the acylation reaction 165• 
o 0 
R_O4% O4_(C 3 	(19) 
CH 
Figure 1.17 Isobutylcarbonic Acid Mixed Anhydride 
Mixed anhydrides can of course react with amines to give two acylated products. 
This regioselectivity problem can be reduced by increasing the steric bulk of the 
non-amino acid component of the anhydride. Furthermore, the use of mixed 
anhydrides in which the amino acid component is more electrophilic than the other 
constituent 
( eg carboxylic-phosphinic mixed anhydrides 165 ) results in only the 
desired acylation being obtained. However, phosphinic anhydrides are known to be 
rather unstable, thereby limiting their application. Symmetrical amino acid 
anhydrides (21) possess no such limitation and have, thus, found widespread use. 
As with mixed anhydrides, they can be easily prepared from protected amino acids 
using DIC or DCC (20). 
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Figure 1.18 Symmetrical Anhydride Formation 
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Possibly the only disadvantage of the symmetrical anhydride approach, is that for 
every amino acid molecule coupled to the growing peptide one is lost as a by-
product of the reaction, thus making the procedure expensive. 
The active ester approach to coupling creates no such waste of expensive amino 
acids. Esters of amino acids only become sufficiently active when the alcohol 
component possesses a negative inductive effect, thereby rendering the carbonyl 
carbon more electrophilic. Ortho- and para-nitrophenyl esters were among the first 
widely used active esters 166•  Other, more recently introduced, active esters can be 
obtained from DICIDCC mediated condensation of 1 -hydroxybenzotriazole 











Figure 1.19 Two Commonly Used Alcohols in Esterification 
1.3.4 Na Protecting Groups 
The prerequisites of an effective N protecting group would be as follows: 
It must mask the amino group of an amino acid or peptide during the acylation 
step. This will ensure the correct peptide bond is formed. 
If the peptide is being synthesised from the C to N terminal, then it must also be 
removable under relatively mild conditions which leave all other protecting groups 
intact. 
Acylation of the a-amino group is an obvious, but ultimately unsuitable means of 
protection. Naacyl protecting groups are not only extremely difficult to remove, 
but also lead to oxazolone (24) formation during the activation step. Base 
abstraction of the a-CH proton after oxazolone formation leads to racemisation of 
the amino acid, as illustrated in figure 1.20. 
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Figure 1.20 Racemisation of NaAcyI Protected Amino Acids 
The observation that carbamic acids (26) spontaneously decarboxylate to give a 
free amino group, serves as the basis on which all modern-day Na  protecting 
groups are designed. Notional esterification of the carbamic acid gives rise to a 
urethane (25) which offers stable protection until its ester component is cleaved 
(see figure 1.21). 
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Figure 1.21 Urethane Deprotection 
The introduction in 1932 of the benzyloxycarbonyl or Z group (27) 169  not only 
signified the first successful application of a urethane to Na protection, but also 
stands as a milestone in peptide chemistry. Removal of the group can be achieved 
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Figure 1.22 Removal of the Z Group 
A demand for urethane protecting groups displaced under milder acidic conditions, 
led to the advent of tertiary butyloxycarbonyl ( Boc, (28) ) derivatives 170 
Urethanes of this type generate a very stable t-butyl carbocation (29) upon 
treatment of mild acid. Even greater acid lability is associated with the 2-(4-
biphenyl)propyl(2)oxycarbonyl (Bpoc) derivatives (30) 171• 
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Figure 1.23 Acid Labile Urethanes 
The difficulties associated with orthogonal protection strategies were greatly eased 
by the introduction of the base labile 9-fluorenylmethoxycarbonyl (Fmoc) urethane 
protecting group 172  Deprotection of Fmoc-amino acids (30) is brought about by 
treatment with a secondary amine. This abstracts the proton on the fluorenyl sp 3 
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fluorenyl sp 3 carbon, generating a stable anionic species (31) which then undergoes 
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Figure 1.24 Deprotection of an Fmoc Group 
The attraction of the Fmoc group is that it offers truly orthogonal peptide synthesis, 
since the side-chains of amino acids can be protected with acid labile groups. 
1.3.5 Side-Chain Protecting Groups 
In order to prevent branching of the growing peptide chain, as well as other well 
documented side reactions, it is necessary to protect the side chains of many amino 
acids 159, 173 The prerequisite for orthogonality means that the nature of this 
semi-permanent side chain protection will depend upon the choice of transient a-
amino protection. Table 1.4 shows typical side-chain protecting groups used with 
the Fmoc and Boc Na  protecting groups. 
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AMINO ACID FMOC STRATEGY BOC STRATEGY 
Lysine Boc 2C1-Z 174 
Arginine Pmc 175 NO2, Tos 
Serine, Threonine But Bzl 
Aspartic & Glutamic Acid OBut ()t,}{ 	176 
Histidine it-Bum 177,  t-Trt  178 it-Born 179,  t-Dnp 
Cysteine Acm 180,  Trt, S.But Acm, But, SBut 
Tyrosine But Bzl 
Glutarnine, Asparagine (Mbh) 181,  Trt  182 Trt  
Tryptophan None Forrnyl 
Methionine None None 
Glycine None None 
Alanine None None 
Valine None None 
Isoleucine None None 
Leucine None None 
Phenylalanine None None 
Proline None None 
( 	) = optional 
Table 1.4 	Fmoc and Boc Protection Strategies 
1.3.6 Synthetic Strategies 
If we consider the construction of an imaginary tetrapeptide, ABCD, then clearly 
there are three possible synthetic strategies (see figure 1.25). 
Assuming a similar yield for each coupling step, then route (ii) (fragment 
condensation ) will always give a higher overall yield than either route (i) or (iii) 
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Figure 1.25 Three Approaches to a Tetrapeptide 
Unfortunately, this simplistic view of things fails to take account of the chemistry 
involved. Routes (i) and (ii) both involve, at one stage or another, the activation of 
the carboxy-terminus of a peptide fragment, whereas route (iii) involves the 
acylation of an Na  peptide, except at the start. As we have already seen ( section 
1.3.4 ), activation of Naacylated amino acids or in this case a peptide, leads to 
5(4H)oxazolone (24) formation and ultimately racemisation. For this reason, 
strategy (iii) (C - N linear condensation ) is the most general approach to peptide 
construction. If the C-terminal amino acid of the peptide to be activated is glycine 
or proline, then clearly racemisation cannot take place and thus fragment 
condensation can be applied. However, this approach is limited to peptides 
containing these residues in a convenient position within the sequence. 
1.3.7 Solution Phase Peptide Chemistry 
Solution phase peptide chemistry has been successfully applied to the synthesis of 
many small peptides, such as oxytocin 183  and secretin 184  In most cases, 
considerations of racemisation have led to the C to N linear condensation approach 
being adopted. In order to maintain orthogonality, the C-terminal carboxy-group 
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must be protected in an analogous manner to side-chain carboxyl groups. Figure 
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Figure 1.26 Solution Phase Construction of a Tripeptide 
The four main problems inherent in solution phase synthesis are: 
1. Excess activated amino acids required to optimize each coupling step must be 
removed from the reaction mixture. 
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Peptide intermediates have to be individually purified. 
The number of acylation, deprotection and purification steps involved in 
constructing even the smallest of peptides, means all solution syntheses are 
extremely laborious 
Protected peptides become increasingly insoluble with increased length, this 
severely restricts the application of the solution phase method. 
1.3.8 Solid Phase Peptide Synthesis (SPPS) 
In 1963, aware of the problems of peptide construction in solution, Merrifield 
introduced the concept of solid phase peptide synthesis 185•  His ingenious idea was 
to use an insoluble polymer support ( a "resin" ) as a carboxy-terminal protecting 
group. Reaction of the C-terminal residue with a chioromethylated styrene-
(1 %)divinylbenzene copolymer (34), results in the attachment of the amino acid to 
the support (35). Elongation of the peptide chain can then be carried out using 
standard solution phase strategies ( see figure 1.28 ). Note that growth of the 
peptide chain actually occurs within polymer beads, which are swollen in solvents 
such as N,N dimethylformamide (DMF). 
Although Merrifield's original solid phase chemistry is still extensively used today, 
it does have one or two minor drawbacks. For example, the methodology is not 
strictly speaking orthogonal, both Na  and side-chain protecting groups are removed 
by acid, TFA and BF respectively. This results in a slow leakage of side-chain 
deprotection throughout the synthesis. Liquid hydrofluoric acid (HF) is an 
extremely corrosive acid and is not only difficult to handle, but can also catalyse 
several disturbing side-reactions such as N - 0 acyl-migration at serine residues 
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Figure 1.28 Merrifield SPPS of a Tripeptide 
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An alternative to the Boc-chemistry based Merrifield solid phase methodology uses 
Fmoc N protection and, hence, offers a means to truly orthogonal peptide 
synthesis ( see figure 1.29 ). Furthermore, the use of acid labile side-chain 
protecting groups, as well as the incorporation of the acid sensitive p-alkoxybenzyl 
alcohol linking group 186  (Wang linker, 36) between the peptide and the resin, 
means that final cleavage and deprotection can be accomplished under relatively 
mild conditions. This minimizes the undesirable side-reactions that occur upon 
cleavage of the peptide from the solid support. 
SPPS has now developed into the general method for peptide synthesis as it has the 
following advantages over the solution method. 
Simplified procedures: - unreacted reagents and by-products can be simply 
washed away. 
No need to isolate intermediates, therefore reduction in mechanical losses in 
addition to quicker syntheses. 
The methodology may be automated. 
Solid phase peptide synthesis offers a reliable and efficient approach to the 
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Figure 1.29 Modified SPPS of a Tripeptide 
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Chapter 2 - Discussion 
Section 2.1 Aims of the Project 
Solid phase peptide synthesis offers access to protein and peptide analogues 
inaccessible via recombinant techniques. Such derivatives could conceivably 
facilitate easier study of complex processes like folding. However, before these 
analogues can be chemically synthesised, it is necessary to prove beyond any doubt, 
that any artificially constructed wild type protein behaves in an identical manner to 
its cellular counterpart. Only then will any subsequent work have relevance. 
We chose to investigate the structural stability of ubiquitin by the construction of 
specific analogues. To begin with though, we were fully aware of the necessity of 
comparing the conformation of a synthetically constructed ubiquitin with that of a 
ribosomally constructed ubiquitin. 
At the outset of this work, the synthesis and purification of a polypeptide the size of 
ubiquitin was certainly at the very limit of what could be achieved by linear solid 
phase peptide synthesis. Therefore, our initial goal was to optimize both the 
synthesis and the purification of the protein, so as to facilitate the isolation of a 
homogeneous material. Having isolated and chemically characterized the synthetic 
ubiquitin, it was then our intention to study its structure and directly compare this 
with that of the natural material. Furthermore, it was necessary to assay the 
biological activity of synthetic ubiquitin and make a quantitative comparison with 
its natural counterpart. 
Assuming our synthetic ubiquitin resembled that of the natural material, it was 
planned to construct and study the behaviour of a carefully chosen specific 
ubiquitin analogue. 
Section 2.2 Background to Present Work 
An early attempt in this laboratory at the chemical synthesis of ubiquitin was 
reported in 1989 by Ramage and co-workers 187•  Synthesis of the polypeptide was 
carried Out using an NaFmoc SPPS strategy in which the side-chains of arginine 
residues were protected with the newly developed 2,2,5,7,8- pentamethylchroman-






Figure 2.1 The Pmc Protecting Group for Arginine 
An in house approach to real time assessment of the progress of the synthesis (see 
section 2.4 for details of monitoring system ) had revealed several problematic 
stages during the construction of the ubiquitin sequence. It was therefore no 
surprise that purification of the required material from the crude cleavage mixture 
proved difficult. The multi-step purification protocol eventually used comprised 
gel filtration chromatography, various types of ion exchange chromatography, 
chromatofocussing and semi-preparative high performance liquid chromatography 
(HPLC). However, this system was by no means ideal. For example, ion exchange 
chromatography was nowhere near as successful as had been hoped, probably 
because the conditions used were not optimum for ubiquitin. Nevertheless, this 
early work did lay the foundations for the more fruitful efforts which followed. 
A second synthesis of ubiquitin carried out by Briand and co-workers 188, fared 
little better than the original work of Ramage. This group had elected to use Boc 
chemistry with SPPS. Subsequent purification by gel filtration, medium pressure 
liquid chromatography and ion exchange chromatography afforded only 7mg of 
homogeneous synthetic ubiquitin. However, this group were able to show that this 
material was immunoreactive towards anti-ubiquitin antibodies and in addition 
demonstrated a conjugation activity comparable with natural ubiquitin. 
Section 2.2 Purification of Bovine Ubiquitin 
Given the apparent inadequacies of existing purification protocols, our initial 
priority was to develop a more effective approach to the purification of synthetic 
ubiquitin. Commercially available bovine ubiquitin (Sigma) is not only 
comparatively cheap, but more importantly, surprisingly impure ( approx 80% ). 
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Therefore it seemed rational to take advantage of this lack of homogeneity whilst 
designing a new purification strategy and remove the contaminants in the 
commercial sample. Such a protocol could then hopefully be successfully applied 
to the purification of synthetic ubiquitin, although of course the contaminants will 
be different. 
Two features of the original mode of purification, gel filtration chromatography 
and dialysis, were deemed sufficiently useful to be retained in the new strategy. 
The remainder of the steps were devised independently of any previous work. 
Crude bovine ubiquitin was subjected to the four step purification outlined below. 
1. Gel Filtration Chromatography 
This relies on the principle of size exclusion to separate the components of a 
mixture. The filtration matrix consists of swollen porous beads which can absorb 
molecules up to a certain size. Therefore, the small and large molecules that 
comprise a mixture will be divided into an absorbed fraction ( stationary phase) 
and an unabsorbed fraction (mobile phase) respectively. If a mixture is pumped 
through a column of gel filtration beads then this partitioning will result in the 
larger molecules of the mixture being eluted before the smaller ones. 
Of the various types of gel filtration media commercially available, we chose to use 
Sephadex G50 (fine) beads (Pharmacia). This packing is particularly useful for 
separations in the 500-10000 Da molecular weight range in which we are operating. 
Crude bovine ubiquitin was dissolved in a running buffer containing 8 M urea, 10 
mM DTT and 50 mM NH4OAc at pH 4.5. The components of this buffer were 
chosen carefully and with particular attention to the properties of crude synthetic 
ubiquitin. High concentrations of urea are known to solubilise protein suspensions. 
While this is of little consequence to the highly soluble bovine ubiquitin, the crude 
synthetic material obtained immediately after cleavage was known to be very 
difficult to get into solution. In addition, 8 M urea is known to denature 
ubiquitin' 12,  thereby conveniently erasing any of the misfolded synthetic ubiquitin 
molecules which might be expected to form during the harsh cleavage conditions. 
The sacrificial reducing agent dithiothreitol (DTT, 38) was included in the hope of 




Under these conditions gel filtration chromatography was found to remove the 
small contaminants found in crude bovine ubiquitin. Crude synthetic ubiquitin 
would of course contain small truncated peptide impurities, as well as organic 
scavenger molecules left behind after initial cleavage off the polymer support. All 
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Figure 2.2 Redox equilibrium of DTT 
2. Dialysis 
Dialysis is a purification technique which, like gel filtration, separates the 
components of a mixture based on molecular size and to a lessor extent charge. A 
typical dialysis membrane consists of amorphous regenerated cellulose in which the 
individual chains are crosslinked in such a way as to create pores. The degree of 
crosslinldng determines the size of these pores through which sufficiently small 
molecules can pass. Dialysis membranes of various porosity are commercially 
available, usually in the form of a cylindrical bag. A dialysis bag with a molecular 
cut-off of approximately 2000 Da was chosen for this work. If a ubiquitin solution 
is sealed in one of these bags surrounded by an aqueous solution, then anything in 
the protein solution of molecular weight less than about 2000 will be free to 
permeate through the bag until its concentration is the same either side of the 
membrane ( see figure 2.3 ). The concentration of solute molecules left in the bag 
will of course be negligible if a large volume of external solution is used. 
Dialysis was principally used as a means by which to control the refolding of our 
denatured post gel filtration ubiquitin. Slowly removing the denaturant from the 
internal solution, by dialysing against ever decreasing external concentrations of 
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Figure 23 Principle of Dialysis 
3. Ion Exchange _Chromatography 
Gel filtration and dialysis are convenient techniques for the removal of 
contaminants which differ markedly in size from the required material. However, 
removal of similarly sized impurities requires a different set of purification criteria. 
Ion exchange chromatography satisfies this requirement since it relies on ionic 
charge to separate a mixture. 
Peptides and proteins usually possess a nett positive or negative overall charge. 
This arises from the combination of individual charges on the basic (+ve) and 
acidic (-ye) side-chains of some amino acids (principally Glu, Asp, Lys & Arg). 
The individual pKa's of these residues results in the value and even the sign of the 
overall charge on a protein varying with pH. Furthermore, every protein has an 
associated pH, known as the isoelectric point (p1), at which the total positive charge 
exactly cancels out the total negative charge. If the pH is raised above the p1 then 
the protein will progressively become more negatively charged, whereas the further 
the pH drops below the p1 then the more positively charged it will become. Ion 
exchange exploits the fact that the components of a protein mixture each have a 
different p1 and so at any given pH will bind more or less tightly to a counter 
charged ion exchange matrix. The binding affinity is also inversely related to the 
ionic strength ( Debye-Huckel ) hence a combination of changing the pH and ionic 
strength, carried out by adjusting the concentration of the buffer, can be tailored to 
the separation in question. 
a) Cation Exchange Chromatography 
In cation exchange the immobilised counter-ion on the exchanger must be 
negatively charged. We decided to use the carboxy-methyl based exchanger, CM- 
Sepharose. Further purifying bovine ubiquitin by cation exchange requires the use 
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of a pH on the acidic side of its isoelectric point (p1=6.7). Therefore, semi-crude 
bovine ubiquiun was loaded onto the cation exchange column in a buffer 
containing 50 mM NH4OAc at pH 4.5. An initial pH gradient going from pH 4.5 to 
pH 5.5 was found to elute various small contaminants, however the bulk of the 
protein remained bound to the column. A subsequent salt gradient ( 50 mM to 0.3 
M NH4OAc at pH 5.5 ) did elute the material from the column, with good 
resolution being achieved between the different components of the mixture. 
b) Anion Exchange Chromatography 
The fourth and final step in the purification was anion exchange chromatography 
which was necessarily carried out at a pH above the p1 of ubiquitin. This technique 
requires the immobilised counter-ion to be positively charged and to this end the 
diethylarninoethane (DEAE)-Sepharose exchanger was chosen. Bovine ubiquitin 
having already been substantially purified by the above, was applied to the column 
in a buffer containing 50 mM NH4HCO3 at pH 9.3. Again a salt gradient (running 
from 50 mM to 0.3 M NH4HCO3 at pH 9.3) was found to give essentially baseline 
resolution of the eluted components, by far the major of which was the required 
material ( see figure 2.4). Anion exchange proved to be exceptionally sensitive to 
pH and even a minor deviation from the optimum pH of 9.3 resulted in an 
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Figure 2.4 Anion Exchange Chromatography on Bovine Ubiquitin 
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Analysis of purified bovine ubiquitin by isoelectric focussing electrophoresis (IEF) 
and analytical HPLC suggested its homogeneity had risen from around 80% to well 
in excess of 95%. The success of this protocol in purifying bovine ubiquitin was 
beneficial in two ways: 
It offered a new approach to the purification of a synthetic ubiquitin. 
It had afforded us with an exceptionally pure natural material which could be 
more easily used in comparative studies with a synthetic ubiquitin. 
Section 2.4 Synthesis and Purification of Ubiquitin 
2.4.1 SPPS of Ubiquitin 
Our approach to the solid phase kynthesis of ubiquitin employed the NaFmoc 
strategy introduced by Carpino 172  and subsequently developed by Shepard 189 
The invaluable information gleaned from previous attempts at the synthesis of 
ubiquitin in Edinburgh 187  was assimilated into our revised synthetic strategy. 
Constructing ubiquitin from the C-terminal towards the N-terminal requires the 
initial attachment of Gly-76 to the polymer support. Conversion of Fmoc-Gly-OH 
to the amino acid chloride (39), by treatment with thionyl chloride, allowed the p-
alkoxybenzyl alcohol resin 186  to be functionalized with this NaFmoc protected 
amino acid ( see figure 2.5). 
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(40) 
Figure 2.5 	Loading of the Resin 
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Of special concern at this stage was the number of available sites on the resin 
actually acylated with the Fmoc protected amino acid. Experience had suggested 
that a resin with high initial loading can lead to steric interactions occurring 
between growing peptide chains, especially towards the end of long syntheses. 
Such interactions could conceivably reduce yields in coupling steps, thereby 
accounting for some of the problems encountered in previous syntheses in which 
the degree of loading was as high as 70% of the available sites ( 0.44 mmol of 
glycine per gram of resin ). It was therefore decided to substantially reduce the 
functionality of the resin in an effort to minimize these unfavourable interactions. 
This was ultimately achieved by reducing the reaction time to 1 hour and molar 
ratio of Fmoc-Gly-Cl to resin to 2:1. Under these conditions the level of loading 
was lowered to around 40% (0.28 mmole per gram ) as established by UV analysis 
of a loaded resin sample deprotected by 20% piperidine in DMF. In addition, no 
glycyiglycine content could be detected by amino acid analysis, indicating the 
shorter reaction time had eliminated the small amount of polymerisation often 
associated with loading of glycine. The remaining 60% of functional groups on the 
resin were capped with benzoylchloride so as to eliminate the possible build up C-
terminal deletion peptides during the synthesis. 
Where necessary, amino acid side-chains were protected with the standard acid 
labile groups used with Fmoc based SPPS ( see table 1.4 ). For example, the 
guanidino group of arginine was protected by the Pmc group and the t-nitogen in 
the imidazole ring of histidine with the trityl (Trt) group (41). In a departure from 
previous syntheses, the amide groups of Asn and Gln were protected with the 4,4'-
dimethoxybenzhydryl (Mbh) group (42). These two amino acids had previously 
been left unprotected. 




Figure 2.6 The Trityl and Dimethoxybenzhydryl Protecting Groups 
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Solid phase peptide synthesis lends itself to automation and this synthesis of 
ubiquitin was carried out on an Applied Biosystems Model 430A peptide 
synthesiser. In an effort to obtain near quantitative acylation at each stage of the 
synthesis most of the amino acids were coupled once as their symmetrical 
anhydride and then twice as their HOBt active esters, each time using DIC as the 
condensing agent. The exceptions to this were Fmoc-His(Trt), Fmoc-Asn & 
Gln(Mbh) and Fmoc-Gly. Activation of Fmoc-His(Trt) as the symmetrical 
anhydride is known to lead to racemisation via the mechanism shown in figure 2.7. 
Prevention of this can be achieved by using a slightly less active species (rendering 
the carbonyl group less electrophilic ) during the coupling step 190  To that end 




X = FmocHis(Trt) 
Trt.... N * N + 
NWFmoc 
it enolisation 
Trt .. N 
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Figure 2.7 Racemisation of Fmoc-His(Trt) Anhydride 
Considerations of cost meant that Fmoc-Asn(Mbh) and Fmoc-Gln(Mbh) were also 
coupled three times as their HOBt active esters. Finally, Fmoc-Gly was coupled 
once in a single symmetrical anhydride step so as to avoid formation of 
glycyiglycine which can form as a result of multiple coupling procedures. Every 
acylation in the synthesis without exception was carried Out using a 1:1 mixture of 
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DMF:dioxan as the solvent, previous syntheses had used 100% DMF. Inclusion of 
the dioxan was observed to give the peptide-resin better swelling properties and 
hence render the growing peptide more accessible to peptide synthesis reagents ' 91 . 
Immediately after each coupling, acetic anhydride in DMF was added to cap any 
unreacted Naamino groups remaining on the peptide-resin, thus preventing the 
accumulation of deletion peptides. Capping was followed by deprotection of the 
NaFmoc group thereby exposing the next amino group to be acylated. Fmoc 
deprotection involved successive treatments with 20% piperidine in DMF for 
periods of 5, 3, 3 & 1 mm. In order for real time assessment of the synthesis a 
diluted aliquot of each deprotection solution, containing the chromophoric fulvene-
piperidine adduct (44), was monitored in a continuous flow mode from the 
synthesiser to a UV detector set at 302nm. An integrator allows the size of every 
deprotection peak to be compared with that of the previous amino acid. In this way 
the relative efficiency of each coupling and deprotection step can be monitored and 
the potential yield of the protein upon completion of the synthesis can be gauged. 
Moreover, unlike ninhydrin analysis 192  this approach does not require the removal 
of any resin from the reaction vessel thus maximising the final protein yield. 
ON 	 0 
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(44) 
Figure 2.8 Fulvene-Piperidine Adduct Formation 
On completing the assembly of the protected ubiquitin the final weight of peptide-
resin was 3.01 g compared to the initial polystyrene weight of 1.15 g. Figure 2.9 
illustrates the deprotection profile obtained for the ubiquitin synthesis from which 
the expected yield of peptide on the resin was approximately 70%. This 
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corresponds to an average yield of 99.8% for each of the 75 coupling steps and 75 
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Figure 2.9 Deprotection Profile for the Ubiquitin Synthesis 
The final amino acid, methionine, was left with its Fmoc group still attached so as 
to allow a quantitative assessment of the amount of this residue linked to the 
peptide. Deprotection of two samples of Fmoc-peptidyl resin with 20% piperidine 
in DMF followed by UV analysis of the piperidine adduct (44) gave yields of 48% 
and 58% for the final Fmoc-Met loading relative to the initial Fmoc content for 
Gly-76. These values probably represent a more realistic estimate of the yield on 
the resin than the rather erratic results obtained from on-line monitoring towards 
the end of the synthesis. 
2.4.2 Purification and Characterization of Synthetic Ubiquitin 
The large quantity (3g) of peptide-resin obtained from the synthesis meant that the 
purification had to be carried out in three batches. Note that all weights referred to 
in this section are in effect aggregate values. 
Before any purification could be carried out it was first necessary to cleave the 
polypeptide from the polymeric support and at the same time remove all side-chain 
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protecting groups. The NUFmoc protecting group on the peptidyl resin was 
initially removed with 20% piperidine in DMF. To remove the side-chain 
protecting groups and to cleave the peptide from the support, the peptidyl resin was 
treated with a mixture of thioanisole (5%, v:v), ethyl methyl sulphide (5%) and 
anisole (5%) for 20 minutes under nitrogen before adding water (5%) and 
trifluoroacetic acid (80%) and stirring at room temperature for 3.5 hours. 
Anisole (45) and thioanisole (46) were added to scavenge the But, Mbh and Trityl 
carbocations produced as by-products of the cleavage, thereby preventing 
alkylation of tyrosine and phenylalanine residues in the peptide. The anti-oxidant 
ethyl methyl sulphide (47) was added as a safeguard against methionine oxidation. 
OMe 	SMe 
I 	I 	MeSEt 
(45) 	(46) 	 (47) 
Figure 2.10 Scavengers used in Cleavage Mixture 
The optimum cleavage time was established by conducting a small scale (50 mg) 
experiment using the same concentrations of cleavage reagents to the above, but in 
reduced volumes. Samples of the TFA mixture were periodically removed from 
this trial cleavage and triturated with diethyl ether to remove scavengers and to 
precipitate the peptide. HPLC analysis of the resulting crude mixtures dissolved in 
aqueous acetic acid revealed a period of 3.5 hours to be the most suitable ( see 
figure 2.11). 
Following deprotection and cleavage the TFA was removed in vacuo leaving a 
brown residue which was subsequently triturated with diethyl ether containing 2% 
-mercaptoethanol. The precipitated peptide was immediately added to a nitrogen 
saturated gel filtration buffer containing 8 M urea, 10 mM DT1' and 50 mM 
NH4OAc at pH 4.5. This suspension was stirred for 16 hours to allow the crude 
peptide to fully dissolve. 
65 
Discussion 
Figure 2.11 HPLC Traces obtained from Trial Cleavage (C8 RP300, 
gradient system A) 
Purification of the required sequence from the crude mixture was accomplished 
using the four step procedure previously developed using bovine ubiquitin ( see 
section 2.3). 
Gel Filtration Chromatography 
The polypeptide solution was subjected to gel filtration on a Sephadex G50 (fine) 
column previously equilibrated with a nitrogen saturated buffer containing 8 M 
urea, 10 mM DIT and 50 mM NH4OAc at pH 4.5 (see figure 2.12a ). The 
required protein fractions, from which small organics and truncated peptides had 
been removed, were isolated and subsequently dialysed. 
Stepwise Dialysis 
The post gel filtration synthetic ubiquitin was allowed to renature by dialysing it 
against gradually decreasing concentrations of urea and dithiothreitol. On 
completion of the dialysis the solution was concentrated in vacuo to 20-30 ml in 
volume and a small sample analysed by HPLC ( see inset to figure 2.12a) and 
amino acid analysis (table 2.1). 
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3. Cation Exchange Chromatography 
The desired material from dialysis was further purified by cation exchange 
chromatography on a CM-Sepharose column pre-equilibrated with starting buffer. 
After loading the synthetic material onto the column an initial pH gradient running 
from pH 4.5 to pH 5.5 was found to elute some contaminants, however the bulk of 
the polypeptide remained bound to the column. Having been left to run isocratically 
at pH 5.5 for approximately 0.5 column volumes a salt gradient of 50 mM to 0.3 M 
NH4OAc at pH 5.5 was applied to elute the protein from the column (figure 2.12b). 
The resulting fractions were isolated and combined on the basis of their HPLC 
spectra (inset to figure 2.12b ) and elution times. Repeated lyophilisation was 
found to remove most of the salt from the combined fractions which were then 
analysed by amino acid analysis (table 2.1). 
5t4(e1!1tJ!! 
The required fractions from the CM-Sepharose column were dissolved in 50 mM 
NH4HCO3 at pH 9.3 and loaded onto a pre-equilibrated DEAE-Sepharose column. 
A linear salt gradient of 50 mM to 0.3 M NH4HCO3 at pH 9.3 was applied and gave 
rise to two peaks, labelled A and B (see figure 2.12c ). The fractions corresponding 
to these two peaks were isolated and repeatedly lyophilised to remove salt, 
thereafter affording 71.8 mg of A and 21.7 mg of B. As with the bovine ubiquitin 
purification, anion exchange chromatography proved to be remarkably sensitive to 
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Figure 2.12 Purification of Synthetic Ubiquitin 
a) Gel Filtration b) Cation Exchange c) Anion Exchange 
Shaded areas are the protein fractions isolated. Insets show 
analytical HPLC spectra (C 8-RP300, gradient A) obtained. 
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Analysis of A & B by analytical HPLC (inset to figure 2.12c ) revealed they both 
possessed single peak purity. Furthermore, both had identical retention times to 
bovine ubiquitin on the C. RP300 column (16.9 mins, gradient system A). Amino 
acid analysis further highlighted the similarities between synthetic A and B, both of 














Asx 7 7.44 7.40 7.54 7.34 
Thr 7 5.12 4.12 5.88 5.36 
Ser 3 2.64 0.78 2.29 1.85 
Gix 12 10.82 13.62 13.00 12.50 
Pro 3 - 3.30 3.54 2.29 
Gly 1 	6 5.66 5.83 6.29 5.87 
Ala 2 1.98 1.79 2.05 1.90 
Val 4 4.64 4.00 4.02 3.94 
Met 1 0.39 0.95 0.95 1.00 
Ile 7 5.83 6.53 6.78 6.73 
Leu 9 8.11 9.29 9.22 9.10 
Tyr 1 1.45 1.26 0.98 1.15 
Phe 2 1.65 2.11 2.06 2.07 
His 1 0.99 1.02 0.94 0.98 
Lys 7 5.28 7.02 7.04 6.98 
Arg 4 3.74 4.06 4.05 1 	4.07 
Table 2.1 	Amino Acid Analysis at Various Stages of the Purification 
40 h hydrolyses in 6 N HCI (5 mg/ml Na2SO) at 1100C 
The isoelectric points of synthetic A and B were determined by Isoelectric 
Focussing Electrophoresis (IEF) to be identical with that of purified bovine 
ubiquitin (p1=6.7). Moreover, IEF provided additional evidence for the high level 
of homogeneity initially suggested by HPLC and amino acid analysis ( see figure 
2.13). 
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Figure 2.13 Isoelectric Focussing Electrophoresis 
lanel = bovine Ub, Iane2 = synthetic Ub A 
Iane3 = synthetic Ub B 
An antibody binding assay ( Western Blot ) was carried Out to compare the 
immunoreactivity of A & B with purified bovine ubiquitin (see figure 2.14). After 
an initial [EF gel the proteins were electroblotted onto nitrocellulose and probed 
with rabbit anti-ubiquitin IgG polyclonal antibodies. An anti-rabbit IgG horse-
raddish peroxidase conjugated secondary antibody was then used to visualize the 
initial anti-ubiquitin antibody. On staining this secondary antibody it was apparent 
that both synthetic materials had very similar immunoactivities to purified bovine 
ubiquitin. Although this is additional evidence for the equivalence of A, B and 
bovine ubiquitin, it should be noted that polyclonal antibodies would more than 
likely recognize continuous epitopes in a truncated or deleted ubiquitin peptide. For 
this reason such a result cannot be construed as a conclusive piece of evidence for 
the three materials being the same. 
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Figure 2.14 Western Blot of Bovine Ub (lane!), Synthetic A (lane 2) 
and Synthetic B (lane3). 
A preliminary mass determination using Laser Desorption Time-Of-Flight Mass 
Spectrometry (LD-MS 193  revealed A and B to have masses of 8568.5 and 8571 
Da respectively. Given that the theoretical mass of ubiquitin is 8565 Da, both these 
experimentally obtained masses were within the error limitations of the instrument 
and hence both materials appeared to have the correct mass for ubiquitin. 
Amino acid analysis and mass spectrometry together suggested synthetic A and B 
had the correct chemical composition for ubiquitin. However, one possible 
explanation for the separation of A and B on the DEAE-Sepharose column was that 
they were diastereomers. Racemisation of amino acids, especially histidine, is often 
associated with peptide synthesis ( see figure 2.7 ), therefore the chiral integrity of 
the amino acids in A and B was checked by carrying Out an enzymatic digestion. 
Three enzymes, pepsin, prolidase and aminopeptidase, all of which recognize only 
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L-amino acids, were used to hydrolyse the two synthetic materials into their 











Asp 5 4.21 4.90 4.63 
Thr 1 	7 9.30 8.85 8.56 
Ser 3 4.67 4.63 4.48 
Glu 6 7.71 6.92 6.71 
Pro 3 2.32 2.40 2.64 
Gly 6 6.24 7.05 6.56 
Ala 2 1.81 2.11 2.07 
Val 4 4.27 4.17 4.00 
Met 1 Met 0 Met 0 Met 0 
Ile 7 6.87 6.65 6.40 
Leu 9 10.35 10.66 10.62 
Tyr 1 0.98 1.46 0.37 
Phe 2 2.70 2.50 2.49 
His 1 1.05 0.92 1.04 
Lys 7 6.36 6.30 6.00 
Arg 4 3.95 3.56 3.50 
Table 2.2 	Total Enzymatic Digestion of A, B and Bovine Ubiquitin 
Although amino acid analysis of these enzymatic hydrolyses did not in general give 
as accurate a set of ratios as analysis of the corresponding acid hydrolyses, it did 
however provide some valuable information. For example, the histidine content in 
both A and B was clearly as required, indicating no racemisation of this amino acid 
had in fact taken place. Evidently the precautions taken to minimize this had been 
successful. Furthermore, asparagine and glutamine residues were not hydrolysed to 
their constituent acids, therefore only the true Asp and Glu contents were observed. 
This made such an enzyme hydrolysis complementary to the acid hydrolysis. 
Enzymatic hydrolysis is not only sensitive to the chirality of amino acids, but also 
to their isomorphism. For example, during cleavage aspartic acid residues can, 
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under extreme conditions, rearrange to -aspartamate (50) via the succinimide 











Figure 2.15 3-AspartyI Formation 
Such a rearrangement cannot be detected by acid hydrolysis of the peptide since 
aspartic acid is still the hydrolysis product. However, an enzyme at neutral pH 
would not recognize the 3-amino acid and so could not fully digest such a peptide. 
Neither synthetic A nor synthetic B is conspicuously low in aspartic acid residues 
relative to bovine ubiquitin, suggesting this type of rearrangement had not occurred 
in either case ( see table 2.2). This contention was given further credibility by the 
remarkable similarity of the 2D NMR spectra of synthetic A and B. Figure 2.16 
shows the amide to CH crosspeak region in the TOCSY spectrum of A 
superimposed upon the same region in the TOCSY spectrum of B. This part of the 
spectrum, known as the fingerprint region, is extremely sensitive to tertiary 
structure and such a high level of coincidence is strong evidence indeed for both 
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Figure 2.16 	Comparison of the TOCSY Spectrum of A (red) and B 
(black). Spectra obtained in 90% H 20: 10% D20 at 
pH 4.8,500C 
Having as far as possible demonstrated that synthetic A and B were chemically 
identical, the observation that at pH 4.8 they were also conformationally equivalent 
presented quite a dilemma. It seemed likely that the answer to this problem lay in 
the conditions used in the final anion exchange step of the purification. The high 
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pH of 9.3 may well have been enough to partially denature the synthetic material 
and hence account for the two peaks observed. If this were the case then not only 
would both materials be chemically identical, but at reduced pH the partially 
denatured state may well refold. This could of course explain why A and B had the 
same TOCSY spectrum at pH 4.8. 
To investigate this possibility a sample of synthetic A was dissolved in a buffer 
containing 20 mM piperazine at pH 9.6 and a small sample of this solution 
periodically analysed by anion exchange chromatography. This involved loading a 
fixed volume of this solution onto an analytical Mono Q FPLC (Fast Protein 
Liquid Chromatography ) column pre-equilibrated with starting buffer, thereafter 
applying a salt gradient of 0 to 1 M NaC1 to elute the protein. Our hypothesis was 
vindicated by the gradual appearance of a second peak on each successive FPLC 
ace ( see figure 2.17(a)). 
(a) 0 h 5 h ,J \ 22 I 4 
(b) 




Figure 2.17 FPLC Monitored Equilibration of Synthetic (a) and 
Bovine Ubiquitin (b) to the A and B Forms 
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By estimating the relative areas of the two peaks and knowing the total number of 
moles injected onto the column, it was possible to show that this equilibrium 
process initially obeyed first order kinetics ( see graph 2.1 and table 2.3 ). 
Moreover, the second peak completely disappeared after dialysing the protein 
solution back to pH 7.0, indicating both the reversible nature and pH dependence of 
the denaturation process. That synthetic material B was indistinguishable from 
material A under these FPLC conditions surely affirms that its initial isolation from 
the DEAE column was as a result of the high pH conditions used. Subsequent 








0 	5e+004 	1e+005 1.5e+005 2e+005 
Time, (seconds) 
• Synthetic Ubiquitin 
A Bovine Ubiquitin 
Graph 2.1 	[B] Form vs Time for Synthetic and Bovine Ubiquitin 
Purified bovine ubiquitin was also shown to undergo an equilibration process when 
dissolved in 20 mM piperazine at pH 9.6 ( see figure 2.16(b) ). This appeared to be 
a first order process approaching equilibrium and gave a rate constant similar to 
that of synthetic ubiquitin (graph 2.1 & table 2.3 ). The position of the equilibrium 
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appears to be further in favour of the less stable form for synthetic ubiquitin (K = 
0.97 ) than for bovine ubiquitin (K = 0.50 ) implying that the former is more easily 
denatured than the latter. While it is possible that synthetic ubiquitin has a 
somewhat less stable conformation than bovine ubiquitin, it should be stressed that 
this experiment was designed primarily to show an equilibrium did exist and not to 
accurately pin-point the position of such a process. 
ks 1 K 
Synthetic Ubiguitin 112±0.73 e -6 0.97 
Bovine Ubiguitin 85 ± 0.98 e -6 0.50 
Table 2.3 	Kinetic and Thermodynamic Data on the Equilibration of 
Bovine and Synthetic Ubiquitin 
From this FPLC work it is fair to conclude that synthetic materials A and B are in 
fact constitutionally identical, albeit initially in different conformations. This means 
that the overall yield of synthetic ubiquitin was 93.5 mg or 4.4%, a ten fold 
increase in yield over any previous attempts at the construction of the protein. 
Having resolved the A and B problem some additional characterization of the 
synthetic ubiquitin was performed. A preliminary mass determination using laser 
desorption mass spectrometry (LDMS) had given satisfactory results for synthetic 
ubiquitin, however it was felt that electrospray mass spectrometry could perhaps 
afford an even more accurate mass determination on the polypeptide ( see figure 
2.18 ). Unlike LDMS this technique does not rely on time-of-flight as a means of 
mass determination instead employing the more familiar quadrapole detection 
system. Although quadrapole detection becomes increasingly less useful as the 
sample gets larger, it will usually yield a more accurate result than time-of-flight 
detection for a protein the size of ubiquitin due to multiple charging. This technique 
did indeed prove to be superior to LDMS, providing a molecular mass of 8564.8 
Da for synthetic ubiquitin compared to a theoretical mass of 8564.9 Da. 
Furthermore, apart from the sodium salt at 8586 Da there were no signs of any 






Figure 2.18 Electrospray Mass Spectrometry on Synthetic Ubiquitin 
Showing the Calculated Mass at 8564.8 Da plus the Sodium 
adduct at 8586 Da 
Extensive characterization of the primary structure of the protein was carried out by 
automated Edman degradation which was fortunate in sequencing through to 
residue 67 without ambiguity. This technique alone, starting as it does at the 
portion of the molecule synthesised last, almost suffices in proving the primary 
sequence was free of deletions. 
Pepude Peptide sequencea 
T-O Ala-Lys (28-29) 
T-1 Ile-Gln-Asp-Lys(30-33) 
T-2 Leu-Arg-Gly-GIy (73-76) 
T-3 Thr-Leu-Thr-Gly-Lys (7-11) 
T-4 Gln-Leu-Glu-Asp-GIy-Arg (49-54) 
T-5 Glu-GIy-Ile-Pro-Pro-Asp-Gln-Gln-Arg (34-42) 
T-6 Thr-Leu-Ser-Asp-Tyr-Asn-Ile-Gin-Lys (55-63) 
T-7 Leu-Ile-Phe-Ala-GIy-Lys (43-48) 
T-8 Met-Gin-Ile-Phe-Val-Lys (1-6) 
T-9 Glu.Ser-Mu-Leu-His-Leu-Val-Leu-Arg (64-72) 
T-10 I ThrI1eThr.Leu.G1u.VaIG1u.PrSer-ASP-Thr-fleG1U.ASflVa1LYs (12-27) 	jI 
Table 2.4 	Identification of the Peptides arising from Tryptic Digest 
of Ubiquitin. a  Determined by amino acid composition. 
Residue numbers are given in parenthesis 
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Figure 2.19 Tryptic Map of Synthetic Ubiquitin 
Separation performed on a C 18 Vydac HPLC Column 
Finally, enzymic digestion of the synthetic material with trypsin 196  further 
demonstrated that its primary sequence matched that of ubiquitin. Isolation of the 
resulting peptide fragments by HPLC ( figure 2.19 ), followed by amino acid 
analysis of these (table 2.4), confirmed the tryptic map was that of ubiquitin. 
In conclusion, ubiquitin has been chemically synthesised and purified in 4.4% 
overall yield. Exhaustive chemical and biochemical characterization of this 
synthetic protein not only confirms that it is the required material, but also that it is 
>95% homogeneous. 
2.43 Structural Analysis of Synthetic Ubiquitin 
At the outset of this work it was known that simply constructing the ubiquitin 
primary sequence was not in itself enough, the synthetic protein would also have to 
adopt the same folded state as natural ubiquiiin before the synthesis was deemed a 
success. Therefore the conformation of the synthetic ubiquitin was investigated 
using both classical techniques, as well as the more comprehensive X-ray 
crystallography and nuclear magnetic resonance approaches. 
2.43(i) Ultra-Violet Absorption Spectroscopy 
Ubiquitin contains a single tyrosine residue in a conformationally sensitive region 
of its tertiary structure, hence this can be used as a convenient probe into the 
conformation of the protein. In the crystal structure of natural ubiquitin the phenolic 
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group of Tyr-59 is known to hydrogen bond to the backbone nitrogen of Glu-5 1 
which would of course raise the pKi of the phenolic group in the tyrosine. Ultra-
violet absorption spectroscopy allows this pKi to be determined since the ionised 
phenolic group absorbs at a wavelength independent from the rest of the 
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Figure 2.20 lonisation of the Phenolic Group in Tyrosine 
A simple base titration monitored by UV absorption at 295 nm affords the pKi of 
the tyrosine. At 298K the pKi of the tyrosine in purified bovine ubiquitin was 
found to be 11.00 
( 
see graph 2.2) and this agrees with a value of 11.10 determined 











- 	 T=30'K ~  
- 
— 	
T 297.8K =  
- 
- 
ii . I 	• 	
I 	 • 
6 	8 	10 	12 	14 
pH 
Graph 2.2 	Spectrophotometric Titration (295 nm) of the Phenolic Group in 
the Tyrosine of Purified Bovine Ubiquitin at Two Temperatures 
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At the same temperature the tyrosine in synthetic ubiquitin has a pKi of 10.50 ( see 
graph 2.3). Although slightly lower than in bovine ubiquitin the tyrosine pKi in 
synthetic ubiquitin is still substantially higher than in several other proteins ( see 











T = 307.5K / T = 297.8K 
z' 
6 	8 	10 	12 	14 
pH 
Graph 2.3 Spectrophotometric Titration (295 nm) of the Phenolic Group 
of Tyr-59 in Synthetic Ubiquitin at Two Temperatures 
When these experiments are carried out at more than one temperature, the resulting 
pKi data can be used to calculate the heat of ionisation (AHi) of the phenolic 
group 197499. The heat of ionisation can be obtained from the change in pKi with 
temperature using relationship (1). 
pki 1 Hi 	= 	2.303*R* LA (lIT) J 
A value of 10.6 kcal mo1 1 was obtained for Al-li of the tyrosine in synthetic 




Example pKi, 298K pKi, 308K tHi, Kcal moE 1 
Synthetic Ub 10.50 10.25 10.6 
Bovine Ub 11.00 10.75 10.8 
BSA 197 11.50 11.20 11.5 
Insulin 198 9.70 NA 7.5 
Ribonuclease 199 9.92 NA 7.0 
Pepsin 197 9.50 NA 6.0 
Phenol 197 9.78 NA 6.1 
Tyrosine 197 10.05 9.90 6.0 
Tyr-Arg 199 1 	9.60 NA 6.0 
NA = Not Available 
Table 2.5 	Thermodynamic Data on Synthetic and Bovine Ubiquitin 
While this thermodynamic data suggests the tyrosine in synthetic ubiquitin is in a 
similar environment to the tyrosine in bovine ubiquitin, the slightly smaller value of 
AJ{i obtained for the former may be because the H-bond between the tyrosine and 
Glu-5 1 is not as strong as in the latter. 
2.4.3(u) Quenching Studies on the Tyrosine Fluorescence 
Fluorescence spectroscopy can perhaps best exploit the solitary tyrosine probe in 
ubiquitin. It is a considerably more sensitive technique than UV spectroscopy and 
should be able to detect subtle changes in the immediate environment of the 
tyrosine fluorophore. 
The fluorescence of a protein solution can be quenched by addition of an external 
heavy atom such as the iodide ion 200201  Collisions with these heavy atoms 
causes spin-orbital perturbation in the fluorophore. This in turn leads to intersystem 
crossing from an excited singlet state ( from which fluorescence would normally 
occur) to a non-fluorescent triplet metastable state ( see figure 2.21). 
Intersystem crossing is usually a forbidden transition and for this reason will only 
occur when a heavy atom collides with the fluorophore 202  Hence, the more 
collisions that take place, the more the fluorescence is quenched. Obviously 
fluorophores residing on the surface of a protein will have their fluorescence 
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Figure 2.21 Principles of Fluorescence and Intersystem Crossing 
If a protein contains a single fluorophore ( eg ubiquitin ) then the degree of 
quenching is related to the heavy atom concentration [HA] by the Stern-Volmer 
law (2). 
F°/F=14-KQ [HA] 	 2 
Where F is the fluorescence at a particular heavy atom concentration, F° is the 
fluorescence in the absence of any heavy atoms and K Q is the Stern-Volmer 
constant. A plot of F°/F vs [HA] should give a straight line of slope K Q. Clearly the 
larger KQ then the more exposed the fluorophore is to the bulk solvent. 
The tyrosine fluorescence in both synthetic and purified bovine ubiquitin was 
quenched by gradually increasing the concentration of iodide ions in the protein 
solution. Graph 2.4 shows the resulting Stern-Volmer plots obtained for the two 
proteins, as well as for an N-acetyl-tyrosine ethyl ester (ATEE) control. 
Example KQ M 
Synthetic Ub 1.82 ±0.05 
Bovine Ub 1.76± 0.08 
ATEE 5.00±0.167 
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Graph 2.4 Stern-Volmer Plots 
The experimentally obtained values of KQ are shown in table 2.6. Synthetic and 
bovine ubiquitin have almost identical Stern-Volmer constants, indicating the 
tyrosine in each has a similar exposure to the bulk solvent. In addition, compared to 
ATEE, which corresponds to complete exposure to the solvent, the values of K Q for 
the ubiquitin is quite small. This suggests the tyrosine in ubiquitin is at least 
partially buried in the structure. Indeed, this is observed to be the case in the crystal 
structure of the protein. 
2.4.3(iii) Denaturation Studies on Synthetic and Bovine Ubiquitin 
The sensitivity of fluorescence spectroscopy to changes in protein structure makes 
it an ideal technique for monitoring the behaviour of a protein exposed to varying 
concentrations of a denaturant, such as guanidinium hydrochloride (GdmCI). A 
protein in its native conformation will generally fluoresce with different intensity to 
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that same protein in a denatured state. This is because in the folded state the 
fluorescence of a protein is partially quenched by amide bonds in the surrounding 
structure. In the unfolded state such bonds are often no longer in the proximity of 
the fluorophore and hence the fluorescence is no longer quenched. Note that in 
some cases ( eg, barnase 142 ) this is the other way round leading to a lower 
fluorescence intensity in the denatured state than in the native form. 
Gradually increasing the [GdmCl] gives rise to a characteristic fluorescence 
denaturation curve from which it is possible to abstract useful thermodynamic 
information on the protein. At any particular denaturant concentration the 
equilibration constant for unfolding, Ku, can be calculated from equation (3), 
Ku = (FN  - F) / (F - FU) 	 3 
where F is the observed fluorescence and FN  and Fu are the values of the 
fluorescence for the native and unfolded form of the protein. The free energy of 
unfolding, AGu, is related to the concentration of the denaturant by equation 
(4)203 . 
iGu = GHZO - m [denaturant] 	 4 
Given that LGu can also be calculated from the fundamental relationship (5), 
Gu = RT1flK 
	
5 
then a plot of iGu vs [denaturant] will afford the free energy of stabilization, 
tG11201 if extrapolated back to the y axis. The free energy of stabilization can also 
be obtained by non-linear regression analysis (Grafit, Microsoft) using equation 
(6) which is derived from equations (3-5). 
F mG 	1 F = FN - [FN - FU ] / 1 + EXP 	-[D] L 6 8 .314* T j  
Graph 2.5 shows the change in tyrosine fluorescence ( measured at 303 nm ) 
produced upon addition of GdmCl to a synthetic ubiquitin solution. The nature of 
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this denaturation curve reveals that the tyrosine fluorescence in synthetic ubiquitin 
is partially quenched in the folded state. 
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Graph 2.5 GdmCl Induced Unfolding of Synthetic Ubiquitin 
Similarly, graph 2.6 shows the fluorescence unfolding curve obtained for purified 
bovine ubiquitin under identical conditions. Clearly the tyrosine fluorescence is 
also quenched in the folded state of the natural protein. Non-linear least squares 
analysis of these data sets ( using equation 6 ) yielded the free energy of 
stabilization, AGH201 for the synthetic and bovine materials (see table 2.7). 
Example AG 0 kcal mold 
Synthetic Ubiguitin -8.1 ± 0.8 
Bovine Ubiguitin -8.0 ± 1.0 
Barnase 142 -9.4 
Table 2.7 Free Energy of Stabilization (iG 0) Data 
The value of iGH20 obtained for synthetic ubiquitin compares favourably with that 
of its natural counterpart, again pointing to the two materials having a similar 
conformation in solution. Furthermore, the free energy of stabilization for ubiquitin 
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is not much different from that calculated for barnase 142  This is especially 
encouraging given that barnase, like ubiquitin, is a relatively small protein with a 
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Graph 2.6 GdmCl Induced Unfolding of Purified Bovine Ubiquitin 
2.4.3(iv) Circular Dichroism Studies on Synthetic and Bovine Ubiquitin 
Circular dichroism (CD) spectroscopy is a technique which unlike UV absorption 
or fluorescence spectroscopies, provides quantitative information on the secondary 
structure content of a protein. The fundamental feature peculiar to CD is that the 
protein solution is exposed to plane polarised light, which can be regarded as a 
mixture of right- and left-handed circularly polarised light. If the protein contains 
structural elements in which the individual chiral chromophores are arranged non-
randomly ( eg, a helix), then at any given wavelength these left- and right-handed 
components will be absorbed to different extents. In effect, this results in the light 
emerging from the protein being tilted through an angle 0 relative to the 
polarisation of the incident light. In general the more secondary structure a protein 
contains then the larger this angle will be. 
As in the previous structural studies, we directly compared synthetic ubiquitin with 
purified bovine ubiquitin. In work carried out at the Scottish circular dichroism 
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facility in Stirling University 204,  the far UV CD spectra of synthetic and bovine 




Synthetic Ubiquitin 	 Bovine Ubiquitin 
Figure 2.22 Far UV CD Spectra of Synthetic and Bovine Ubiquitin in 
50 mM Boric Acid at pH 7.5 
The secondary structure content of synthetic and natural ubiquitin were determined 
using the CONTIN procedure devised by Provencher and Glockner 205 •  This 
involves comparing the 190-240 nm region in the CD spectrum of the sample with 
a linear combination of the CD spectra of 16 proteins whose secondary structures 
are known from X-ray crystallography. In general, this technique provides more 
reliable results than direct comparison with a single reference spectrum 206  Table 
2.8 summarises the secondary structure contents calculated using this procedure. 
Example a-helix f-sheet Remainder 
Crystal Structure 14.4% 42% 43.5% 
Bovine Ub, pH7.5 15±2.5% 57±2.6% 28 ± 4.5% 
Synthetic Ub,pH7.5 16±1.1% 53± 1.9% 32±2.1% 
Bovine Ub, pH9.3 17±0.7% 32± 1.3% 51 ±1.2% 
Synthetic Ub, pH9.3 20±0.9% 32± 1.8% 48±1.6% 
Table 2.8 	Secondary Structure Contents Derived From CD 
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From these results synthetic and bovine ubiquitin would appear to have very similar 
secondary structure compositions at pH 7.5. In each case the calculated proportion 
of cc-helix in the structure is much closer to the known value ( from the crystal 
structure) than is the rather high 13-sheet content. 
Having established that COY-MN treatment of the CD spectra gives reasonably 
accurate secondary structure data, we decided to investigate the effect of high pH 
on the CD spectra of synthetic and bovine ubiquitin ( see figure 2.23). 
10000. 
tOOOO kI 
Syn & Boy Ub, pH 7.5 Syn &Bov Ub, pH 9.3 
Figure 2.23 Effect of pH on the Far UV CD Spectra of Synthetic 
and Bovine Ubiquitin 
Previous studies had revealed a partial denaturation of ubiquitin at high pH (section 
2.4.2 ). This denaturation apparently manifests itself as a slight increase in a-
helicity and a substantial drop in 13-sheet content when the CONTIN procedure is 
applied to the CD spectra of synthetic and natural ubiquitin (table 2.8 ). Although 
the small rise in the a-helix content is a rather curious observation, the considerable 
loss of f3-sheet at the high pH was consistent with the formation of a denatured 
state. Indeed, a similar drop in 13-sheet content was associated with the alcohol 
induced molten globule state of ubiquitin reported by Williams et a1134. 
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2.4.3(v) NMR Spectroscopy Studies on Synthetic Ubiquitin 
By far the most comprehensive way of studying the solution conformation of a 
peptide or protein is to use NMR spectroscopy. Present day high-field NMR 
spectrometers can yield considerable information on proteins up to around 15 kDa 
in size. This is in part due to the resolution of these instruments and also because of 
the ascendancy of multi-pulse experiments which afford invaluable information on 
the interconnectivities of individual resonances in a spectrum. Such two 
dimensional NUR experiments not only allow complete assignment of complex 
spectra like those of proteins, but also facilitate the identification of secondary and 
tertiary structure within these molecules. Three of the most commonly used 2D 
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Figure 2.24 Three commonly used 2D NMR Experiments and the 
Connectivity Information they yield 
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All 2D NMR experiments have a variable delay time (ti) between the first two 
pulses. Gradually increasing the length of t in standard increments produces a 
corresponding set of free induction decays (FIDs) which when Fourier transformed 
in two dimensions give rise to the familiar 2D NMR spectrum. A comprehensible 
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Figure 2.25 Region From TOCSY Spectra of Synthetic (Red) and Bovine 
Ubiquitin (Black) obtained in 90% H 20:10% D 20, pH4.8, 50CC 
Discussion 
There have been two thorough 2D 'H NMR studies carried out on natural 
ubiquitin4'5 and together these greatly eased the proton NMR assignment of the 
synthetic material. As in all previous studies, synthetic ubiquitin was directly 
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Figure 2.26 Region From the NOESY Spectra of Synthetic (Red) and 
Bovine Ubiquitin (Black), 90/10% H 20/D20 at pH4.8, 50°C 
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A TOCSY experiment was performed on both synthetic and bovine ubiquitin using 
conditions identical to those in the original papers 45.  Figure 2.25 shows a 
superimposition of the aNH - CH crosspeak regions in the two spectra. This part of 
a TOCSY spectrum is very sensitive to the solution conformation of a protein and 
for this reason is often known as the fingerprint region 121  Consequently, the 
exceptional level of coincidence between these two spectra was strong evidence 
that synthetic ubiquitin had adopted the native conformation. Furthermore, a direct 
comparison with the natural ubiquitin 1H assignment 45  allowed 529 out of the 
579 observable protons in synthetic ubiquitin to be easily identified ( this data is 
tabulated in appendix 1). 
An even more precise measure of a protein's solution conformation is its NOESY 
spectrum. This experiment, which affords all important through space interactions, 
was performed on both synthetic and natural ubiquitin using conditions equivalent 
to those employed in previous studies 4'5  (see figure 2.26). Again, the spectrum 
obtained for synthetic ubiquitin was more or less indistinguishable from that 
acquired for purified bovine ubiquitin. Given that the presence of a crosspeak in a 
NOESY spectrum is very much dependant upon the structure of the molecule, such 
a high degree of congruence proved conclusively that both materials had an 
identical tertiary structure in solution. Upon mixing natural and synthetic ubiquitin 
only a single set of NMR crosspeaks were obtained in a TOCSY experiment, this is 
effectively the ultimate piece of evidence for the equivalence of the two materials. 
2.4.3(vi) X-Ray Crystallography Studies on Synthetic Ubiquitin 
X-ray crystallography, like NMR spectroscopy, can provide absolute information 
with regard to the conformation of a protein. Unlike NMR, this technique is not 
limited to the study of relatively small polypeptides, instead being applicable to 
proteins orders of magnitude larger. However, the protein must be available in a 
crystalline form, a precondition that is often as much an obstacle as size is to NMR 
spectroscopy. Note, there is no rule that the structure in the crystal matrix should 
match that of the protein in solution. Ubiquitin is a notoriously difficult protein to 
crystallize, to date this has only been achieved by the group responsible for the 
original crystal structure 114.  It was therefore not surprising that efforts to obtain 
crystals of synthetic ubiquitin were, in the first instance, unsuccessful. Fortunately, 
we were able to grow good crystals of the synthetic protein by seeding a synthetic 
ubiquitin solution with a single crystal of natural ubiquitin (kindly supplied by Dr 
Discussion 
W. J. Cook of the University of Alabama Medical School ). Synthetic ubiquitin 
crystals which grew independently of the seed crystal were then used as seeds in 
further crystallization experiments. This effectively minimized the risk of 
contamination with the natural ubiquitin crystal, as well as yielding larger synthetic 
crystals typically 0.3 mm in diameter. An example of the type of orthorhombic 
synthetic ubiquitin crystals obtained is shown in figure 2.27. 
-- 	 - 
Figure 2.27 Crystals of Synthetic Ubiquitin 
Diffraction of these crystals was carried out by Sawyer and his team in the 
Biochemistry Department at the University of Edinburgh 208 ( see appendix 2 for 
details ). In order to facilitate a more convenient comparison with synthetic 
ubiquitin, diffraction data from one of the natural crystals was also collected. 
Initial studies revealed that synthetic ubiquitin had crystallized isomorphously in 
the same space group (P21 2 21) as the natural protein and with almost identical 
unit cell parameters, a=50.83A°, b=42.74A° c=28.98A° ( natural ubiquitin 
a=50.73A°, b=42.74A°, c=28.78A°). 
A detailed comparison of the synthetic and natural ubiquitin structure factors with 
those calculated from the published model of natural ubiquitin ( 1UBQ in 
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Brookhaven database ) revealed the data set of the synthetic material ( R 
factor=18.3% ) conformed to the literature model slightly better than did the data 
set acquired for the natural crystals ( R factor--19.8% ). Nevertheless, direct 
comparison of the synthetic and natural experimental data sets confirmed the high 
overall similarity of the structures (RsYN-NAT=lO.4%). 
Refinement of the synthetic electron density map was subsequently performed 
using the molecular model of native ubiquitin in a molecular replacement 
procedure. Least-squares refinement was carried out and the results inspected and 
adjusted using the molecular graphics program FRODO 209 After 6 rounds of 
refinement the synthetic structure had converged to R=16.5% or 1.7A° resolution. 
Note that the published crystal structure for natural ubiquitin is at 1.8A° resolution. 
The hydrogen bond network and dihedral angles of the main chain were very 
similar to the native ubiquitin starting point. Figure 2.28 shows the peptide 
backbone of synthetic ubiquitin superimposed upon that of its natural counterpart. 













The bulk of the side-chain positions were concordant with those in the literature 
crystal structure ( see figure 2.29 ). However, the side-chains of five branched 
residues (Leu-15, lle44, Arg-54, Leu-69 & Arg-72 ) were slightly rotated relative 
to the literature model. Each of these side-chains is flexible and it is entirely 
reasonable that under the experimental conditions they can adopt essentially 
isoenergetic conformations. 
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Figure 2.29 Mean Deviations of the Side- and Main-Chain Positions in 
Synthetic Ubiquitin from the Natural Model 
In one further departure from the published structure, 82 water molecules were 
located in the course of the refinement, 50 of which were from the original 58 in 
the starting model. Most of the additional 32 water molecules were added to the 
bulk solvent in between the neighbouring protein molecules in the unit cell. 
2.4.4 Protein Conjugation Activity of Synthetic Ubiquitin 
The in vitro protein conjugation activity of synthetic ubiquitin was assayed 210 
Human placental tissue was initially lysed in phosphate buffer and the supernatent 
fractionated on a DE-52 Whatman anion exchange column at pH 7.2. The resulting 
high salt fraction H (Fil), containing the components of the ubiquitin ligase system 
but importantly not ubiquitin, then served as the basis of the assay. Synthetic 
ubiquitin, radiolabelled with 125i,  was assayed for its ability to conjugate both 
endogenous and exogenous proteins. 
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Radiolabelled synthetic and bovine ubiquitin were incubated with human placental 
fraction II, supplemented with ATP, for 2 hours at 37 0C. The contents of the assay 
were then separated by SDS-PAGE and the resulting ubiquitin-protein conjugates 
were visualized by autoradiography ( see figure 2.30). 
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Figure 2.30 Endogenous Protein Conjugation Activities of Synthetic and 
Bovine Ubiquitin. Results from Autoradiography 
lanel=Bov Ub 	 lane4=Syn Ub 
lane2=Bov Ub + F!! + ATP 	lane5=Syn Ub + Fil + ATP 
lane3=Bov Ub + Fl! 	 lane6=Syn Ub + FL! 
The two important lanes (2&5) contain a great number of high molecular weight 
conjugates, indicating both purified bovine ubiquitin and synthetic ubiquitin 
possess El, E2 and E3 recognition activities. Although it is difficult to precisely 
determine their relative activities, it was found that from the same incorporated 
counts per minute (cpm) of ubiquitin, similar conjugation activities were obtained. 
In addition, the ATP dependence of this ubiquitin-protein conjugation activity was 




In a further study, the ability of synthetic ubiquitin to conjugate exogenous 
lysozyme was investigated. In this assay, synthetic and purified bovine ubiquitin 
were incubated with human placenta fraction II, supplemented with ATP and 
lysozyme, for 60 minutes at 37 0C ( see figure 2.31) 
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Figure 2.31 Exogenous Protein Conjugation Activities of Synthetic and 
Bovine Ubiquitin. Results from Autoradiography 
lanel=Bov Ub + F!! + ATP 
Iane2=Bov Ub + FU + ATP + 5OiM lysozyme 
lane3=Syn Ub + F!! + ATP 
lane4=Syn Ub + Fl! + ATP + 50j.tM lysozyme 
Lanes 2&4 contain a series of bands corresponding to mono-, di-, tn-, etc 
ubiquitinated lysozyme, indicating both materials are able to conjugate the protein. 
Again synthetic and natural ubiquitin were apparently indistinguishable with regard 
to this activity. 
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Section 2.5 Synthesis and Studies on Ubiquitin 
Ala 26,30  (Ubdes-Core) 
2.5.1 Considerations Leading to the Design of Ubdes-Core 
It has long been assumed, if not fully understood, that the hydrophobic core of a 
globular protein plays a large part in determining its conformation and mechanical 
stability. Recent studies by Lim and Sauer have revealed a number of components 
to the stability of a hydrophobic core, each contributing to the overall effect 
146,211• The most important feature is the hydrophobicity itself, ie the van der 
Waals interactions between neighbours. There are other fine tuning components 
which determine the precise structure and stability of the protein, namely; steric 
and volume constraints. 
Allied to the hydrophobic effect in governing the folding of a protein, is the 
network of hydrogen bonds throughout the structure. Although the controversy 
over the relative propensities of these two fundamental elements has already been 
dealt with in section 1.2.3, it is worth reiterating that this is one of the great 
unresolved problems in physical-biology. Given the complete freedom a peptide 
chemist has in choosing a synthetic sequence, his endeavours as much as anyones 
are predisposed to the study of the structural stability of proteins. 
In the previous work it was conclusively demonstrated that it is possible to 
chemically synthesise and subsequently purify ubiquitin in a biologically active and 
conformationally authentic form. Having achieved this it was now possible to 
realize our principle objectives by designing a ubiquitin analogue which would 
explore the stability of the tertiary structure in the protein. Access to the 
crystallographic dataset ( 1UBQ in the Brookhaven database ) on an Evans and 
Sutherland molecular graphics workstation made it possible to study closely the 
tertiary structure of ubiquitin. Careful inspection of the protein's hydrophobic core 
revealed it comprised primarily seven residues, the side-chains of which were 
closely packed together in the heart of the structure ( see table 2.9). 
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L67 VS 130 L43 L56 V26 L55 
L67  
VS 5.70  
130 8.53 4.21  
L43 4.48 5.07 4.58  
L56 4.89 8.96 9.13 6.66  
V26 4.70 5.46 4.26 4.01 3.87  
L55 4.18 8.57 8.84 4.82 6.89 	1 7.22  
Table 2.9 	Relative Distance (A°) Between Terminal Methyl Carbon 
Atoms in the Side-Chains of Hydrophobic Core Residues 
Armed with this information it was decided to investigate the importance of the 
hydrophobic core in stabilizing the tertiary structure of ubiquitin. To that end the 
seven key residues in the core were replaced by the small non-hydrophobic amino 
acids shown in figure 2.32. 
Va15 	to 15N-Glycine 
Va126 to Alanine 
11e30 	to Alanine 
Leu43 to 15N-Glycine 
Leu50 to 5N-G1ycine 
Leu56 to 15N-Glycine 
Leu67 to 15N-Glycine 
Figure 2.32 Substitutions in the Hydrophobic Core of Ubiquitin 
Glycine was used to replace 5 of the 7 amino acids, essentially because it has no 
side-chain and is thus relatively non-polar. Isotopic enrichment of these additional 
glycines with 15N was intended to allow easier identification in an NMR 
experiment. For example, a 1 H/15N heteronuclear correlation spectrum of the 
analogue would clearly distinguish these five residues from the remainder of the 
proton resonances in the protein 212•  This is extremely useful, since these 15N-
glycine handles could then be used as starting points for sequential assignment of 
the rest of the 1 H resonances in the spectrum 121• 
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Valine-26 and isoleucine-30 are both involved in the a-helix in ubiquitin which 
incorporates residues 23-34. Given that we had no desire to deliberately destroy 
this element of secondary structure, these residues had to be replaced with 
something able to propagate the helix whilst being non-hydrophobic. The work of 
Baldwin213 and recently Fersht 214, indicates glycine is unable to sustain an a-
helix when located at an internal position ( as in this case). However, in the same 
location alanine appears to better accommodate a helical structure. Fortunately, 
alanine possesses a relatively small side-chain, resulting in it being the obvious 
choice for substitutions in this area of ubiquitin. 
These replacements amounted to the removal of 24 methylene groups, which 
according to Fersht 141,142  should represent a loss in stabilization of between 24 
and 38 kcal mold. We have already calculated the free energy of stabilization of 
ubiquitin to be about 8.0 kcal moi 1 , therefore the above loss in free energy would 
be enough to completely devastate the compound's tertiary structure. Indeed, 
replacement of Leu-67 and Leu-69 with Asn is known to completely eliminate 
ubiquitin's ability to conjugate proteins 130 
To recapitulate, what was done was to completely remove the hydrophobic core 
from this small globular protein, in an attempt to elucidate whether hydrogen 
bonding alone is sufficient to hold together the native structure. 
23.2 Synthesis and Purification of Ubdes-Core 
The experience drawn from the previous work on the synthesis of ubiquitin was 
employed in the construction and purification of this ubiquitin analogue. The 
design of this analogue required a relatively large amount of Fmoc 15N-glycine (53) 
starting material. Although commercially available, this material is rather 
expensive. Fortunately, it is easily prepared from 15N-glycine (51) and 9-
fluorenylmethyl succimimidyl carbonate (52) using the procedure of Shute and 
Rich 215 
Ubdes-Core contains the same number of amino acids as the natural sequence, 
therefore a similar synthetic strategy to before was considered appropriate. Initial 
attachment of Gly-76 to the Wang support via the amino acid chloride gave a 
sufficiently low loading (40.5%, 0.291 mmole/g) to allow unhindered elongation of 
the resin bound peptide chains. As in the previous synthesis, the remaining 60% of 
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the functional groups on the support were capped with benzoyl chloride and the 
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Figure 2.33 Preparation of Fmoc Amino Acids 
The synthesis was again carried out on an ABI 430A machine (0.25 mmole scale) 
using 1:1 DMF:dioxan as the solvent during all coupling steps. Most amino acids, 
with the same exceptions as before, were triple coupled and any urireacted amine 
groups on the peptide capped with acetic anhydride at the end of every cycle. 
Throughout the synthesis all the piperidine initiated Fmoc deprotections were 
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Figure 2.34 Deprotection Profile for Ubdes-Core 
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The overall efficiency of the synthesis on the resin was 44%, as judged by the UV 
substitution of the final methionine relative to the theoretical value calculated for 
100% yield on every step of the synthesis. 
A trial cleavage was carried out on a small sample of the resin and as before 
anisole, thioanisole and ethyl methyl sulphide were found to be the best scavengers. 
The optimum time of 4.5 hours was slightly longer than the 3 hours required to 
cleave the wild-type sequence. Electrospray mass spectrometry 195  was performed 
on this crude material and clearly showed the correct molecular ion (expected 
mass=8234.2 Da) was present, as well as other truncated and partially protected 
species (see figure 2.35). 
109 	 8232.5 
DebydrWon 
C 
8214.9 	 But 
8309.1 
B 







782 .9 	 8492.5 / —8441.1 ,8587.4 
7889.9 
7753.8— 
sass 	7709 7809 7900 8090 81 
	
8500 8699 8790 8889 
Figure 235 Electrospray Mass Spectrometry on Crude Ubdes-Core 
Showing the Correct Molecular Ion at 8232.5 Da 
The cleavage conditions now having been established, the bulk of the resin was 
divided into three equal portions and each was cleaved and purified in the same 
way. An almost identical purification protocol to before was employed, namely: 
1. Deprotection - 20% piperidine in DMF, 3 x 10 minutes. 
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Cleavage - 4.5 hours under nitrogen, 80% TFA and 5% each of H20, anisole, 
thioanisole and ethyl methyl sulphide. 
Sephadex G50 Gel Filtration - Eluting buffer contained 8 M urea, 10 mM 
DTF and 50 mM NH4OAc at pH 4.5. 
Stepwise Dialysis - stepwise removal of urea and finally DTF. 
CM-Sepharose Cation Exchange - pH gradient of 4.5 to 5.5, 50 MM  NH40Ac 
followed by a salt gradient of 50 mM to 0.3 M NH 4OAc at pH 5.5. 
DEAE-Sepharose Anion Exchange - salt gradient of 50 mM to 0.3 M 
NH40Ac at pH 9.30. 
These were followed by one additional step. 
Semi-Preparative HPLC - C8 RP300 column, gradient system A. 
The crude polypeptide material behaved more or less as expected in all steps up to 
the DEAE-Sepharose column where difficulties were experienced in attempting to 
bind the protein to the anion exchange matrix. Indeed, the material washed straight 
through on several occasions. These problems were eventually overcome by 
making sure the protein solution was exactly (within 0.05 of a pH unit) the same 
pH as the column and also by running the column in starting buffer for long periods 
of time before attempting a salt gradient. Such a difficulty had not been 
encountered when working with synthetic or natural ubiquitin, and it certainly 
could not have been predicted from isoeleciric focussing since Ubdes-Core has a p1 
identical to the wild-type sequence ( see figure 2.38). The most likely explanation 
for this observation is that Ubdes-Core is extremely unstable at this basic pH. Even 
if the analogue had folded into a tertiary conformation it was very unlikely that this 
structure would be resilient to such a high pH. Therefore, the conditions employed 
in this step would probably be enough to denature the analogue and thus drastically 
alter its ion exchange behaviour. 
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The problems associated with anion exchange meant that it was usually necessary 
to carry out an additional semi-preparative HPLC step before homogeneous 
material could be isolated ( see figure 2.36). 
a. 	 F;! 
Figure 2.36 HPLC Trace of Ubdes-Core Before (a) and After (b) HPLC 
Purification. C. RP300 column, gradient system A 
Minor purification problems aside, the overall yield of Ubdes-Core was a 
respectable 81 mg or 3.9%. Compared with the 40% yield on the resin this figure 
does indicate that a considerable amount of material was lost during cleavage, and 
to a lesser extent purification of the ubiquitin analogue. 
Exhaustive characterization of this material was carried out in a manner analogues 
to that of synthetic ubiquitin. Amino acid analysis, carried out after each stage of 
the purification, served as a good indicator of the increasing homogeneity of the 
polypeptide ( see table 2.10). Acid and enzymic hydrolyses of the purified material 
confirmed that it had an amino acid composition consistent with that of Ubdes-












Asp/Asn 7 (5) 6.94 7.06 7.06 4.71 
Thr 7 5.02 5.59 6.22 9.70 
Ser 3 2.24 2.27 2.23 4.97 
Glu/Gin 12 (6) 12.30 12.96 12.60 6.97 
Pro 3 2.33 2.60 2.76 2.41 
Gly 11 12.46 12.18 11.15 14.80 
Ala 4 3.81 4.02 4.00 3.60 
Vat 2 1.89 2.02 2.00 2.79 
Met 1 0.56 0.78 0.94 Met 0 
Ile 6 5.12 5.57 5.85 5.92 
Leu 5 4.95 5.13 4.97 6.34 
Tyr 1 0.99 0.97 0.90 1.18 
Phe 2 1.59 1.75 2.05 2.33 
His 1 1.14 1.12 0.97 0.98 
Lys 	1 7 6.30 6.84 	1 7.05 	1 6.58 
Arg 	1 4 4.04 4.19 	1 3.70 	1 3.99 
Table 2.10 Acid and Enzymatic Hydrolyses of Ubdes-Core 
a Pepsin, Prolidase and Aminopeptidase. 
Figures in Parenthesis are Asp and Glu Contents 
Enzymatic digestion with trypsin revealed the isolated material had a primary 
sequence consistent with that of Ubdes-Core. Isolation of the resulting peptide 
fragments by HPLC followed by amino acid analysis of these, confirmed the tryptic 
map was that of the analogue. 
Electrospray mass spectrometry indicated the isolated material had a mass of 
8234.0 Da which compares favourably with the theoretical mass of 8234.2 Da 
calculated for Ubdes-Core 195  As well as further establishing the authenticity of 
the polypeptide, electrospray mass spectrometry provided additional evidence for 




Figure 2.37 Electrospray Mass Spectrometry on Ubdes-Core Showing the 
Calculated Mass of 8234.0 Da 
The isoelectric focussing results shown in figure 2.38 neatly illustrate how 
successful ion exchange chromatography can be in purifying a polypeptide of this 
size. Anion exchange chromatography was, in spite of the afore mentioned 
problems, clearly able to resolve the three major components that comprised the 
principle fraction from cation exchange ( lane8 ). Furthermore, lane3 not only 
reveals Ubdes-Core to have an identical plto ubiquitin, but also provides additional 
confirmation of its high degree of homogeneity. 
Ubdes-Core was found to be recognized by anti-ubiquitin IgO polyclonal 
antibodies in a Western blot assay similar to the one performed on synthetic 
ubiquitin. While this was certainly an encouraging observation, it was considered 
dangerous to read too much into it at this stage. The polyclonal nature of these 
antibodies probably means that they would recognize many of the ubiquitin-like 
epitopes remaining in the analogue. Many of these would of course be antigenic 
regardless of the overall structure of the analogue. Therefore, the result can in no 
way be regarded as evidence for Ubdes-Core having a native ubiquitin 
conformation. A far better antibody would be a monoclonal antibody raised to a 
discontinuous epitope on the surface of the native conformation of ubiquitin. 
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Figure 2.38 	Isoelectric Focussing Gel of Ubdes-Core at Various Stages 
of Purification 
lane! = Boy Ub lane6 = Boy Ub 
lane2 = DEAE Fl Iane7 = CM-Seph. F2 
lane3 = DEAE F2 	* laneS = CM-Seph. F3 * 
lane4 = DEAE F3 lane9 = CM-Seph. F4 
laneS = Standards lanelO = CM-Seph. F5 
* - fractions isolated for further purification 
2.5.3 Structural Studies on Ubdes-Core 
Having sufficiently characterized the primary structure of Ubdes-Core we were 
then able to turn our attention to the real objectives of this study. In carrying out 
this comprehensive structural analysis our approach was, as before, to make use of 
classical techniques, as well as the more exhaustive NMR and if possible X-ray 
crystallography techniques. 
2.5.3(i) Ultra-Violet Absorption Spectroscopy 
Once again the lone tyrosine residue in the protein proved to be invaluable in 
probing the conformation of Ubdes-Core. Spectrophotometric titration of this 
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tyrosine revealed its phenolic group had a pKi of 9.88 at 25.0°C and 9.68 at 35.20C 
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Graph 2.7 Spectrophotometric Titration (295 nm) of the Phenolic Group of 
Tyr-59 in Ubdes-Core at Two Temperatures 
From this data the heat of ionisation (AHi) of the phenolic group was calculated to 
be 9.3 kcal mo1 1 . This represents a significant drop from the 10.8 kcal mol 1 
determined for the wild type protein. Evidently removing the hydrophobic core 
from ubiquitin results in the hydrogen bond environment around Tyr-59 becoming 
destabilized, hence the lower value of AM for Ubdes-Core. It is however worth 
pointing out that this value of iHi is still substantially higher than for many other 
proteins and for free tyrosine, perhaps suggesting the phenolic group is involved in 
at least some hydrogen bonding (see table 2.5 for comparisons). 
2.5.3(11) Fluorescence Studies on Ubdes-Core 
A similar set of fluorescence based studies were performed on Ubdes-Core as had 
previously been carried Out on bovine and synthetic ubiquitin. 
Quenching of the tyrosine fluorescence by addition of potassium iodide can provide 
valuable information on the degree of exposure of the residue to the bulk solvent. 
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Analysis of the Stem-Volmer plot obtained for Ubdes-Core reveals its tyrosine is 
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Graph 2.8 Stern-Volmer Plots of Ubdes-Core, Boy Ub and ATEE 
A Stern-Volmer constant of 3.27 ± 0.21 M 1 signified the tyrosine in Ubdes-Core 
was not as buried as in natural ubiquitin ( KQ = 1.76 M 1 ). Nevertheless, a 
comparison with the N-acetyl tyrosine ethyl ester control (KQ = 5.00 M 1 ) clearly 
indicated some shielding from the bulk solvent. 
Monitoring the denaturation of Ubdes-Core by fluorescence led to a value of 4.3 ± 
1.5 kcal mol 1 being obtained for its free energy of stabilization (see graph 2.9). 
Although there are rather large error boundaries associated with this value 
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(primarily due to the small difference between FN and Fu ) it is clearly much 
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Graph 2.9 GdmCI Induced Unfolding of Ubdes-Core 
A value of around 3.7 kcal mo1 1 for &GH20 (the change in AGH2o between wild 
type and analogue ) does confirm the importance of the hydrophobic effect. 
However, it is somewhat smaller than the huge loss in stability predicted by the 
Fersht model 11 , 142. It was also interesting that deprived of the hydrophobic 
effect ubiquitin still had approximately 4.3 kcal mo1 1 nett stabilization from 
hydrogen bonding contributions. Whether this was enough to maintain the ubiquitin 
fold remained to be seen. 
2.5.3(iii) Circular Dichroism Studies on Ubdes-Core 
Circular dichroism was again performed in Stirling University 204• CONTIN 
secondary structure analysis significantly revealed there to be no a-helix in Ubdes-
Core; this was in spite of the efforts made to keep the helix intact ( see figure 2.39). 
In addition, this analysis indicated the f3-sheet content in Ubdes-Core was 
approximately the same as in natural ubiquitin ( see table 2.11). It is noteworthy 
that while Ubdes-Core apparently contains a similar amount of [i-sheet as the 
natural sequence, it cannot be determined from CD whether these sheets bear any 
resemblance to one another in a qualitative sense. Loss of the helix may be due to 
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elimination of important ternary interactions between core residues and this 
element of secondary structure. Indeed, both valine-5 and leucine-43 do he very 
close to the helix in the natural fold. Furthermore, the ubiquitin fragment Ubl-35 
which contains the a-helix has been found to have no structure in solution by NMR 
spectroscopy 216,  suggesting that the remainder of the ubiquitin structure is 
required to stabilize the a-helix. Of course it is also possible that the two 
substitutions made in the helix itself led to its destabilization in Ubdes-Core. The 
ubiquitin analogue in which these two residues have been replaced with the wild 
type amino acids is currently being synthesised, and should provide important 
information with regard to the stability of the helix. It is perhaps interesting to note 
that secondary structure prediction programs (Garnier-Osguthorpe-Robson 217  and 
Chou-Fasman 218 ) intimated that the a-helix would be retained in Ubdes-Core 
and that the p-sheet would be reduced. 
Bovine Ubquitin 	Ubdes-Core 
Figure 2.39 Far UV CD Spectra of Ubdes-Core and Purified Bovine 
Ubiquitin in 50 mM Boric Acid at pH 7.0 
Previous studies by Wilkinson and Mayer had indicated increased heicity could be 
induced into the ubiquiun fold by exposing the protein to various alcohols 131 
Upon dissolving Ubdes-Core in 50% aqueous trifluoroethanol (TF) the analogue 
was observed to undergo an intriguing structural reorganization as judged by 
circular dichroism spectroscopy (see table 2.11). Indeed the secondary structure 
content of Ubdes-Core in 50% TFE was remarkably similar to bovine ubiquitin 
dissolved in water, and although a qualitative description of this alcohol generated 
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conformation was impossible from this CD spectrum a ubiquitin like fold could not 
be ruled out. Bovine ubiquitin was itself subject to a substantial structural 
rearrangement upon exposure to TFE (see table 2.11 ). This observation is in 
keeping with the original results of Wilkinson and Mayer. 
Example a-helix 13-sheet Remainder 
Boy Ub in H20 15± 2.5% 57± 2.6% 28 ±4.5% 
Ubdes-Core in 0 ± 3.4 x 10% 
H20  
52± 1.5% 48 ± 1.5% 
Boy Ub in 50% 63 ±0.73% 
TFE______________ 
37 ±0.73% 0 ± 7.1 x 10% 
Ubdes-Core in 17±1.0% 
50% TFE  
55 ± 1.1% 28±1.9% 
Table 2.11 Secondary Structure Contents derived from CD using 
CONTIN Procedure 
2.5.3(iv) X-Ray Crystallography 
Along with NMR spectroscopy, X-ray crystallography provides unrestricted 
information on the tertiary structure of a protein and was thus a technique we 
wished to make use of in this study. In the previous work we were able to use 
natural ubiquitin crystals to initiate the crystallization of the synthetic material, 
however, this approach could not be extended to the crystallization of the 
chemically different Ubdes-Core. Therefore, attempts were made at the ab initio 
crystallization of this analogue and while 20 different vapour diffusion experiments 
were set up, no crystals could be grown in the following three month period. 
Protein crystallization is generally accepted as being a rather unpredictable affair 
and it is not inconceivable that the required conditions were not covered by our 
scan. Equally a protein devoid of any organized tertiary structure will not 
crystallize for entropic reasons, perhaps providing an alternative explanation for 
our lack of success. 
2.5.3(v) Nuclear Magnetic Resonance Studies on Ubdes-Core 
Two dimensional NMR was used to investigate in detail the solution conformation 
of Ubdes-Core. Comparison of the TOCSY spectrum obtained for the analogue 
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with that acquired for purified bovine ubiquitin very quickly confirmed that 
removal of the hydrophobic core from ubiquitin prevents the protein from folding 
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Figure 2.40 Region from the TOCSY Spectra of Ubdes-Core (red) and 
Purified Bovine Ubiquitin (black) obtained in 90% H 20/ 











The lack of crosspeak dispersion in the TOCSY spectrum of the analogue was in 
stark contrast to the large distribution in the TOCSY spectrum of bovine ubiquitin. 
Given the sensitivity of this region to the solution conformation of a protein, this 
observation was considered quite conclusive evidence that Ubdes-Core did not have 
the native ubiquitin fold. 




Figure 2.41 Heteronuclear Multiple Quantum Coherence Transfer 










Although the isotopic enrichment of the five glycine substitutions with 15N did 
allow unambiguous identification of their proton resonances ( see figure 2.41 ), the 
remainder of the proton resonances were impossible to assign due to serious 
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Figure 2.42 Region from TOCSY Spectrum of Ubdes-Core dissolved 




The analogue apparently gives rise to a form of collapsed 2D NMR spectrum 
usually indicative of proteins in which there is no well defined tertiary structure. 
This finding is seemingly at odds with the UV, CD and fluorescence studies all of 
which suggest the analogue does have some detectable structure. However, in a 
recent paper Tsai and co-workers reported that a phospholipase A2 mutant 
exhibited secondary structure when examined by CD spectroscopy, but failed to 
show any amide chemical shift dispersion in a 1D NMR experiment 219  This 
group suggested the mutant exists in a molten globule state containing isolated 
elements of secondary structure, but no stabilizing tertiary structure interactions. 
Consequently, the mutant has many internal degrees of freedom which result in this 
secondary structure being invisible on an NMR timescale (ms). It is therefore 
possible that Ubdes-Core possesses elements of secondary structure such as 13-sheet 
which are detectable on an electronic timescale, but cannot be observed on the 
much longer NMR timescale. Indeed, circular dichroism spectroscopy clearly 
indicates that Ubdes-Core contains more secondary structure when dissolved in 
50% TFE, whereas the TOCSY spectrum of the analogue in this medium is little 
different from that of the protein in water ( see figure 2.42 ). The inconsistent 
nature of these observations points to NMR not being able to detect elements of 
secondary structure in dynamic equilibrium. 
2.5.4 Ubiquitin Thioester and Protein Conjugation Activities of Ubdes-Core 
In a further collaboration with Mayer and co-workers in Nottingham the ability of 
Ubdes-Core to form an El thioester and therefore endogenous protein conjugates 
was assayed 210  Purified bovine ubiquitin and Ubdes-Core were initially 
radiolabelled with 1251 before being incubated with human placental fraction II 
(Fil) supplemented with ATP for 30 minutes at 37 0C. The contents of these two in 
vitro systems were then separated by SDS-PAGE and any radiolabelled species 
visualized using autoradiography. For comparative purposes a similar assay was 
performed in which any thioesters produced during the incubation were destroyed 
by incubation with 13-mercaptoethanol at 90 0C. This additional step resulted in only 
endogenous protein conjugates being seen by autoradiography. 
Analysis of the bovine ubiquitin assay with and without 13-mercaptoethanol (lanes 
1 and 5 respectively ) reveals the Ub-El thioester to be the dark band just above 
116 kDa. Clearly no thioester can form with Ubdes-Core ( lane 6 ) and 
correspondingly the analogue is unable to form endogenous protein conjugates 
117 
Discussion 
(lane 2 ). Studies by Ecker et al suggest that El recognizes both the tertiary 
structure of ubiquitin and residues in the tail of the protein 130•  Therefore, the 
inability of Ubdes-Core to form a thioester with the El enzyme presents additional 
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Figure 2.43 .  Thioester and Endogenous Protein Conjugation Activities 
of Ubdes-Core and Bovine Ubiquitin 
Results from Autoradiography 
lane! = Bovine Ub + F!! + ATP + -mercaptoethanoL 
lane2 = Ubdes-Core + F!! + ATP + -mercaptoethanol 
lane3 = Bovine Ub 
lane4 = Ubdes-Core 
laneS = Bovine Ub + F!! + ATP 
lane6 = Ubdes-Core + F!! + ATP 
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2.5.4 Conclusions on the Importance of the Hydophobic Core in Ubiquitin 
Removal of the hydrophobic core in ubiquitin appears to have a devastating effect 
upon the stability and hence structure of the protein. Ubdes-Core cannot adopt the 
native conformation of ubiquitin, implying that hydrogen bonding contributions are 
not in themselves sufficient to stabilize such a globular fold. Whether this analogue 
is able to form an alternative structure is impossible to say with any certainty. 
Initial UV, CD and fluorescence studies would suggest the analogue contains some 
structure, however, there seems to be no evidence from NMR to support this. One 
possibility is that the analogue exists in a molten globule like state in which there 
are isolated areas of secondary structure. 
Section 2.6 Chemical Synthesis of Human CEP52 and Human UbCEP52 
2.6.1 Introduction 
The recent discovery of a series of genes encoding ubiquitin fused to a carboxy-
terminal protein (CEP) has created a whole new area of ubiquitin research. While 
it is now accepted that CEPs are involved in ribosome biogenesis, there is still 
relatively little known about the structure of these or of their ubiquitin fused 
precursors ( UbCEPs ). All CEPs apparently contain within their primary sequence 
a putative zinc finger DNA/RNA binding motif. This class of oligonucleotide 
binding protein is characterized by having a tetrahedrally coordinated Zn 2 atom 
between a region of a-helix and p-sheet 220,221  There are three general sub-
classes of zinc finger, each of which differs in the identity of the four amino acid 
ligands 102  Type I zinc fingers, by far the most common, contain a metal centre 
coordinated to two cysteine and two histidine residues, type II zinc fingers contain 
four cysteine ligands and type III one histidine and three cysteines. Zinc fingers are 
so called because the coordinated metal ion holds the a-helix and f3-sheet together 
in such a way as to create a structure capable of forming interactions within the 
major groove of DNA ( see figure 2.44). 
Ubiquitin carboxy-terminal extension proteins generally contain sequences which 
conform to the type II zinc finger sub-class. However, other than sequence 
similarities there is no direct evidence that these proteins bind zinc or adopt a zinc 
finger like conformation. 
119 
Discussion 
Figure 2.44 A Zinc Finger Interacting within the Major Groove of DNA 
To investigate whether CEPs actually behave as zinc fingers and whether this 
behaviour is in any way modified when the peptide is tethered to ubiquitin, it was 
decided to chemically synthesise a suitable CEP, as well as its UbCEP precursor. 
Note that in vivo processing of UbCEPs makes isolation of these precursors almost 
impossible from natural sources. Two CEPs have been identified in the human 
genome 14,15,  a 52 amino acid peptide and an 80 amino acid protein. The latter has 
a precursor 156 amino acids in length while the former is derived from a 128 amino 
acid protein. Obviously the construction of UbCEP52 would present less of a 
problem than the synthesis of the much longer UbCEP80. Therefore, human 
CEP52 and UbCEP52 were deemed reasonable synthetic targets (see figure 2.45). 
I.c.R. K..Y. A. R. L. H. R. R. A. V. N.c.R. 
K. K. K..G.H.T.N.N.L.R.P.K.K. K. V. K 
-CO2H 
Figure 2.45 Primary Sequence of Human UbCEP52 
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2.6.2 Solid Phase Peptide Synthesis of CEP52 and UbCEP52 
The sequential relationship between CEP52 and UbCEP52 meant that a single 
linear synthesis could theoretically afford both materials if a portion of the 
peptidyl-resin was removed at the appropriate point ( see figure 2.46). 
H2N—I 	Ub 	I  CEP 	I—CO2H 
1 	 76 	 128 
Figure 2.46 The Sequential Synthesis of CEP52 and UbCEP52 
All the synthetic considerations which had proved to be so crucial to the success of 
previous syntheses were reapplied to this synthesis. Initial loading of the support 
with Lys-128 was achieved by treating the Wang resin with the Fmoc protected 
amino acid anhydride in the presence of dirnethylaminopyridine (DMAP). Unlike 
the achiral glycine, Fmoc-Lys(Boc)-OH cannot be activated as the amino acid 
chloride because of the associated racemisation ( see figure 1.15 ). Reducing the 
reaction time to 15 minutes allowed only 14% (0.1 mmole/g ) of the available sites 
on the resin to be acylated, the remainder were capped with benzoyl chloride. Such 
an exceptionally low initial loading was considered necessary if interactions 
between resin bound protein chains were to be minimized. 
Solid phase peptide synthesis of initially CEP52 and ultimately UbCEP52 was 
carried out on an ABI 430A peptide synthesiser ( 0.1 mmole scale) using a 1:1 
mixture of DMF/dioxan as the solvent during all coupling steps. In an effort to 
obtain near quantitative acylation, most amino acids were coupled once as their 
symmetrical anhydride followed by twice as their HOBt active esters. Exceptions to 
this were Fmoc-Gly which was coupled once as a symmetrical anhydride and 
Fmoc-His(Trt), Fmoc-Asn(Mbh) and Fmoc-Gln(Mbh) all of which were coupled 
three times as their HOBt active esters. Any unreacted amine groups were 
subsequently capped with acetic anhydride. Where necessary, amino acid side-
chains were protected with the same groups used in the previous two syntheses. All 
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five cysteine suiphydryls in CEP52 were protected with the reductively removable 
t-butyl suiphenyl ( S-Bus ) group. The acid and base stability of this protecting 
group meant that the cysteine residues could be deprotected at a much later stage in 
the purification, thereby delaying the difficulties associated with handling cysteine 
containing peptides. Glycine-76, which lies at the interface of Ub and CEP52, was 
isotopically labelled with 15N. This measure was intended to allow straight forward 
NT-.4R identification of this strategically important residue which was ultimately 
hoped to be used as the starting point for sequential assignment in either direction. 
Real time UV monitoring of the synthesis produced a rather unexpected 










0 	20 	40 	60 	80 100 120 140 
Progress of Synthesis 
Figure 2.47 Deprotection Profile of the CEP52 and UbCEP52 Synthesis 
During construction of the initial CEP52 segment the apparent yield of each 
deprotection step gradually increased to around 250% of the original deprotection. 
After 52 cycles approximately one third of the resin was removed, hence the large 
drop at this point, and thereafter the yields began to decrease in the familiar way. A 
possible explanation for the initial increase would be a change in the swelling 
properties of the peptidyl-resin during the first part of the synthesis. This could 
conceivably result in the deprotection aliquot used in the monitoring having a 
higher piperidine-fulvene adduct concentration. Manual deprotection of the final 
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Fmoc protected amino acid, methionine, followed by quantitative UV analysis of 
this adduct at 302 nm, indicated the overall yield of the synthesis on the resin was 
73.5%. If accurate, this value represents an average yield of 99.9% for each of the 
254 steps in the synthesis of UbCEP52. 
2.63 Purification and Characterization of CEP52 
In purifying this 52 amino acid peptide a conscious effort was made to leave the 
five cysteines protected for as long as possible. Therefore, in designing the 
cleavage conditions care had to taken not to include any scavengers like 
thioanisole, known to deprotect the reductively removed SBut group. Preliminary 
studies revealed a 6 hour aqueous TFA cleavage using ethanedithiol (EDT ), EMS, 
anisole and phenol scavengers to be optimum ( see figure 2.49a ). Following 
cleavage the crude peptide was subjected to gel filtration on a Sephadex G50 
column using 30% acetic acid as the eluting buffer ( figure 2..49b ). The material 
was then gradually dialysed back into water using a 2000 MWCO bag. Reductive 
removal of the five cysteine protecting groups was effected by treatment with tn-
butyiphosphine (54) in the presence of a small amount of water ( see figure 2.48). 















Figure 2.48 Proposed Mechanism for Reductive SBut Deprotection 
Deprotected CEP52 was then exposed to a further Sephadex G50 gel filtration 
column, this time eluting with a buffer containing 10 mM D1'T and 50 mM 
NH4OAc at pH 6.0 (see figure 2.49c ). Inclusion of the Dfl' was required to 
prevent unwanted oxidation of the deprotected cysteines to disulphides. The next 
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step in the purification, semi-preparative HPLC, was carried out on a C8-RP300 
column (gradient system B ) and yielded 21mg of essentially homogeneous 
material (see figure 2.49d). 
a) Cleavage 	 c) SBut Removal 
b) Gel Filtration 	 d) Semi-Prep HPLC 
Figure 2.49 	HPLC Analysis of CEP52 at each stage of the Purification 
C8-RP300 column, gradient system A 
Amino acid analysis of the purified polypeptide revealed it contained an amino acid 
composition consistent with the required material ( see table 2.12 ). The low 
cysteine content was presumably due to oxidation of these residues to cysteic acid.. 
Indeed, this would account for the apparent high proline content since cysteic acid 
co-elutes with this amino acid. 
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Amino Acid Expected Obtained 
Asx 5 4.98 
Thr 1 0.73 
Ser 1 1.05 
Gix 3 4.41 
Pro 3 5.61 
Gly 1 0.96 
Ala 3 3.09 
Cys 5 1.41 
Val 2 2.00 
Met 1 1.17 
Ile 3 2.75 
Leu 4 4.46 
Tyr 2 2.08 
His 2 2.31 
Lys 10 10.43 
Arg 6 6.43 
Table 2.12 Amino Acid Analysis of Synthetic CEP52 
40 hour hydrolysis in 6N HCI (5mg/mi Na2S03 ) at 1100C 
Electrospray mass spectrometry 195 confirmed the identity of the material to be 
CEP52 (see figure 2.50). The experimentally determined mass of 6178.8 Da was 
almost exactly 2 mass units less than the expected value for CEP52 (6180.52 Da). 
Such a difference can be accounted for by the formation of a single disulphide 
bridge in the peptide. 




1 hour 2.50 
24 hours 1.14 
Table 2.13 Oxidation of Synthetic CEP52 in Water 
125 
Discussion 
As mass spectrometry had suggested the cysteines in the peptide were prone to 
oxidation, this possibility was further investigated by dissolving the peptide in 
water and periodically determining the number of free thiols present using a 
standard Eiirnans assay 222•  Table 2.13 summarises the results which indicate one 
disulphide bond forms after about an hour and a second is created more slowly. 
Hence, CEP52 is inclined towards disulphide bridge formation. 
Figure 2.50 Electrospray Mass Spectrometry on CEP52 
2.6.4 Purification and Characterization of UbCEP52 
Purification of the 128 amino acid UbCEP52 was always going to present a greater 
challenge than the relatively small CEP52. The scale of the problem became 
evident during initial cleavage studies ( see figure 2.51). Although the optimum 
cleavage conditions were identical to those used with CEP52, 6 hours under N 2 in 
aqueous TFA with EDT, EMS, anisole and phenol scavengers, the resulting broad 
HPLC peak revealed the high level of contamination in the crude material. As in 
the purification of CEP52, the five cysteine residues were initially left protected. 
Crude UbCEP52 was dissolved in a buffer containing 8 M urea and 50 mM 
NH40Ac at pH 6.0 before being applied to a Sephadex G75 gel filtration column 
pre-equilibrated with the same buffer. Following elution from this column the urea 
was slowly dialysed from the protein solution. A molecular weight cut off of 10000 
Da ensured the removal of both urea and a great many truncated peptide impurities. 
After dialysis the material was freeze dried and the five cysteines deprotected by 




UbCEP52 was then dissolved in a buffer containing 10 mM DTT and 50 mM 
NH4OAc at pH 6.0 and subsequently subjected to a second round of gel filtration. 
Analysis of the isolated fraction by SDS PAGE revealed it to contain a 
heterogeneous mixture of polypeptides ( figure 2.53, lane 2) and clearly further 
purification was necessary. 
Figure 2.51 HPLC Traces obtained during Trial Cleavage of UbCEP52 
C8-RP300 column and gradient system A 
Ion exchange chromatography seemed the obvious way of removing the impurities 
from the crude UbCEP52 mixture. Efficient use of this technique requires that the 
p1 of the peptide be known and the best way of determining this is to use isoelectric 
focussing electrophoresis. UbCEP52 contains a high proportion of basic lysine (17) 
and arginine (10) residues and indeed carries an apparent nett charge of +14. It was 
therefore no surprise when the material focussed off the end of the IEF pH 3.5 - 9.5 
gel, indicating that UbCE52 has a p1 greater than pH 9.5. In an early attempt at 
cation exchange chromatography, the synthetic protein was observed to bind 
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irreversibly to the CM-Sepharose matrix. This is in spite of the fact that the 50 mM 
to 1 M NH4OAc salt gradient was carried out at pH 9.5. After this initial set-back, 
analytical cation exchange HPLC was used as a rapid means of searching out a 
more appropriate set of ion exchange conditions. However, despite screening from 
pH 4.0 to 11.0 no suitable conditions could be found. The protein would either 
remain stubbornly bound to the column or alternatively elute as a broad band. DNA 
binding proteins, themselves highly basic, are often purified using the weak cation 
exchange matrix heparin-agarose and it seemed worthwhile to try this out on 
UbCEP52. Unfortunately, as with many of the previous attempts, the synthetic 
protein could not be desorbed from the column, even when employing a 50 mM to 
2 M (NH4 )2SO4 salt gradient at pH 8.0. 
Figure 2.52 CM-Sepharose Cation Exchange on UbCEP52 
In their work with the bovine 80 amino acid extension protein, Redman and 
Rechsteiner had found that buffers containing formic acid could be successfully 
used with cation exchange to remove contaminants from this naturally isolated 
protein 101 Accordingly, UbCEP52 was loaded onto a CM-Sepharose column pre-
equilibrated with a buffer containing 50 mM NH4C1, 1 mM DTF, 0.1 mM ZnCl2 
and 50 mM formic acid at pH 4.0. A subsequent salt gradient running from 50 mM 
to 1.5 M NH4 Cl was found to elute the various components of the mixture from the 
column (see figure 2.52). Note that a similar buffer containing 50 mM acetic acid 
at pH 4.0 had previously been tried, unsuccessfully, with analytical cation exchange 
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HPLC. At this time it is not known why the inclusion of the formic acid should 
make such a difference. The five fractions isolated from the CM-Sepharose column 
were analysed by homogeneous 20% SDS-PAGE which clearly revealed the extent 
to which the cation exchange chromatography had resolved the components of the 
crude mixture (see figure 2,53). 
2 3 4 5 6 7 8 
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Figure 2.53 Homogeneous 20% SDS-PAGE Analysis of UbCEP52 
lane! & 8 - molecular weight markers 
lane2 - crude fully deprotected UbCEP52 
lane3 - CM-Sepharose F! 
lane4 - CM-Sepharose F2 
laneS - CM-Sepharose F3 
lane6 - CM-Sepharose F4 
lane7 - CM-Sepharose F5 
The major band in lane7 (F5) has an apparent molecular weight more or less 
consistent with that expected for UbCEP52 (theoretical mass 14728.59 Da ). 
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Moreover, a simple inspection of the gel suggested this material was at least 80% 
homogeneous. Further purification would undoubtedly have removed some of the 
remaining contaminants, however, given the limited supply of F5 (16 mg) it was 
decided to accept this level of purity and so the purification was stopped at this 
point. 
Acid hydrolysis of various duration were carried out on F5 and the resulting amino 
acid analyses are shown in table 2.14. By and large the amino acid composition of 
the synthetic material was as expected for UbCEP52. Again the cysteine residues 
appeared to oxidise to cysteic acid, but encouragingly the methionine content was 
not much lower than expected. This is of special significance given that the final 
residue to be coupled was a methionine. 
Amino Acid Expected 48 hour 72 hour 	- 96 hour 
Asx 12 11.2 11.88 12.47 
Thr 8 7.31 6.51 6.12 
Ser 4 5.66 4.60 4.27 
Gix 15 18.90 18.40 18.20 
Pro 6 - 6.36 7.74 
Gly 7 - - - 
Ala 5 5.17 6.83 6.44 
Cys 5 3.42 2.38 1.57 
Val 6 5.42 5.67 5.70 
Met 2 1.70 1.50 1.54 
Ile 10 8.94 8.83 8.79 
Leu 13 12.62 12.30 12.70 
Tyr 3 2.95 2.90 2.95 
Phe 2 1.99 1.80 1.98 
His 3 3.19 1.17 3.35 
Lys 17 15.54 15.50 16.12 
Arg 10 	1 9.55 9.74 	1 9.34 
Table 2.14 Amino Acid Analysis of Synthetic UbCEP52 
Times as indicated, 6N HO (5 mg/ml Na2SO3  ) at 11OC 
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The primary sequence of the protein was further characterized by automated 
Edman degradation which confirmed the N-terminal residue was methionine 221• 
Indeed, the first 30 residues in the protein were unambiguously sequenced and 
found to be in agreement with those in UbCEP52. Although circumstantial, there 
was evidence that the last 52 amino acids in UbCEP52 were also present and 
correct. The major product after the first part of the synthesis had already been 
shown to be CEP52 (section 2.6.3 ) and given that the construction of UbCEP52 
was merely a continuation of this synthesis, it is fair to assume that the final 
product will also contain this 52 residue segment 
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Figure 2.54 Electrospray Mass Spectrometry on Synthetic UbCEP52 
Theoretical mass = 14728.59 Da 
Electrospray mass spectrometry was performed on the synthetic material, however, 
the results it afforded could not be easily interpreted 195  The technique is known 
to have some difficulty dealing with samples containing salts and this may account 
for the incongruous data it produced for UbCEP52 ( see figure 2.54). 
Laser desorption mass spectrometry gave a slightly more realistic mass 
determination for the synthetic material 224  However, the experimentally obtained 
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Figure 2.55 Laser Desorption Time-Of-Flight Mass Spectrometry on 
Synthetic UbCEP52 
14836 & 7425 = M & M2 of synthetic UbCEP52 
16951 & 8484 = M & M2 of apomyoglobin standard 
During the final step of the purification the protein was exposed to ZnC1 2, thereby 
giving it the opportunity to bind the metal ion. Indeed, an Elimans assay indicated 
the isolated protein contained 0.13 free thiol groups, suggesting either zinc binding 
or some other form of sulphydryl protection (eg disulphides). Zinc has an atomic 
weight of 65.38 Da, therefore a single coordinated ion could not itself account for 
the observed mass difference. If, however, the protein had been acetylated during 
the purification (mass change = +42 Da) then the combination of this and the 
metal coordination would explain the increase in mass. On the other hand, given 
the accuracy of the instrument in this mass range (± 10 Da), there are a number of 
other chemical modifications that could rationalise such a finding, for example, 
trifluoroacetylation, poly-formylation, various forms of alkylation etc. 
Alternatively, the mass determination itself may be at fault; the mass of the protein 
was calculated based on its time-of-flight relative to the internal apomyoglobin 
standard. Further mass studies using different internal standards are currently being 
carried out. 
2.6.5 In Vitro Biological Activity of UbCEP52 
Preliminary studies into the biological activity of UbCEP52 have been carried out 
by Mayer and co-workers 225  All UbCEPs are rapidly processed in vivo by 
specific amidases, liberating both mature ubiquitin and the free CEP. This 
processing event served as the basis of the in vitro assay carried out on synthetic 
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UbCEP52. Presumably the amidase responsible for the cleavage would not 
recognize the processing site in UbCEP52 if the synthetic protein was in way 
defective in its primary or tertiary structure. 
Anti-ubiquitin polyclonal antibodies ( Dako Biochemicals ) were found to 
recognize synthetic UbCEP52 ( see figure 2.56, lane 4) thus allowing the putative 
processing of the precursor to be easily monitored by Western analysis. Human 
brain tissue was lysed in phosphate buffered saline ( pH 7.0 ) and the resulting 
soluble protein fraction ( S2) incubated with UbCEP52 for 2 hours at 37 0C. The 
contents of the assay were then separated by SDS-PAGE and probed with anti-
ubiquitin polyclonal antibodies ( see figure 2.56). 
—24 
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Figure 2.56 Western Analysis of the In Vitro Processing Assay on UbCEP52 
lane! = Bovine Ub 	 laneS = S2 + UbCEP52 at T=2 h 
lane2 = UbCEP52 + S2 at T=0 	lane6 = S2 at 1= 2 hrs 
lane3 = S2 at 1=0 	 lane7 = UbCEP52 at T=2 h 
lane4 = UbCEP52 at T=0 
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Comparison of lanes 2 and 5 reveals that ubiquitin is liberated from the UbCEP52 
after a 2 hour incubation with human brain soluble protein fraction. Synthetic 
UbCEP52 was also shown to be processed when incubated with rabbit reticulocyte 
lysate, implying that a similar amidase is present in both human and murine tissues. 
Naturally this assay is not able to detect the liberated CEP52 since this peptide is 
not immunoreactive against anti-ubiquitin antibodies. Therefore the possibility that 
CEP52 is digested by protease in the system cannot be completely ruled out. 
However, by radiolabelling the 3 tyrosines in UbCEP52 with 'I, both products of 
the processing can be detected by autoracliography. Furthermore, the extreme 
sensitivity of autoradiography should make it possible to detect any endogenous 
protein conjugates the mature ubiquitin might form after the processing event. The 
presence of such conjugates would of course be strong evidence that the ubiquitin 
component had folded into its native conformation. Studies involving radiolabelled 
UbCEP52 are currently in progress 225 
2.6.6 Structural Studies on CEP52 and UbCEP52 
The principal aim of this study was to investigate both the zinc binding and 
structural properties of CEP52 and UbCEP52. To do so we employed a 
combination of CD spectroscopy, UV spectroscopy and NMR spectroscopy. Where 
appropriate the results were compared with those obtained for purified bovine 
ubiquitin. 
2.6.60) Circular Dichroism Studies on CEP52 and UbCEP52 
The far UV CD spectra of CEP52 and UbCEP52 were acquired in various buffered 
solutions and in each case the secondary structure content determined using the 
CONTIN procedure ( see table 2.15 ). In aqueous boric acid at pH 6.0, neither 
CEP52 nor UbCEP52 had a CD spectrum consistent with a high amount of 
secondary structure. Indeed, it was significant that UbCEP52 apparently had less a-
helix than mature ubiquitin ( see figure 2.57). No obvious change was observed in 
the CD spectra of CEP52 upon the addition of ZnC1 2 (10 eq). Zinc finger peptides 
commonly contain between 20 and 40% a-helix, therefore CEP52 did not appear to 
be adopting a structure analogues to these peptides. The possibility that disulphide 
bridge formation was preventing zinc binding was investigated by adding 
dithiothreitol, however, inclusion of this reducing agent had no conspicuous effect 
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Figure 2.57 Far UV CD Spectra of Bovine Ubiquitin, CEP52 and 
UbCEP52 in 50 mM Boric Acid at pH 6.0 
UbCEP52 had already been exposed to zinc during the purification of the protein, 
thus making it impossible to study the effect the metal ion had on its structure. 
Nevertheless, the a—helix content in UbCEP52 exposed to zinc was still 
substantially lower than that in a classical zinc finger motif. Again, addition of 
DTF had no effect on the level of helicity in the protein. 
Exposure of the samples to trifluoroethanol (50% by volume ) dramatically altered 
their far UV CD spectra. In each case an appreciable increase in a-heicity was 
associated with the addition of this alcohol ( see table 2.15 ). Indeed, both CEP52 
and UbCEP52 exhibited CD spectra more akin to those expected for zinc finger 
type motifs. However, such an artificial environment also induced a considerable 
increase in the a-helicity in bovine ubiquitin, raising questions over the ultimate 
importance of these TFE generated structures. 
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Sample a-helix 13-sheet Remainder 
Bovine Ub 15±2.5% 57± 2.6% 28±4.5% 
+50%TFE 63±0.73% 38±0.73% 0±7.1 x 10 
CEP52 3±048% 38±0.55% 59±0.95% 
+Zn2 (1Oeq)+ 4±0.80% 
DTF (5eq)  
42±0.83% 54± 1.5% 
• Zn2 (10eq) + 
D1'T(5eq) +TFE  
24 ± 0.37% 28 ±0.54% 48± 0.66% 
UbCEP52 + Zn2 3 ±0.69% 55 ±0.72% 42 ± 1.3% 
+50%TFE 31±1.2% 43±1.2% 27±2.2% 
Table 2.15 Secondary Structure Contents Derived from CD using 
CONTIN Procedure: all samples dissolved in 50 mM 
boric acid at pH 6.0 containing additives stated 
2.6.60) Ultra-Violet Absorption Studies on CEP52 and UbCEP52 
Coordinated transition metal ions very often give rise to distinctive absorption 
bands in the UV-visible region of the electromagnetic spectrum. These bands are 
produced in two distinct ways. The first, d-d transitions, involve discrete electronic 
shifts between the split d-orbitals of the coordinated metal centre. All d-d 
transitions are forbidden processes (iM=0) and for this reason are generally weak 
in intensity. On the other hand, charge-transfer bands, which involve transitions 
between the molecular orbitals of the ligand and the metal d-orbitals, are allowed 
transitions and are thus of greater intensity. Tetrahedrally coordinated Zn2+ (00) 
does not have any d-d transitions and therefore no identifying absorption bands in 
the UV-visible region. Fortunately tetrahedrally coordinated Co 2 (d7) does have a 
characteristic d-d transition in the 600-700 nm region, and for this reason is often 
used in place of Zn2  in UV-visible binding studies 226• Furthermore, if the Co2 
is coordinated to cysteinate ligands there will also be strong charge-transfer bands 
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Figure 2.58 Optical Absorption Spectra of Reduced CEP52 with and 
without Co2 : (a) 50 p.M CEP52; (b) 50 p.M CEP52 + leq 
CoCl2 ; (c) 50 p.M CEP52 + Seq CoCl2 
Spectra (b) and (c) have been corrected by subtracting the 
spectrum of free CoCl2 
Samples of CEP52 and UbCEP52 were sonicated overnight at 400C in a buffer 
containing 50 mM Tris.HC1 at pH 7.2, 10 mM DTF and 10 mM EDTA. The 
reduced samples were then recovered by semi-preparative HPLC and immediately 
lyophilised ready for use. UV-visible analysis significantly revealed that addition of 
CoCl2  to CEP52 was not accompanied by the appearance of the d-d band in the 
required 600-700 nm region ( see figure 2.58 ). Similarly, no such band was 
observed in the UV-visible spectrum of UbCEP52 upon addition of CoC1 2 ( see 
figure 2.59 ). These results appear to indicate Co 2 is not tetrahedrally complexed 
in either CEP52 or UbCEP52, thereby implying the two samples do not bind Zn 2 
in a tetrahedral manner. 
Interestingly, both CEP52 and UbCEP52 have a noticeable increase in absorbance 
in the 300-350 nm region upon addition of the CoC1 2. Such an absorbance appears 
to be consistent with the cysteinateCo 2+ charge-transfer band usually associated 
with zinc and cobalt binding peptides. Why this charge-transfer band should be 
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present and not the d-d transition is difficult to explain, although it is possible that 
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Figure 2.59 Optical Absorption Spectra of Reduced UbCEP52 with and 
without Co2 : (a) 25 jiM UbCEP52; (b) 25 p.M UbCEP52 
+ leq CoCl2 ; (c) 25 p.M UbCEP52 + Seq CoC12 
Spectra (b) and (c) have been corrected by subtracting the 
spectrum of free CoC12 
2.6.6(iii) NMR Studies on CEPS2 and UbCEPS2 
The sensitivity of NMR to changes in peptide/protein structure makes it ideally 
suited to monitoring the effect an additive, like ZnCI21  has on the conformation of 
such a molecule. In situ titration of a sample of reduced CEP52 with ZnC1 2 was 
followed by 1D NMR, the results of which are shown in figure 2.60. Addition of 
the metal ion did not appear to bring about any great change in the amide proton 
region, although there were some minor differences in the 8.4 - 8.6 ppm range of 
the spectrum. Note, the 1D 1H NMR spectrum of CEP52 + ZnC1 2 (lOeq) + DTT 
(5eq) was no different from that of CEP52 + ZnC1 2 (leq). The tetrahedral 
coordination of Zn2+  in peptides normally results in considerable conformation 
reorganization, and hence conspicuous changes in the 1D NMR spectrum of the 
peptide 225  Therefore, the small differences observed in the 1D NMR spectrum of 
CEP52 must be regarded as insignificant in comparison with those usually 
associated with Zn2+  binding. Consequently, there does not seem to be any 
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evidence from NMR to support the contention that CEP52 is a zinc binding 
peptide. Indeed, this conclusion is entirely in keeping with the observations from 
circular dichroism and ultra-violet absorption spectroscopies. 
CEP52 no Zinc 
CEP52 0.2eq Zinc 
CEP52 O.Bea Zinc 
CEP52 i.OeQ Zinc 
1111111 liij 111111 ''t 1111 1 1111 1 1111 1 1111 1111 1 111  I liii I lilij III I 1111 1 111 iii 111 1 1111 1 111 iii 111111 Iii iiii I 111 1 11 liii  1111111111111 I 1111 1 1111 1 1111 1 1 l i i i 
8.8 	8.4 	8.0 	7.6 	7.2 	6.8 	6.4 ppm 
Figure 2.60 1D 'H NMR Spectra of CEP52 indicating the effect of 
ZnCl2 addition. Spectra recorded at 25 0C in 90% H20: 
10% D20 at pH 6.0 
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Two dimensional NMR was used to study in more detail the solution conformation 
of CEP52 and UbCEP52. The complete lack of NH - ctCH crosspeak dispersion in 
the TOCSY spectrum of CEP52 in the presence of ZnCJ 2 (lOeq) confirmed the 
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Figure 2.61 Region from the TOCSY Spectrum of CEP52 in 90% H 20: 
10% D20 at pH 6.0 containing lOeq ZnCl 2, 25°C 
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Figure 2.62 Region from the TOCSY Spectra of UbCEP52 (red) and 
Bovine Ubiquitin (black). Spectra obtained in 90% H 20: 
10% D20 at pH 6.0 containing lOeq ZnC1 2, 25°C 
Interestingly, the TOCSY spectrum of CEP52 did not appear to change when the 
peptide was exposed to 50% TFE, an observation apparently in disagreement with 
the previous CD studies. The possibility that in this medium the peptide exhibits 
isolated areas of secondary structure, more easily detected by CD than NMR, 














Although the role of the ubiquitin component in UbCEP52 is not absolutely certain, 
it is not unreasonably to suggest that it in some way allows the CEP to adopt its 
native conformation. Indeed, given that CEP52 appeared to be essentially random 
coil in aqueous solution, this function did have some attraction. It therefore came as 
some surprise when the TOCSY spectrum of UbCEP52 not only indicated the 
CEP52 component had no structure, but also the ubiquitin segment had unfolded 
(see figure 2.62). As in the case of CEP52 exposure of the protein to 50% aqueous 
TFE had no visible effect on the TOCSY spectrum. 
The random coil nature of CEP52 and UbCEP52 indicated by the exceptional 
spectral crowding and overlap, made assignment of their proton resonances 
impossible. 
2.6.7 Conclusions 
All the evidence accumulated from these structural studies seems to suggest that 
neither CEP52 nor UbCEP52 are able to bind Zn 2 in a tetrahedral manner. In situ 
disulphide formation would of course prevent these peptides from coordinating 
Zn2+, and hence explain their apparent indifference to the addition of this metal 
ion. However, the random coil nature of CEP52 and UbCEP52, as indicated by 
both CD and NMR, would seem to rule out the existence of structure inducing 
disulphide bridges. Initial biochemical investigations indicate that UbCEP52 is 
correctly processed into mature ubiquitin and CEP52 in vitro. Presumably the 
amidase responsible for this process is sensitive to the structural surrounding the 
cleavage site, and hence is happy with the random coil nature of synthetic 
UbCEP52. It is not inconceivable that ubiquitin unfolds within UbCEPs so as to 
allow this amidase easier access to the processing site. This unfolding of ubiquitin 
within UbCEPs would surely be a handicap to the folding of the CEP component. 
Whether or not this putative ubiquitin induced precursor unfolding is a general 
phenomenon remains to be seen. However, given the relatively short in vivo half-
lives of many heterologous gene products encoding ubiquitin N-terminally fused to 
various proteins 106-108,  it is easy to speculate that being tethered to ubiquitin 




Chapter 3 - Experimental 
Section 3.1 Notes 
All Fmoc protected amino acids were purchased from Novabiochem and Raylo 
(Fmoc-Arg(Pmc)OH) and unless otherwise stated were of the L-configuration. 
15N-Glycine was purchased from Sigma and used as supplied. Melting points were 
recorded in open capilliaries on a Buchi 510 melting point apparatus and are 
uncorrected. Thin layer chromatography (t.l.c.) was carried out on commercially 
available plastic sheets pre-coated with silica gel 60 F 254 (Merck) using the 
following system: CHC1 3 / MeOH / AcOH (9:1:0.5). Visualization of the 
compounds was achieved by ultra-violet absorption at 254 nm and ninhydrin in the 
case of free amino groups. Infrared spectra were recorded on a Perkin Elmer 781 
double beam spectrophotometer in the solvent indicated. Polystyrene (1603 cm -1 ) 
was used as the standard. Ultra-violet spectra were recorded on a Varian Cary 210 
spectrophotometer in the solvent indicated. Where necessary temperature control 
was achieved by continuously pumping water from a thermostatic bath (Techne 
TE-8J) through the thermostated cell compartment of the instrument. Temperatures 
were measured using a Comark electronic thermometer. Refractive indices were 
measured on an Abbe 60 refractometer. A Corning ion analyser 150 was used for 
all pH measurements. Circular dichroism (CD) spectra were recorded on a JASCO 
J600 spectropolarimeter in the solvent indicated. Fluorescence spectra were 
recorded on a Perkin Elmer LS50 luminescence spectrometer fitted with a Grant 
LTD-6 thermostatic control. Proton NMR spectra were acquired on a Varian VXR 
5000 (600 MHz) instrument in the solvent indicated and the chemical shifts were 
measured relative to TMS assigned to zero. High and low resolution fast atom 
bombardment (FAB) were measured on a Kratos MS50TC machine. High 
performance liquid chromatography (HPLC) was carried out using either a 
WatersfKratos system: 2 x Kratos spectroflow 400 pumps, a Waters U6K injector, a 
Waters 680 automatic gradient controller and a Waters 450 variable wavelength 
detector, or one of two Applied Biosystems systems: A) 2 x 400 solvent delivery 
systems, a 491 injector/mixer and a 783A detector/programmer, B) 2 x 1406A 
solvent delivery systems, a 1480A injector/mixer and a 1783A 
detector/programmer. Analytical and semi-preparative separations were performed 
using the conditions and columns described in the text. Amino acid analysis was 
carried out on an LKB 4151 amino acid analyser following either sealed Carius 
tube hydrolysis with 6N HC1 (containing 5 mg/ml Na2S03) at 110°C for the time 
indicated in the text, or total enzymatic hydrolysis using the enzymes indicated in 
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the text. Protein sequencing was performed by the Welmet protein characterization 
group on an Applied Biosystems 477A protein sequencer. Fast protein liquid 
chromatography (FPLC) was carried out on a Pharmacia instrument using the 
conditions and columns indicated. Isoelectric focussing electrophoresis (IEF) was 
performed on a LKB 217 multiphor horizontal bed instrument powered by a 
Pharmacia ECPS 3000/150 constant powerpack using the conditions and gels stated 
in the text. SDS-PAGE was carried out on a Pharmacia phastsystem using precast 
20% homogeneous SDS phastgels and buffer strips. All gels were stained with 
Coomassie blue R250. Gel filtration and ion exchange chromatography were 
carried out using Pharmacia/LKB apparatus: 2 x LKB 2138 UVICORDS, a 
Pharmacia 2132 Microperpex peristaltic pump, an LKB 2112 redirac fraction 
collector and where appropriate a Pharmacia GM gradient mixer. All separations 
employed the columns and conditions stated in the text. All solvents were distilled 
before use and the following were dried using the reagents given in parenthesis 
when required: dichloromethane (calcium hydride), diethyl ether (sodium wire), 
ethanol (magnesium iodine). The dimethylformamide (DMF) and 1,4-dioxan used 
were peptide synthesis grade, supplied by Rathburn Chemicals. 
Section 3.2 Solid Phase Peptide Synthesis 
All peptides described were synthesised on an Applied Biosystems 430A automated 
peptide synthesiser equiped with an Applied Biosystems 757 absorbance detector 
linked to a Hewlett Packard HP3396A Integrator for online monitoring of the 
deprotection solution containing the piperidine-fulvene adduct. 
An orthogonal synthetic strategy was employed in which the base-labile 9-
fluorenylmethoxycarbonyl (Fmoc) group was used for Naamino protection. This 
allowed both acid-labile side-chain protection and acid-labile peptide-resin linkage. 
The following side-chain protecting groups were used: tertiary-butyl (But) ethers 
for serine, threonine and tyrosine; But  esters for glutamic and aspartic acid; 4,4'-
dimethoxybenzhydryl (Mbh) for asparagine and glutamine; tertiary-
butyloxycarbonyl (Boc) for lysine; t-triphenylmethyl (Trityl, Trt) protection for 
histidine and 2,2,5,7,8-pentamethylchroman-6-sulphonyl (Pmc) protection for the 
guanidino group of arginine. The sulphydryl group of cysteine was protected with 
the non-acid-labile tertiary-butylthio (SBut) group. 
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The first (C-terminal) amino acid was attached to the acid sensitive p-alkoxybenzyl 
alcohol (Wang) group on the resin outwith the synthesiser. The syntheses were 
monitored using real-time assessment of the deprotection solution (2 ml aliquot) 
containing the chromophoric piperidine-fulvene adduct at 302 nm in a continuous 
flow mode from the synthesiser to the UV detector. Most amino acids were triple 
coupled, firstly as a symmetrical anhydride (2 mmol amino acid) followed by two 
1-hydroxybenzotriazole (HOBt) active ester (1 mmol amino acid) couplings using 
N,N-diisopropylcarbodiimide (DIC) in dioxan as the activating agent. Exceptions 
to this were glycine which was single coupled as a symmetrical anhydride (4 mmol 
amino acid) and histidine, asparagine and glutamine which were coupled three 
times as their respective HOBt active esters (1 mmol amino acid). Following 
coupling any unreacted Naamino groups were capped by treatment with acetic 
anhydride. 
Recurrent deprotection, activation, coupling and capping steps were carried out 
using the following programmed cycles. 
1. Deprotection: 
The Fmoc group was removed from the peptide-resin with successive 5, 3, 3 and 1 
minute treatments with 20% piperidine in DMF. The resin was drained and washed 
twice with DMF between consecutive deprotections. 
2. Wash: 
The resin was washed 5 times with DMF. 
3. Coupling: 
The protected amino acid was preactivated as a symmetrical anhydride using 
DIC in dioxan 15 minutes prior to being added to the resin. Coupling was then 
allowed to proceed in a 1:1 mixture of DMF:dioxan for 30 minutes. 
A second coupling of the amino acid pre-activated as an HOBt active ester for 
20 minutes was carried out in a 1:1 mixture of DMF:dioxan for 30 minutes. 
The amino acid was once again coupled as an HOBt acive ester for 30 minutes 
in a 1:1 mixture of DMF and dioxan. 
4. Wash: 




Capping of the resin was achieved with a mixture containing 1 ml of 0.5 M acetic 
anhydride in DMF and 1 ml of 0.5 M pyridine in DMF for 2 minutes, drained and 
washed twice then capped a second time for 4 minutes. 
Wash: 
The resin was washed 5 times with DMF. 
Note, 1-hydroxybeozotriazole which is purchased (Fluka) as the hydrate (12-17%) 
was dried over anhydrous MgSO 4  and recrystallized from dry ethanol before being 
used. DIC and acetic anhydride were purchased from Aldrich and used as supplied. 
Section 3.3 Experimental 
Counlini the C-Terminal Amino Acid onto the p-Alkoxvbenzvl Alcohol Resin 
The first amino acid was attached to the polymeric support using one of the 
following manual procedures. 
Acid Chloride Counling 
The Fmoc-amino acid (3.16 mmol) was suspended in dry DCM (50 ml) and thionyl 
chloride (2.20 ml, 30.16 mmol) added under nitrogen. The mixture was heated 
under reflux at 500C for 2 hours after which the DCM and excess thionyl chloride 
were removed under vacuum. The resulting solid was then redissolved in DCM and 
concentrated in vacuo. This was repeated to give a pale yellow solid; Vm 1710- 
1720 (COd), 1800 (Fmoc C=O) cm'. p-Alkoxybenzyl alcohol resin (2.0g, 1.58 
mmol) was pre-swollen in dry DCM (25 ml) and pyridine (3 ml) for 30 minutes 
before adding the Fmoc amino acid chloride (from above) dissolved in dry DCM 
(10 ml). After sonicating for 1 hour the resin was filtered, washed with DCM (3 x 
50 ml), diethyl ether (3 x 50 ml) and dried in a dessicator overnight. The resin 
substitution and percentage loading was then determined. 
Diisonronvlcprbocjjlmjde Counling 
The Fmoc-amino acid (1.2 mmol) was activated as the symmetrical anhydride by 
treatment with diisopropylcarbodiimide (DId) (94 .tl, 0.6 mmol) in DMF (10 ml). 
This mixture was sonicated for 15 minutes before being added to p-alkoxybenzyl 
alcohol resin (1.5 g, 1.2 mmol) previously swollen in DMF (20 ml). 4-
Dimethylaniinopyridine (DMAP) (10 mg, 0.09 mmol ) was added and the resin 
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sonicated for 15 minutes. The resin was then filtered, washed with DMF, DCM and 
diethyl ether and dried overnight in a dessicator. The resin substitution was then 
determined. 
Coupling method 1 was used only with Fmoc-glycine, all other amino acids were 
attached to the resin using the second procedure. Note that the reaction times and 
molar ratios of reagents in both coupling methods were chosen to give low initial 
loading on the resin. 
The loading efficiency was determined by sonicating a sample of the dried resin (3-
4 mg) for 10-20 minutes in the presence of a 20% (v:v) piperidine in DMF solution 
(10 ml). The UV absorbance of the solution at 302 nm was then measured and the 
concentration of the piperidine-fulvene adduct therein determined using the Beer-
Lambert law (Eau302 wn = 15400 dm3 mo!-1 cm-1 ). This value then allows the 
initial loading of the resin to be calculated. 
Fmoc-amino acid-resin (1.60 g) was suspended in DCM (30 ml) and cooled to 0°C. 
Pyridine (0.5 ml) and benzoylchloride (0.5 ml) were then added and the mixture 
stirred for 5 hours at room temperature. The resin was filtered, washed with DCM 
(3 x 50 ml), diethyl ether (3 x 50 ml) and dried in a dessicator overnight. 
Glvcvlglvcine Content in Loaded Resin 
In the case where the first amino acid is glycine, it is necessary to check for 
unwanted polymerisation of this residue. A sample of the resin (20 mg) was treated 
with 20% piperidine in DMIF (30 ml) for 20 minutes to remove the Fmoc group. 
Glycine was removed from the resin by treatment with 95% aqueous TFA for 1 
hour. After removal of the TFA in vacuo the residue was triturated with diethyl 
ether to give a white powder which was isolated by filtration and dissolved in citric 
acid buffer at pH 2.2 for amino acid analysis. The retention time (R T) of the amino 
acid in the sample was then compared with those of glycine (R T = 6.19 mm) and 
glycylglycine (RT = 39.2 mm) standards. 
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Determination of the Fmoc Content in ComDleted PeDtide 
The overall yield of the synthesis on the resin was determined in the following way. 
The final (N-terminal) amino acid was left with the Fmoc protecting group attached 
so as to allow UV monitoring. A sample of dried Fmoc-peptide-resin (2-5 mg) was 
sonicated for 10-20 minutes in the presence of 20% piperidine in DMIF (10 ml). 
The UV absorbance of the solution at 302 nm was then measured and the 
concentration of the piperidine-fulvene adduct therein determined using the Beer -
Lambert law. This value allows the final Fmoc-amino acid loading to be calculated 
and this can be compared with the theoretical final loading given 100% yield in 
every step of the synthesis (determined using computer programme). 
Preliminary Acidolvtic Cleavage of Resin Bound Pentide 
Peptide cleavage conditions were optimized in the following way. Fmoc-peptide-
resin was deprotected with 20% piperidine in DMF for 10-20 minutes before being 
washed with DMF, DCM and diethyl ether and dried overnight in a dessicator. 
Deprotected peptide-resin (30-50 mg) was swollen in a mixture of scavengers 
(0.25 ml, 5% v:v of each) for 30 minutes under nitrogen. Depending upon the 
peptide these scavengers would be chosen from the following: anisole; thioanisole; 
phenol; ethyl methyl sulphide (EMS); ethane dithiol (EDT). Trifluoroacetic acid 
(TFA) (5 ml, 95% v:v) and H20 (0.25 ml, 5% v:v) were then added to the pre- 
swollen resin which was then gently stirred under nitrogen. Aliquots (0.75 ml) of 
the cleavage mixture were periodically removed and concentrated in vacuo. The 
resulting residues were triturated with diethyl ether to give white peptide 
precipitates. These were filtered off, dissolved in 20% aqueous acetic acid and 
analysised by HPLC. 
High Performance Liquid Chromatogranhv (HPLCI 
Unless otherwise stated all analytical HPLC was performed on an Aquapore C 8 
reverse phase column (100 x 4.6 mm, 300 A° pore size, 7.tm) employing a flow 
rate of 1 ml/min and monitoring at 214 nm. Semi-preparative HPLC was 
accomplished on an Aquapore C 8 reverse phase column (100 x 10 mm, 300 A° 
pore size, 20 gm) using a flow rate of 5 ml/min and monitoring at 214 nm. The 
following gradient systems were used with both analytical ans semi-preparative 
HPLC. 
Gradient System A: 
A = H20, B = CH3CN, 0.1% TFA, 10-90% B over 30 minutes. 
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Gradient System B: 
A = H20, B = CH3CN, 0.1% TFA, 20 - 40% B over 20 minutes. 
Purification of Bovine Ubiauitin (Sigma) 
Commercially available bovine ubiquitin was purified in the following manner. 
Gel Filtration Chromatography 
Bovine ubiquitin (93.7 mg, 10.9 j.Lmol) was dissolved in a buffer containing 8 M 
urea, 10 mM DTT and 50 mM NH4OAc at pH 4.5 (10 ml) and applied to a 
Sephadex G50 (fine) column (800 x 30 mm) pre-equilibrated with the same buffer. 
The column was then eluted with 8 M urea, 10 mM DTT and 50 mM NH 4OAc (pH 
4.5) at 45 ml h- 1  with similtaneous monitoring at 226 and 277 nm. The protein was 
eluted in fractions 8-12 (105-180 ml) and these were combined and analysed by 
HPLC (C8 RP300, gradient system A, R,=16.9 mm., 45% B). 
Stepwise Dialysis 
The combined fractions from gel filtration were sequencially dialysed (MWCO 
2000 Da, Spectropor) against nitrogen saturated solutions of 6 M urea, 10 mM 
DTF, 50 mM NH4OAc at pH 4.5; 4 M urea, 10 mM DTT, 50 mM NH4OAc at pH 
4.5 and 2 M urea, 10 mM DTT, 50 mM NH4OAc at pH 4.5 for 24 hours each step. 
As a final step the protein was dialysed against nitrogen saturated 50 mM NH 4OAc 
for 3 x 24 hours. The dialysed material was then lyophilised to concentrate the 
solution to 10-15 ml. 
Cation Exchange Chromatography 
Cation exchange chromatography was carried out using a CM-Sepharose (CLB 
beads Pharmacia) column (320 x 18 mm). Bovine ubiquitin dissolved in 50 mM 
NH40Ac at pH 4.5 (15 ml) was loaded onto the CM-Sepharose column pre-
equilibrated with the same buffer. A pH gradient of 50 mM NH 40Ac at pH 4.5 to 
50 mM NH40Ac at pH 5.5 was run at 30 ml 0 for 19 hours with simultaneous 
monitoring at 226 and 277 nm. The column was then run isocratically at 50 mM 
NH4OAc at pH 5.5 for 3 hours after which a salt gradient of 50 mM NH 4OAc at pH 
5.5 to 0.3 M NH40Ac at pH 5.5 was applied to elute the protein from the column. 
The protein was eluted in fractions 86-91 (860-920 ml, approx. 0.15 M NH 40Ac). 
These were combined and repeatedly lyophilised to give a white solid (78.8 mg). 
Analysis by HPLC (C8 RP300, gradient system A, R=16.9 mm., 45% B), amino 
acid analysis and IEF confirmed the material was bovine ubiquitin. 
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4. Anion Exchange Chromatography 
Anion exchange chromatography was performed on a DEAE-Sepharose 
(Pharmacia) column (320 x 18 mm) equilibrated with 50 mM NH 4HCO3 at pH 9.3. 
Bovine ubiquitin (78.8 mg) was dissolved in starting buffer (10 ml) and loaded 
onto the pre-equilibrated column. A salt gradient of 50 mM NH4HCO3 at pH 9.3 to 
0.3 M NH4HCO3 at pH 9.3 was run at 30 ml 0 for 21 hours with simultaneous 
monitoring at 226 and 277 nm. The protein was eluted in fractions 18-23 (180-240 
ml, approx. 0.13 M N}{4HCO3). These were combined and repeatedly lyophilised 
to give a white solid (50.6 mg). Analysis by HPLC (C 8 RP300, gradient system A, 
R=16.9 mm., 45% B), amino acid analysis and IEF confirmed the material was 
homogeneous bovine ubiquitin. 
Synthesis of Ubiauitin 
Fmoc-Gly-OH was attached to the p-alkoxybenzyl alcohol resin via the amino acid 
chloride (0.288 mmol of Fmoc-Gly per gram of resin, 41% loading efficiency). No 
glycylglycine content could be detected by amino acid analysis. The synthesis of 
ubiquitin was carried out using the functionalised resin on a 0.25 mmol scale. The 
side-chains of amino acids were protected as previously indicated. Most amino 
acids were treble coupled, once as a symmetrical anhydride and twice as an HOBt 
active ester. Glycine was single coupled as a symmetrical anhydride and histidine, 
glutamine and asparagine were each coupled three times as their HOBt active 
esters. The synthesis was monitored using real time assessment of the deprotection 
solution in a continuous flow mode from the synthesiser to a UV detector set at 
302 nm. The final Fmoc group was left on the resin bound peptide (substitution 
0.032 mmol/g, 54% of theoretical maximum) which was stored in dioxan at 0-4 0C 
until required. The resin was divided into three equal portions and each deprotected 
and cleaved in the same way. Note that all weights are in effect aggregate values. 
The peptidyl-resin was swollen in DMF then treated with 20% piperidine in DMF 
for 15 minutes. After washing with DMF (3 x 50 ml), DCM (3 x50 ml) and diethyl 
ether (3 x 50 ml) the deprotected resin was dried in a dessicator overnight. The dry 
resin (2.42 g) was swollen in a mixture of anisole, thioanisole and ethyl methyl 
sulphide (1 ml of each, 5% v:v) for 30 minutes under nitrogen before adding H 20 
(1 ml, 5% v:v) and TFA (16 ml, 80% v:v). After stirring under nitrogen for the 
optimal time of 3.5 hours the resin was filtered off and washed with TFA (2 ml) 
(dry wight=623 mg). The combined washings and filtrate were then concentrated in 
vacuo and the resulting brown residue triturated with diethyl ether containing 2% 
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f3-mercaptoethanol (50 ml) to give a white solid. This was filtered off and 
immediately suspended in a buffer containing 8 M urea, 10 mM DTT and 50 mM 
NH4OAc at pH 4.5 (15 ml). This suspension was stirred for 16 hours to allow the 
crude peptide to fully dissolve. 
The synthetic material was purified in three batches in the following way. 
Gel Filtration Chromatography 
The solution containing the crude peptide was applied to a Sephadex 050 (fine) 
column (800 x 30 mm) pre-equilibrated with running buffer. The column was then 
eluted with 8 M urea, 10 mM DTT and 50 mM NH4OAc (pH 4.5) at 45 ml h4 with 
similtaneous monitoring at 226 and 277 nm. Synthetic ubiquitin. was eluted in 
fractions 13-19 (180-285 ml). These were combined and analysed by HPLC (C 8 
RP300, gradient system A, R,=16.9 mm., 45% B). 
Stepwise Dialysis 
The combined fractions from gel filtration were sequencially dialysed (MWCO 
2000 Da, Spectropor) against nitrogen saturated solutions (2 1) of 6 M urea, 10 mM 
DTF, 50 mM NH4OAc at pH 4.5; 4 M urea, 10 mM DTF, 50 mM NH4OAc at pH 
4.5 and 2 M urea, 10 mM DTT, 50 mM NH4OAc at pH 4.5 for 24 hours each step. 
As a final step the protein was dialysed against nitrogen saturated 50 mM NH 4OAc 
for 3 x 24 hours. The dialysed material was then lyophilised to concentrate the 
solution to 10-15 ml. Analytical HPLC (C 8 RP300, gradient system A, R=16.9 
mm., 45% B) and amino acid analysis confirmed the improved purity of the 
synthetic material. 
Cation Exchange Chromatography 
The concentrated solution from dialysis was loaded onto the CM-Sepharose column 
(320 x 18 mm) pre-equilibrated with 50 mM NH40Ac at pH 4.5. A pH gradient of 
50 mM NH4OAc at pH 4.5 to 50 mM NH40Ac at pH 5.5 was run at 30 ml h for 
20 hours with simultaneous monitoring at 226 and 277 nm. The column was then 
run isocratically at 50 mM NH 40Ac (pH 5.5) for 3 hours after which a salt gradient 
of 50 mM NH40Ac at pH 5.5 to 0.3 M NH4OAc at pH 5.5 was applied to elute the 
protein from the column. The desired material was eluted in fractions 62-72 (620- 
730 ml, approx. 0.10 M NH4OAc). These fractions were combined and repeatedly 
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lyophilised to give a white solid (125 mg). This material was analysed by HPLC 
(C8 RP300, gradient system A, R,=16.9 mm., 45% B), amino acid analysis and IEF. 
4. Anion Exchange Chromatography 
The synthetic material isolated from the CM-Sepharose column was dissolved in 50 
mM NH4HCO3  at pH 9.3 (20 ml) and applied to a DEAE-Sepharose column (320 x 
18 mm) pre-equilibrated with the same buffer. A salt gradient of 50 mM NH 4HCO3 
at pH 9.3 to 0.3 M NH4HCO3 at pH 9.3 was run at 30 ml 0 for 20 hours with 
simultaneous monitoring at 226 and 277 nm. The protein was eluted in two major 
bands labelled A and B which consisted of fractions 12-15 (120-160 ml, approx. 
0.11 M NH4HCO3) and fractions 20-24 (200-250 ml, 0.14 M NH4HCO3 ) 
respectively. These were combined and repeatedly lyophilised to give 71.8 mg of A 
and 21.7 mg of B. Analysis by HPLC (C 8 RP300, gradient system A, R=16.9 mm., 
45% B), amino acid analysis, IEF and electrospray mass spectrometry indicated 
both materials were chemically identical to authentic bovine ubiquitin (see 
discussion section 2.4.2). 
Synthesis of Ubi auitin 15N-G1 v 5'43'50'56'67AIp 26,30  (Ubdes-Core) 
1!E174 iIi IITTTh I}t'Lfl ills) iki 
s ZTatl  
The compound was prepared by the method of Shute and Rich 215 15N-Glycine 
(1 g, 13.4 mmol) was dissolved in water (10 ml) and triethylamine (4.67 ml, 33.5 
mmol) added with stirring. A suspension of 9-fluorenylmethylsuccinimidyl 
carbonate (4.88 g, 14.5 mmol) in dioxan (10 ml) was added and mixture stirred at 
room temperature for 24 hours. The solution was then acidified (pH 1-2) with 2M 
KHSO4  before being extracted with ethyl acetate (3 x 20 ml). The combined 
organic layers were washed with water, dried over anhydrous MgSO 4 and 
concentrated to give a yellow oil. Trituration of this oil with 40-60 petroleum gave 
a white solid which was recrysyallised from ethyl acetate (3.06 g, 78%); m.p. 171-
173°C (lit = 173-174 0C); t.l.c. RF=0.54 (ninhydrin negative); m/z (FAB), 299 
(tflJj+), 257, 234, 179. 
Synthesis of Ubdes-Core 
Fmoc-Gly-OH was attached to the p-alkoxybenzyl alcohol resin via the amino acid 
chloride (0.291 mmol/g, 41% loading efficiency). No glycyiglycine content could 
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be detected by amino acid analysis. The synthesis of ubiquitin was carried out using 
the functionalised resin Fmoc-Gly-(OCH 2C6H40R) on a 0.25 mmol scale. The side-
chains of amino acids were protected as previously described for the synthesis of 
ubiquitin. Most amino acids were coupled once as a symmetrical anhydride 
followed by twice as an HOBt active ester. 15N-Glycine was single coupled as an 
HOBt active ester and 14N-glycine was single coupled as a symmetrical anhydride. 
Histidine, glutamine and asparagine were each coupled three times as their HOBt 
active esters. The synthesis was monitored using real time assessment of the 
deprotection solution in a continuous flow mode from the synthesiser to a UV 
detector set at 302 nm. The final Fmoc group was left on the resin bound peptide 
(substitution 0.027 mmol/g, 44% of theoretical maximum) which was stored in 
dioxan at 040C until required. The resin was divided into three equal portions and 
each deprotected and cleaved in the same way. Manual deprotection of the final 
Fmoc group was achieved by treating the resin with 20% piperidine in DMF for 15 
minutes. After washing with DMF, DCM and diethyl ether the deprotected resin 
was dried in a dessicator overnight. The peptide was cleaved from the resin with 
simultaneous removal of acid-labile side-chain protection in the following way. 
Dry resin (2.63 g) was swollen in a mixture of anisole, thioanisole and ethyl methyl 
sulphide (1 ml of each, 5% v:v) for 30 minutes under nitrogen before adding H 20 
(1 ml, 5% v:v) and TFA (16 ml, 80% v:v). After stirring under nitrogen for the 
optimum time of 4.5 hours the resin was filtered off and washed with TFA (2 ml) 
(dry wight=937.3 mg). The combined washings and filtrate were then concentrated 
in vacuo and the resulting brown residue triturated with diethyl ether containing 2% 
3-mercaptoethanol (50 ml) to give a white solid. This was filtered off and 
immediately suspended in a buffer containing 8 M urea, 10 mM DTT and 50 mM 
NH40Ac at pH 4.5 (15 ml). This suspension was stirred for 16 hours to allow the 
crude peptide to fully dissolve. 
Purification of Ubdes-Core 
The synthetic material was purified in three batches in the following way. Note that 
weights given are in effect aggregate values. 
1. Gel Filtration Chromatography 
The solution containing the crude peptide was applied to a Sephadex 050 (fine) 
column (800 x 30 mm) pre-equilibrated with running buffer. The column was then 
eluted with 8 M urea, 10 mM DTT and 50 mM NH40Ac (pH 4.5) at 45 ml h - I with 
similtaneous monitoring at 226 and 277 nm. The peptide was eluted in fractions 14- 
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21(195-315 ml). These were pooled and analysed by HPLC (C 8 RP300, gradient 
system A, R1=15 mm., 45% B) and amino acid analysis. 
Stepwise Dialysis 
The combined fractions from gel filtration were sequencially dialysed (MWCO 
2000 Da, Spectropor) against nitrogen saturated solutions (2 1) of 6 M urea, 10 mM 
DTF, 50 mM NH4OAc at pH 4.5; 4 M urea, 10 mM DTF, 50 mM NH 40Ac at pH 
4.5 and 2 M urea, 10 mM DTF, 50 mM NH40Ac at pH 4.5 for 24 hours each step. 
As a final step the protein was dialysed against nitrogen saturated 50 mM NH 4OAc 
for 3 x 24 hours before being lyophilised to concentrate the solution to 10-15 ml 
ready for cation exchange chromatography. 
Cation Exchange Chromatography 
The concentrated solution from dialysis was applied to a CM-Sepharose column 
(320 x 18 mm) pre-equilibrated with 50 mM NH4OAc at pH 4.5. A pH gradient of 
50 mM NH4OAc at pH 4.5 to 50 mM NH40Ac at pH 5.5 was run at 30 ml h for 
20 hours with simultaneous monitoring at 226 and 277 nm. The column was then 
run isocratically at 50 mM NH4OAc at pH 5.5 for 5 hours after which a salt 
gradient of 50 mM NH40Ac at pH 5.5 to 0.3 M NH4OAc at pH 5.5 was applied to 
elute the protein from the column. The desired material was eluted in fractions 100-
110 (1000-1110 ml, approx. 0.14 M NH4OAc). These fractions were combined and 
repeatedly lyophilised to give a white solid (155 mg) which was analysed by HPLC 
(C8 RP300, gradient system A, R=15 mm., 40% B), amino acid analysis and IEF. 
Anion Exchange Chromatography 
The synthetic material isolated from the CM-Sepharose column was dissolved in 50 
mM NH4HCO3  at pH 9.3 (15 ml) and loaded onto a DEAE-Sepharose column (320 
x 18 mm) pre-equilibrated with the same buffer. The column was then run 
isocratically at 50 mM NH4HCO3  at pH 9.3 for 3 hours at 30 ml h - I with 
simultaneous monitoring at 226 and 277 nm afterwhich a salt gradient of 50 mM 
NH4HCO3 at pH 9.3 to 0.3 M NH4HCO3  at pH 9.3 was applied to elute the peptide. 
The desired material was eluted in fractions 33-38 (330-390 ml, 0.17 M NH 4HCO3 ) 
These were combined and repeatedly lyophilised to give a white solid (92 mg). 
which was analysed by HPLC (C 8 RP300, gradient system A, R=15 mm., 40% B), 
amino acid analysis and IEF. 
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5. Semi-Preparative HPLC 
The synthetic material was further purified by semi-preparative HPLC on an 
Aquapore C8 reverse-phase column (100 x 10 mm, 20 gm, gradient system A) 
using a flow rate of 5 ml/min. Removal of the solvents by lyophilisation gave the 
title compound (81 mg, 3.9%) as judged by HPLC (C 8 RP300, gradient system A, 
R=15 mm., 40% B), amino acid analysis, IEF and electrospray mass spectrometry 
(see section 2.5.2). 
Synthesis of Human 52 Residue Carboxv-Extension Protein (CEP52) 
Fmoc-Lys(Boc)-OH was attached to the p-alkoxybenzyl alcohol resin via the 
symmetrical anhydride (0.104 mmol/g, 14% loading efficiency). The synthesis was 
carried out on the functionalised resin Fmoc-Lys(Boc)-(OCH 2C6H40R) on a 0.10 
mmol scale. The side-chains of amino acids were protected as previously described. 
All five cysteines were protected with the SBut group. Most amino acids were 
coupled once as a symmetrical anhydride followed by twice as an HOBt active 
ester. Exceptions to this were glycine which was single coupled as a symmetrical 
anhydride and histidine, glutarnine and asparagine which were each coupled three 
times as their HOBt active esters. All Fmoc deprotections were monitored in a 
continuous flow mode from the synthesiser to a UV detector set at 302 nm. The 
final Frnoc group was left on the resin-bound peptide, two thirds of which were 
stored for later use. Manual deprotection of the final Fmoc group was accomplished 
by treating the resin with 20% piperidine in DMF for 20 minutes. After washing 
well with DMF, DCM and diethyl ether the deprotected resin was dried in a 
dessicator overnight. The peptide was cleaved from the resin with simultaneous 
removal of side-chain protection (with the exception of the cysteine protection) in 
the following way. Dry resin (634.5 mg) was swollen in a mixture of anisole, 
phenol, ethanedithiol and ethyl methyl sulphide (1 ml of each, 5% v:v) for 30 
minutes under nitrogen before adding H20 0  ml, 5% v:v) and TFA (15 ml, 75% 
v:v). After stirring under nitrogen for the optimum time of 6 hours the resin was 
filtered off and washed with TFA (2 ml) (dry weight=335.8 mg). The combined 
washings and filtrate were then concentrated in vacuo and the crude peptide (299 
mg) was precipitated with diethyl ether. This was filtered off, dissolved in 30% 
aqueous acetic acid (20 ml) and applied to a Sephadex G50 column (90 x 2.5 cm) 
pre-equilibrated with the same buffer. The column was eluted with 30% acetic acid 
at 30 ml h- I with monitoring at 226 and 277 nm. The peptide was eluted in 
fractions 7-11 (70-120 ml). These fractions were combined and sequencially 
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dialysed (MWCO 2000 Da) against solutions (2 1) of 30% AcOH; 20% AcOH; 
10% AcOH and H20 for 24 hours each step. Following lyophilisation the cysteine 
t-butylthio protection was removed by Bu 3P treatment. The cysteine-protected 
peptide was dissolved in TFE (5 ml), H20 (0.25 ml) and Bu3P (0.3 ml) was added. 
The reaction was left stirring under nitrogen for 3 hours after which the solvent was 
removed in vacuo and the peptide filtered off and washed with diethyl ether. The 
fully deprotected peptide was immediately dissolved in a buffer containing 10 mM 
DTT and 50 mM NH4OAc at pH 6.0 (15 ml) and subjected to a second round of gel 
filtration on a Sephadex 050 column (90 x 2.5 cm) pre-equilibrated with the same 
buffer. Elution of the column with 10 mM DTT, 50 mM NH4OAc (pH 6.0) at 30 
ml h4  afforded the desired material in fractions 7-13 (70-140 ml). These fractions 
were combined and concentrated (20-30 ml) by lyophilisation. 
The peptide was purified by semi-preparative HPLC on an Aquapore C 8 reverse- 
phase column (100 x 10 mm, 20 j.tm, gradient system B) using a flow rate of 5 
ml/min. Removal of the solvents by lyophilisation gave the title compound (21 mg, 
3.4%) as judged by HPLC (C 8 RP300, gradient system A, R=14.5 mm., 38% B), 
amino acid analysis and electrospray mass spectrometry (see section 2.6.3). 
15 
The synthesis of UbCEP52 was carried out using the remaining two thirds of the 
Fmoc protected resin-bound CEP52. In effect the construction of UbCEP52 was a 
continuation of the initial CEP52 synthesis. The side-chains of amino acids were 
protected as previously described for ubiquitin. Most amino acids were coupled 
once as a symmetrical anhydride followed by twice as an HOBt active ester. 15N- 
glycine-76 was single coupled as an HOBt active ester, all other glycines were were 
single coupled as symmetrical anhydrides. Histidine, glutamine and asparagine 
were each coupled three times as their HOBt active esters. All Fmoc deprotections 
were monitored in a Continuous flow mode from the synthesiser to a UV detector 
set at 302 nm. The final Fmoc group was left on the resin-bound peptide 
(substitution 0.0135 mmol/g, 73% of theoretical maximum). Manual deprotection 
of the final Fmoc group was accomplished by treating the resin with 20% 
piperidine in DMF for 20 minutes. After washing well with DMF, DCM and 
diethyl ether the deprotected resin was dried in a dessicator overnight. The peptide 
was cleaved from the resin with simultaneous removal of side-chain protection 
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(with the exception of the cysteine protection) in the following way. Dry 
deprotected resin (768.1 mg) was swollen in a mixture of anisole, phenol, 
ethanedithiol and ethyl methyl sulphide (1 ml of each, 5% v:v) for 30 minutes 
under nitrogen before adding 11 20 (1 ml, 5% v:v) and TFA (15 ml, 75% v:v). After 
stirring under nitrogen for the optimum time of 6 hours the resin was filtered off 
and washed with TFA (2 ml) (dry weight=205.5 mg). The combined washings and 
filtrate were then concentrated in vacuo and the crude peptide (562.6 mg) was 
precipitated with diethyl ether.The synthetic protein was then suspended in a buffer 
containing 8 M urea and 50 mM NH 4OAc at pH 6.0 (20 ml) and stirred overnight 
to allow all the material to dissolve. The crude protein solution was then applied to 
a Sephadex G75 (superfine) column (90 x 2.5 cm) preequilibrated with running 
buffer and eluted with 8 M urea, 50 mM NH 40Ac (pH 6.0) at 30 ml h' with 
monitoring at 226 and 277 nm. The peptide was eluted in fractions 32-53 (320-540 
ml). These fractions were combined and sequencially dialysed (MWCO 10000 Da) 
against solutions (2 1) of 6 M urea, 50 mM NH 4OAc (pH 6.0); 4 M urea, 50 mM 
NH4OAc (pH 6.0) and 2 M urea, 50 mM NH 40Ac (pH 6.0) for 24 hours each step. 
As a final step the protein was dialysed against nitrogen saturated H 20 for 3 x 24 
hours before being lyophilised. The cysteine t-butylthio protection was removed by 
Bu3P treatment. The cysteine-protected peptide was dissolved in TFE (10 ml), H 20 
(0.50 ml) and Bu3P (0.50 ml) was added. The reaction was left stirring under 
nitrogen for 3 hours afterwhich the solvent was removed in vacuo and the peptide 
filtered off and washed with diethyl ether. The fully deprotected peptide was 
immediately dissolved in a buffer containing 10 mM DTT, 50 mM NH4OAc at pH 
6.0 (20 ml) and subjected to a second round of gel filtration on a Sephadex G50 
column (90 x 2.5 cm) pre-equilibrated with running buffer. Elution of the column 
with 10 mM DTT, 50 mM NH40Ac (pH 6.0) at 30 ml 0 afforded the desired 
material in fractions 5-12 (50-130 ml). These fractions were combined and 
repeatedly lyophilised. 
Initial small scale attempts at cation exchange were as follows. 
1. CM-Sepharose Cation Exchange Chromatography 
The fully deprotected synthetic material (5 mg) was dissolved in a buffer 
containing 10 mM DTT and 50 mM NH4HCO3 at pH 9.5 (2 ml) and applied to 
CM-Sepharose column (150 x 13 mm) previously equilibrated with the same 
buffer. A salt gradient of 10 mM DTT, 50 mM NH 4HCO3 at pH 9.5 to 10 mM 
DTT, 0.5 M NH4HCO3 at pH 9.5 was run at 15 ml h for 25 hours with 
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monitoring at 226 and 277 nm. This was followed by a second salt gradient of 0.5 
M NH4HCO3 (pH 9.5), 10 mM DDT to 1 M NH4HCO3 (pH 9.5), 10 mM 1YIT. No 
protein was observed to elute from the column during either of these gradients. 
2. Analytical Cation Exchange HPLC 
Cation exchange HPLC was performed on an Aquapore CX-300 column (100 x 4.6 
mm, 7 pm) employing a flow rate of 1 ml/min and monitoring at 280 nm. The 
protein dissolved in starting buffer was applied (30 jtl of a 1 mg/ml solution) to the 
column and a linear gradient of 0-100% B over 30 minutes carried out using each 
of the systems outlined below. 
A =50 mM NH40Ac at pH 4.0; B = 1 M NaCl, 50 mM NH 40Ac at pH 4.0. 
Synthetic material - did not elute form column. 
Bovine ubiquitin - R 1 = 9 mm., 30% B. 
A = 50 mM MOPS at pH 6.0; B = 1 M NaCl, 50 mM MOPS at pH 6.0. 
Synthetic material - did not elute from column. 
Bovine ubiquitin - R = 4.5 mm., 15% B. 
A =50 mM HEPES at pH 8.0; B = 1 M NaCl, 50 mM Hepes at pH 8.0. 
Synthetic material - did not elute from column. 
Bovine ubiquitin - R =0 mm., 0% B. 
A =50 mM Tricine at pH 9.5; B = 1 M NaCl, 50 mM Tricine at pH 9.5. 
Synthetic material - did not elute from column. 
A = 50 mM Bis-tris propane at pH 11.0; B = 1 M NaCl, 50 mM Bis-tris 
propane at pHi 1.0. 
Synthetic material - partially soluble at this pH, did elute as a broad band 
R=24min., 80% B. 
3. Heparin-Agarose Weak Cation Exchange Chromatography 
The synthetic protein (4 mg) was dissolved in a buffer containing 50 mM Tris.HC1 
at pH 8.0, 50 mM (N}i4 )2SO4 , 1 mM Dl"!' and 1 mM ZnCl2 (5 ml) and applied to a 
heparin-agarose column (80 x 13 mm) pre-equilibrated with the same buffer. A salt 
gradient of 50 mM Tris.HC1 at pH 8.0, 50 mM (NH4)2SO4 , 1 mM DTT and 1 mM 
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ZnC12 to 50 mM Tris.HC1 at pH 8.0, 600 mM (NH4 )2SO4, 1 mM DT7 and 1 mM 
ZnCl2 was run at 15 ml 0 for 22 hours. This was followed by a second salt 
gradient of 50 mM Tris.HC1 at pH 8.0, 600 mM (NH4)2SO4, 1 mM DTF and 1 mM 
ZnC12 to 2 M NaCl, 50 mM Tris.HC1 at pH 8.0, 600 mM (NH4)2S041  1 mM DTF 
and 1 mM ZnC12. HPLC analysis of the resulting fractions indicated no protein had 
eluted from the column during either gradient. 
Cation exchange chromatography was successfully carried out using the following 
system. 
4. CM-Sepharose Cation Exchange Chromatography 
The synthetic material (56 mg) was dissolved in a buffer containing 50 mM NH4C1, 
1 mM DTT, 0.1 mM ZnCl2  and 50 mM formic acid at pH 4.0 and applied to a CM- 
Sepharose column (320 x 18 mm) previously equilibrated with the same buffer. A 
salt gradient of 50 mM NH4C1, 1 mM D1'T, 0.1 mM ZnC12, 50 mM formic acid at 
pH 4.0 to 1.5 M NH4C1, 1 mM DTT, 0.1 mM ZnCI21  50 mM formic acid at pH 4.0 
was run at 30 ml h- I for 30 hours with simultaneous monitoring at 226 and 277 
nm. The desired material was eluted in fractions 43-47 (430-480 ml, approx. 1.1 M 
NH4C1). These fractions were combined and dialysed (MWCO 2000 Da) against 
water for 24 hours after which lyophilisation afforded a white solid (16 mg, 1.1%). 
Analysis by HPLC (C 8 RP300, gradient system A, R=15.7 mm., 42% B), amino 
acid analysis, SDS-PAGE, sequencing and laser desorption mass spectrometry 
indicated this was the required material (see section 2.6.5). 
Isoelectric Focussing Electrophoresis and Western Blotting 
All samples were dissolved in 50 mM Tris., pH 8.0 (1 mg/ml) of which 20 I.Ll 
aliquots were loaded onto a pre-focussed broad range pH 3.5-9.5 PAG plate gel 
(Pharmacia). Electrofocussing was then carried out at 18 mA, 5 W for 1000 Vh 
after which the gel was either Coomassie stained or prepared for electroblotting by 
placing in a transfer buffer containing 250 mM Tris., pH 8.3, 1.5 M glycine and 
20% v:v MeOH. After removal of the plastic backing from the gel the protein was 
electroeluted onto nitrocellulose for 2 h at 0.6 to 1.2 mA (LKB 2005 Transphor 
system). 
Following electroblotting the remaining sites on the nitrocellulose were blocked 
overnight in 10 mM Tris. pH 8.0, 400 mM NaCl (TBS) containing 20% by weight 
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dried milk. After washing with TBS (3 x 5 mm) the nitrocellulose was placed in 
TBS containing 5% w:v dried milk (30 ml) with rabbit anti-ubiquitin IgO 
polyclonal antibodies (5 p.1) and shaken overnight. The nitrocellulose was then 
washed with TBS (3 x 5 mm) before being treated with TBS (30 ml) containing 
anti-rabbit IgO horse-raddish peroxidase conjugated secondary antibodies (10 p.1, 
Sigma) and shaken for 2 hours. After washing well with TBS (3 x 10 mm) the 
secondary antibody was visualized by staining with a mixture of dianisidine (0.5 
ml, 5 mg/ml), imidazole (1 mg, 0.1 M pH 7.4), 30% H202 and H20 (8.4 ml). 
Total Enzymic Digestion 
Protein (1 mg) was dissolved in performic acid (100 p.1) at 0°C for 1 hour after 
which the solution was lyophilised and the resulting residue redissolved in 8 M 
urea, 5% formic acid (100 p.1) and left for 2 h. This solution was dialysed (MWCO 
500 Da) against 5% formic acid over 24 hours before being lyophilised. The 
resulting solid was taken up in 5% formic acid (100 p.1) and digested with pepsin 
(1% by wt, 25 p.1) for 24 hours after which a fresh aliquot of pepsin was added and 
the digestion allowed to proceed for a further 24 h. The solution was lyophilised 
and dissolved in 0.2 M NH4HCO3 at pH 7.75 (0.25 ml) with leucine 
aminopeptidase microsomal (2 U/mi, 15 p.1), prolidase (200 U/ml, 28.1 p.1) and 25 
mM MnC12 (50 p.1). The digestion was allowed to proceed for 48 h after which the 
solution was repeatedly lyophilised and the resulting residue was dissolved in pH 
2.2 citrate buffer (2 ml) for amino acid analysis. 
TrvDtic MaDDing 
Tryptic digestion was carried out according to the method of Cox et a! 196•  Protein 
(5 mg) was dissolved in 1 ml of a buffer containing 50 mM Tris. (pH 8.2), 6.5 M 
urea and 10 mM CaCl 2. Trypsin (5% w:w with the protein) was added and the 
digestion allowed to proceed for 4 hours at 37 0C before a further aliquot of trypsin 
(5% w:w) was added. After a total of 8 h digestion the protein solution was 
acidified to pH 2 with 6 M HC1 and stored at -20 0C until required. 
Peptide mapping was carried out with reverse-phase HPLC using a C 18 column 
(Vydac, 5 p.m, 250 x 4.1 mm) and the following solvent system. 
0.1% TFA, 0.1% TEA in H 20 
0.1% TFA, 0.1% TEA in 40% aqueous acetonitrile 
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The digest solution was injected onto the column in 20 41 aliquots and a linear 
gradient employed with a flow rate of 1 ml/min. The gradient began at 10% B for 2 
mm, rose to 70% B at 50 mm, and then to 100% B at 52.5 mm. It was then left to 
run isocratically at 100% B for 5 min and then re-equilibrated to 10% B. UV 
monitoring was carried Out at 205 nm (1.5 Aufs) and the peptide fragments were 
isolated in 1 ml fractions. These were lyophilised, dissolved in citrate buffer at pH 
2.2 and subjected to amino acid analysis for identification. 
Results obtained for Synthetic Ubiquitin 
Peptide R1 (mm) Amino Acid Analysis 
TO (28-29) 3.2 Ala 1 1.0:Lys 1 1.1 
Ti (30-33) 4.4 Asx 1 1.0 :G1x 1 1.1 :11e 1 0.9 :Lys 1 1.0 
T2 (73-76) 5.4 G1y2 1.8 :Leu 1 1.12 :Arg 1 0.9 
T3 (7-11) 8.8 -'2 1.9 :G1y 1 1.0 :Leu 1 1.0 :Lys 1 1.0 
T4 (49-54) 11.0 ASX 1 1.0 :G1x2 2.2 :Gly 1 1.0 :Leu 1 0.9 :Arg 1 0.9 
T5 (34-42) 16.6 Asx 1 	1.2 :G1x3 2.7 :GIy i 	1.0 :Pro2 2.3 	:11e 1 0.9 
:Arg 1 0.9 
T6 (55-63) 28.0 Asx2 2.1 :Thr 1 1.0 :Ser 1 0.9 :G1x 1 1.4 :11e 1 1.0 :Leu 1 
1.0 :Tyr 1 0.9 :Lys 1 1.0 
T7 (43-48) 34.0 01YJ 1.2 :A1a 1 1.0 :11e 1 0.9 :Leu 1 1.0 :Phe 1 0.9 :Lys 1 
1.0 
T8 (1-6) 37.6 G1x 1 1.3 :Va1 1 1.0 :Met 1 0.7 :11e 1 0.9 :Phe 1 0.9 :Lys 1 
0.9 
T9 (12-27) 42.4 Asx2 2.2 :Thr3 2.6 :Ser 1 1.0 :G1x3 3.6 :Pro, 1.3 :Va12 
2.0 :lle.2 1.9 :Leu 1 1.1 :Lys 1 1.0 
T10 (64-72) 43.6 Thr1 1.0 :Ser 1 1.0 :G1x 1 1.6 :Va1 1 1.2 :Leu3 2.8 :His 1 
1.0 :Arg 1 1.0 
Figures given in parenthesis are residue numbers 
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Results for Ubdes-Core 
Peptide R (mm) Amino Acid Analysis 
T0(28.29) 4.2 Ala 1 i.1:Lys 1 1.1 
Ti (49-54) 4.2 Asx 1 1.1 :G1x2 2.2:G1y2 2.8:Arg 1 0.9 
T2 (7.11) 9.3 Thr 1.7 :GIy 1 1.3 :Leu 1 0.9 :Lys 1 1.0 
T3 (30-42) 16.5 Asx2 2.6 :G1x4 4.2 :G1y 1 1.7 :Pro2 1.8 Ala 1 1.0 :11e 1 
1.0: Lys 1 1.0 :Arg 1 0.9 
T4 (55-63) 19.0 Asx2 2.2 :Thr1 0.9 :Ser3 0.9 :G1x 1 1.6 Gly 1 1.1 :11e 1 
0.8 :Tyr 1 0.5 :Lys 1 1.0 
T5 (43-48) 27.3 01Y2 2•° :A1a 1 1.0 :11e 1 0.9 :Phe 1 1.0 :Lys 1 1.1 
T6 (64-72) 28.8 Thr1 0.9 :Ser 1 0.9 :G1x 1 1.2 G1y 1 1.3 :Va1 1 0.8 :Leu2  
2.3 :His 1 0.9 :Arg 1 1.0 
T7 (1-6) 33.0 G1x 1 1.5 :G1y 1 1.3 :Met 1 - :11e 1 1.0 :Phe 1 0.9 :Lys 1 
T8 (12-27) 38.0 Asx2 2.4 :Thr3 3.1 :Ser 1 1.0 :G1x3 3.0 :Pro, 1.3 :A1a 1 
1.0: Val 	0.9:11e2 1.7 :Leu 1 1.1 :Lys 1 1.2 
Figures given in parenthesis are residue numbers 
Crystals of purified synthetic ubiquitin were reproducibly obtained from a vapour 
diffusion (hanging drop) experiment in which the synthetic solution was seeded 
with a natural ubiquitin crystal. Several large natural ubiquitin crystals were 
supplied by Dr W.J. Cook (University of Alabama Medical School). One such 
crystal was carefully added to a single 10 p.1 drop containing 5 p.1 of concentrated 
synthetic ubiquitin solution (20 mg/ml in H 20) and 5 p.1 from the well solution 
which contained 30% (w:v) polyethylene glycol 4000 (PEG4000) in 50 mM 
cacodylate-HC1 (pH 5.6). Small single crystals formed independently of the seed 
crystal in the original drop and were transferred into fresh drops of the same 
composition for further growing. These crystals were then removed from the 
second drop and put into fresh ones containing PEG4000 at a concentration of 25% 




Attempts were made at the crystallization of purified Ubdes-Core without initial 
seeding using the vapour diffusion (hanging drop) technique. In each case the 10 p.1 
hanging drop contained 5 p.1 of concentrated Ubdes-Core solution (10 mg/ml in 
H20) and 5 p.1 from the well solution. The following 18 well solutions were 
screened: 
50 mM cacodylate-HC1 (pH 5.0) containing 36, 38 and 40% (w:v) PEG4000 
50 mM cacodylate-HCI (pH 5.2) containing 36, 38 and 40% (w:v) PEG4000 
50 mM cacodylate-HC1 (pH 5.4) containing 36, 38 and 40% (w:v) PEG4000 
50 mM cacodylate-HC1 (pH 5.6) containing 36, 38 and 40% (w:v) PEG4000 
50 mM cacodylate-HC1 (pH 5.8) containing 36, 38 and 40% (w:v) PEG4000 
50 mM cacodylate-HC1 (pH 6.0) containing 36, 38 and 40% (w:v) PEG4000 
No crystals of Ubdes-Core were grown under any of the above conditions. 
Fast Protein Linuid Chromatogranhv (FPLC1 Studies on the Partial 
Unfolding of Bovine and Synthetic Ubiauitin 
Protein was dissolved in 20 mM piperazine at pH 9.6 (1 mg/ml, 0.116 mM) and 
incubated at 250C. Aliquots (100 p.1) of this solution were periodically analysed by 
FPLC using a Mono Q anion exchange column (Pharmacia, HR 515, 10 p.m) and 
the following solvent system: 
A =20 mM piperazine at pH 9.6. 
B = 20 mM piperazine at pH 9.6, 1 M NaCl. 
The protein was eluted from the column using a linear salt gradient with a flow rate 
of 0.5 ml/min. The gradient began at 0% B for 6 mm, rose to 40% B at 70 mm, and 
then to 100 % B at 76 min before being re-equilibrated at 0% B. UV monitoring 
was carried out at 280 nm (Aufs=0.05). R of native ubiquitin = 21 mm., 12% B 
and P., of denatured ubiquitin = 22 mm., 13.5% B. 
SDectroDhotometric Titration of the Phenolic Group in Tyrosine 
Measurements of pH were made on a Corning Ion Analyzer 150 calibrated with 
standard buffer solutions (Whatman) at pH 7.0 and 10.0. All measurements were 
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accurate to ± 0.01 of a pH unit. UV absorption measurements were carried out 
using 3 ml quartz cuvettes of light path 10 mm. The temperature of the cell was 
maintained at 25 or 350C by circulating water from a thermostatic bath at the 
appropriate temperature. All £295 values are accurate to within ± 75 dm3 mo!-1 
cm 
Protein was dissolved in 0.16 M KC1 solution (0.5 mg/ml) and the pH altered to 
around 7.0 by the careful addition of the appropriate amount of 0.1 M HCJ or 0.5 M 
KOH. The UV absorbance of this solution was then measured in the range 400-229 
nm (Aufs=0.5). The pH of the protein solution was then slowly increased in 
increments of around 0.5 by addition of 0.5 M KOH and at each stage a UV 
spectrum recorded. The temperature of the protein solution was maintained at either 
25 or 350C between successive UV measurements. All absorbance measurements 
were corrected for the gradual dilution of the protein solution caused by addition of 
the base. The data are presented as plots of £295 vs. pH. 
Spectra were recorded in the region 240-190 nm at 250C. Samples were dissolved 
in 50 mM boric acid (pH 6.0 or 7.0 as indicated in the text) containing the additives 
referred to in the text. Protein concentrations were typically 50 iM. 
Fluorescence Ouenching Studies 
Solutions of protein (50 tM) in 50 mM NH4OAc (pH 6.0), 0.16 M KC1 were 
incubated for 45 minutes (250C) with 0-1 M K!. Na2S203 was added to a 
concentration of 0.1 mM to prevent formation of 1 3-. Fluorescence emission was 
monitored at 250C at 303 nm with excitation at 280 nm (Em./Ex. slit width =5 nm) 
and expressed as F°IF where F° is fluorescence of the protein in the absence of 
quencher. The data are presented as direct Stern-Volmer plots of F°/F vs. quencher 
concentration. 
All experiments used highly purified enzyme grade guanidinium hydrochloride 
(GdmCl) purchased from Life Technologies Inc. The buffer used in all denaturation 
experiments was 4-morpholinepropanesulphonic acid (MOPS) from Sigma. The 
MOPS sock solution was made to 50 mM at pH 7.0 using Milli-Q HPLC grade 
water. The guanidinium hydrochloride stock solution was prepared gravimetrically 
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in volumetric flasks with MOPS buffer and stored at room temperature. The 
molarity of the GdmCl stock solution was determined using refractive index 
measurements and the following equation 228: 
Molarity = 157.147 x (AN)) + (38.68 x (AN)2 ) - (91.60 x (AN) 3 ) 
where AN is the difference in refractive index between the denaturant solution and 
the buffer. All protein stock solutions (100 i.LM) were prepared with MOPS stock 
buffer. For each data point in the chemical denaturation experiments, 100 .tl of 
protein stock solution was added to the appropriate amount of GdmCl stock 
solution and the final volume made to 1 ml with MOPS stock solution. All volumes 
were measured using Gilson micropipettes (accuracy ± 0.8%). The final 
concentration of protein solution was 10 xM. All protein/denaturant solutions were 
preequilibrated at 25 0C for 1-2 hours before any fluorescence measurements were 
made. Fluorescence emission was monitored at 303 nm with excitation at 280 nm 
(Em./Ex. slit width = 5 nm). Thermostated cuvette holders at 250C were used to 
maintain the temperature during all spectroscopic measurements. All fluorescence 
measurements were reproducible to within ± 1 of a fluorescence unit. The data are 
presented as unfolding curves of fluorescence vs. denaturant concentration. All 
unfolding curves were found to be reversible by diluting samples of unfolded 
protein to low GdmCl concentration and measuring the recovery of fluorescence. 
Elimans Assay for Free Thiol Groups 
CEP52 or UbCEP52 were reduced by treatment with DTT. The peptide was 
dissolved in a buffer containing 50 mM Tris., pH 7.2, 10 mM DTT, 10 mM EDTA 
and sonicated overnight at 400C. The reduced peptide was purified by semi-
preparative HPLC (C 8 RP300, 100 x 10 mm, 20 gm, gradient system A), 
lyophilised and stored at -20 0C. 
The number of free thiols was determined by the reaction with 5,5'-dithiobis(o-
nitrobenzoic acid) (DTNB) 222 The peptide (0.5-2.0 mg) was dissolved in 2.5 ml 
denaturant buffer containing 0.1 M Tns. at pH 8.0, 8 M urea and 0.01 M EDTA. A 
solution containing 10 mM DTNB in 50 mM sodium phosphate at pH 7.0 (100 Ill) 




Immediately after reduction: requires 9.70 x 10 -6 mol dm-3  
found 9.17 x 106 mol dm -3  
After 1 hour in water: 	requires 2.20 x iø mol dm -3  
found 1.03 x 10-4 mol dm-3 
After 24 hours in water: 	requires 1.16 x iO" mol dm -3  
found 2.66 x 10-5 mol dm-3 
UbCEP52 
requires 7.05 x 10-5 mol dm-3  
found 1.89 x 10-6 mol dm-3 
Cobalt (II) Binding Studies 
CEP52 or UbCEP52 were reduced by treatment with DTT. The peptide was 
dissolved in a buffer containing 50 mM Tris., pH 7.2, 10 mM DTT, 10 mM EDTA 
and sonicated overnight at 400C. The reduced peptide was purified by semi-
preparative HPLC (C 8  RP300, 100 x 10 mm, 20 gm, gradient system A), 
lyophilised and stored at -200C. 
Lyophilised peptide was dissolved in a buffer containing 50 mM Tris. (pH 7.2) and 
100 mM NaCl. The peptide concentration was 50 l.LM in the case of CEP52 and 
25.tM for UbCEP52. The UV spectrum of the peptide solution in the region 700-
250 nm (Aufs=0.5) was then recorded. CoC1 2 solution (10 jil, 1 equiv) was then 
added and the UV spectrum of the peptide solution recorded. This was repeated for 
5 equivalents (50 p1) of CoC12  solution. In each case the spectrum of free Cod 2 
was subtracted from the spectrum of the peptide solution. 
Appendix 1 
ADDendix 1 -111 NMR Assignments of Synthetic Ubiciuitin 
'H NMR assignments of synthetic mammalian ubiquitin. 20 mg m1' protein in 
90% H20: 10% D20 at pH 4.8. Spectrum acquired at 500C on the 600 MHz 
spectrometer. ö (OH, H20) 4.8 ppm. 
Na a 0 0 ,  7 Y 6 6' C NW 
MI  4.26 2.30 N N N 
Q2 8.99 5.43 2.17 1.88 2.42 2.42  
13 8.54 4.36 N  0.82 N N N 
F4 8.77 5.80 3.24 3.06 7.08  7.27  7.42 
V5 9.46 5.03 2.10  0.92 0.88 1 
K6 9.17 5.45 1.91 1.88 1.60 1.48 1.77 1.63 3.09 
Ti 8.89 5.15 4.97  1.37  
L8 9.12 4.52 1.99 N 2.11  1.26 1.19  
T9 7.79 4.63 4.79  1.48  
010 8.00 4.55 3.80  
KII 7.44 4.56 1.98 1.98 1.60 1.44 1.90 1.85 3.12 
T12 8.70 5.28 4.14  1.27  
113 9.71 4.70 2.07  1.31 N 0.92 1.06  
T14 8.78 5.15 4.23  1.32  
L15 8.90 4.94 1.54 1.44 1.62  0.94 0.89  
E16 8.25 5.08 N N N N 
V17 9.08 4.88 2.54  0.93 0.66  
E18 8.86 5.26 1.97 2.38 2.61 2.50  
P19  4.34 2.61 2.22 2.41 2.25 4.21 4.00  
S20 7.23 4.57 4.35 3.98  
D21 8.21 4.89 3.15 2.72  
T22 8.02 5.12 4.98  1.46  
123 8.67 3.83 2.64 0.98 N N N 
E24 N 4.10 2.27 2.23 2.60 2.54  
N25 8.09 4.74 3.38 3.07  N 
V26 8.27 3.60 2.54  1.18 0.89  
K27 N N N N N N N N N 
A28 8.18 4.36 1.83 	1 
K29 8.06 4.39 2.34 2.32 1.78 1.68 2.12 1.99 N 
130 8.44 3.70 2.54  0.87 0.87 1.07 N 
Q31 8.73 4.02 2.68 2.16 2.47 2.47 N 
D32 8.14 4.55 3.04 2.94  
K33 7.65 4.52 2.21 2.21 1.91 1.80 2.04 2.04 N 
E34 8.89 N 2.44 1.88 2.35 2.26  
035 8.65 4.33 4.13  
136 6.37 4.63 1.60 1.28 1.13 0.98 1.65  
P37 4.82 2.62 2.20 2.27 2.27 4.37 3.77  
P38 4.32 2.42 2.27 2.42 1.86 N 3.97  
D39 8.68 4.63 2.96 2.88  
040 7.98 4.67 2.02 2.02 	1 2.60 2.60  N 
Q41 7.63 4.42 2.13 2.10 2.72 2.72  N 
R42 8.67 4.68 1.88 1.83 1.70 1.61 3.32 3.26  
L43 8.95 5.55 1.77 1.67 1.37  
144 	1 9.32 5.12 1.95 	1 N 0.88 	1 0.88 	1  
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F45 9.04 5.35 3.19 3.01 7.67  7.55  7.73  
A46 8.94 3.89 1.10  
G47 8.14 4.31 3.64  
K48 8.19 N 2.10 2.10 1.72 1.72 2.06 2.06 3.38  
049 1 8.73 N 2.44 2.15 1 2.19 2.19  N 
L50 8.71 4.27 N 1.22 1.65  0.71 0.06  
ES! 8.47 4.68 2.42 2.15 2.62 2.52  
D52 8.25 4.57 2.84 2.72  
G53 9.50 4.39 4.54  
R54 7.63 4.94 2.43 2.43 2.29 1.86 3.35 3.28  7.27 
T55 9.02 5.42 N  1.34  N N 
L56 8.36 4.26 2.29 1.45 N  N N 
S57 8.61 4.45 4.05 3.96  
D58 8.10 4.49 3.17 2.47  
Y59 7.46 4.87 3.65 2.73 7.32  7.03  
N60 8.34 4.55 3.50 2.99  N 
161 7.39 3.59 1.59  0.68 0.58 0.68 0.04  
Q62 7.72 4.68 2.45 2.09 2.57 2.52  N 
K63 8.57 4.17 2.23 2.10 1.68 1.68 1.92 1.92 3.26  
E64 9.43 3.52 2.59 N 2.42 N 
S65 7.84 4.86 4.10 3.85  
T66 8.79 5.48 4.25  1.16  
L67 9.57 5.27 1.83 1.82 1.96 0.87 0.87  
H68 9.39 5.35 3.06 3.24  7.01  8.02  
L69 8.49 5.36 1.83 1.28 1.54 1.05 0.94  
V70 9.31 4.56 2.24  1.04 1.13  
L71 8.13 5.24 1.84 1.73 1.88 1.16 1.05  
R72 8.74 4.47 1.75 1.96 1.70 1.70 3.34 3.34  7.27 
L73 8.38 4.60 1.85 1.78 1.65  1.12 1.08  
R74 8.49 4.50 2.07 1.98 1.86 1.82 3.42 3.38  7.41 
G75 8.52 4.17 4.17  
076 8.02 	f 4.00 3.93  




A data set to a maximum resolution of 1.6 A° was collected from one crystal using 
a Siemens-Nicholet-Xentronic area detector on a Rigaku rotating anode generator 
RU200 operating at 40 kV, 100 mA and fitted with a graphite monochromator to 
select Cu-Ka radiation. There were 14404 observations representing 6322 unique 
reflections to 1.6 A°. The data were reduced using the Xengen v.1.3 program to 
give an unweighted absolute value for the R-merge on intensity of 5.3%. Because 
of the poor quality of the weak reflections at high resolution, the data were 
restricted to 1.8 A° resolution thus providing 5058 out of a possible 6050 
reflections which represents 85% of the expected diffraction pattern. After a 1c(I) 
cutoff was applied, 4349 reflections in the range between 6.0 and 1.8 A° were left 
for model refinement. In comparison, the final refinement of the original model of 
the natural ubiquitin was based upon 5554 reflections in the same range with a 
similar c(I) cutoff, indicating that the weak reflections in that study were measured 
more accurately. In order to minimize the possibility that significant differences in 
structure were the result of different ambient conditions between Edinburgh and 
Alabama, data was collected from a crystal of the natural ubiquitin to a similar 
resolution using a Siemens-Stoe AED-24-circle diffractometer and graphite-
monochromated, Cu-Kct radiation from a sealed beam tube operating at 50 kV, 35 
mA. 4295 reflections were collected. 
Data Set Comparison 
Comparison of the synthetic and natural ubiquitin structure factors with those from 
the published model for natural ubiquitin and 58 associated water molecules 
(1UBQ in the Brookhaven Databank), revealed that the data collected for the 
synthetic protein conform to the model somewhat better than the data collected 
from the natural ubiquitin crystal; Rsyn-mod = 18.3% and Rnat-mod = 19.8%. 
After model temperature factor refinement, the R-factor dropped to 17.1% for the 
synthetic data set, which is close to the final R-index for the original model of 
17.6%. 
To reduce the influence of the model upon the phases, and so reveal possible real 
minor differences between native and synthetic ubiquitin, experimental data sets 
were compared directly rather than each of them to the model structure factors. 
Rsyn-nat was found to be 10.4% confirming the high overall similarity of the 
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structures. This value is somewhat higher than expected but reflects the comparison 
of a data-set collected serially (natural) with one collected on an area detector. 
To estimate the size of differences, (2[Fsyn]-[Fnat]) Fourier synthesis and 
difference ([Fsyn] - [Fnat]) synthesis were compared. The phases derived from the 
natural ubiquitin model before refinement with the data collected in this work, were 
used. The maximum of the difference map was found to be 5 times lower than 
r.m.s. deviation of the first synthesis suggesting that the synthetic and natural 
protein structures are indistinguishable at this resolution. 
Model Refinement 
The molecular model of native ubiquitin was taken from the Brookhaven databank 
and used as a starting model. Careful inspection of the (2[Fsyn-Fnat]) density map 
revealed that the conformation of some of the side-chains, and the position of some 
of the water molecules could be improved. The model was therefore refined using 
release 4 of the TNT restrained least-squares procedure. 4349 reflections were used 
for TNT refinement and the set of 5031 reflections including poorly measured 
weak reflections was used for electron density calculation in the resolution range 
6.0 to 1.8 A°. After every round of refinement (10 cycles), the (2[Fo]-[Fc]) and 
difference Fourier maps were inspected and adjusted using the program FRODO 
running on an ESV 10/20 molecular graphics workstation. Water molecules were 
added during this process. Because the last 3 residues at the C-terminus are very 
flexible and therefore poorly defined, throughout the refinement their positions and 
occupancies were fixed as in the original model. The positions of the 2 C-terminal 
residues previously determined were based on the difference map between the 
whole ubiquitin molecule and that with the last 2 removed since the calculated 
phases are more reliable than if based on the data collected from ubiquitin-76 only. 
Each round of refinement consisited of 5 cycles of positional refinement for the 
non-hydrogen atoms in the protein and water molecules, followed by 5 subsequent 
cycles of temperature factor and occupancy refinement. All positive peaks in the 
(2[Fo]-[Fc}) and ([Fo] - [Fc]) Fourier maps higher than the la level that were not 
already covering model atoms were examined. Water molecules were added to the 
model only if they occupied stereochemically reasonable positions. After 6 rounds 
of refinement the model had converged to R=16.5%. 
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